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 Helicobacter pylori is the major bacterial colonizer of the human stomach.  It is 
estimated that approximately 50% of humans worldwide are chronically infected with this 
bacterium.  Epidemiologically, H. pylori is recognized as the major risk factor and 
etiological agent of peptic ulcer disease and gastric adenocarcinoma.  Most animal 
models utilized for evaluating H. pylori infection have examined the gastric effects of 
chronic infection with regard to ulcer and cancer development.  However, interest into 
the potential extra-gastric influences of chronic H. pylori infection has been growing in 
the field.  Utilizing a Sprague-Dawley rat based model for chronic H. pylori infection, the 
role of chronic infection in the development of systemic and neuro-inflammation was 
evaluated.  High sensitivity ELISA assays were utilized to determine the change in key 
inflammatory markers locally within the stomach, systemically in the plasma and within 
the liver and the spleen, and within the central nervous system in the hippocampus and 
cerebellum.  Eradication studies were conducted to determine the causal relationship 
between H. pylori infection and observed levels of inflammation.  Finally, cognitive 
behavioral studies were conducted to evaluate the potential influence of chronic H. pylori 
infection on cognitive function and health.  Altogether, these studies illustrate a model by 
which chronic infection established during early life modulates the immune system 
response to generate a mild, but chronically sustained, systemic and neuro-inflammatory 
state which is associated with impairment of pre-frontal cortex mediated cognition.  
Furthermore, it is proposed that the development of these cognitive impairments arise 
during key developmental windows resulting in persistence of the impairment after 
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Chapter 1: Introduction 
1.1 Microbiota-Gut-Brain Axis 
The gut-brain axis was initially proposed by psychologists and psychiatrists in the 
later nineteenth and early twentieth century236,237 based on the empirical observations of 
emotions influencing gastrointestinal activity57 as well as abdominal pain syndromes 
modulating emotional responses180.  Modern examination into the interactions between 
the central nervous system (CNS) and the gastrointestinal tract began with the discovery 
of the enteric nervous system126,127,138,149.  Despite the enteric nervous system’s early 
characterization of independence from the CNS115,391, progress in understanding its role 
in physiology has revealed aspects of the complexities of its intercommunication with the 
CNS206.  Interactions along the gut-brain axis can be broadly grouped into three 
categories based on the physiological mode of communication: neuronal, hormonal, and 
immunological.  The microbiota acts as both a moderator and a direct participant in 
these process by varied mechanisms including interactions with the vagus 
nerve35,48,86,134, secretion of metabolites which have neuroactive properties152,216,363, 
release of tryptophan metabolism intermediates which serve as precursors for the 
production of the neurotransmitter serotonin61,321, and active stimulation of the innate 
immune response82,97,350. 
Animal studies evaluating the microbiota-gut-brain axis have largely focused on 
evaluation of behavioral disorders, such as anxiety and depression120.  Physiologically, 
clinical major depressive episodes have been associated with pathogenic modulation of 
the hypothalamic-pituitary-adrenal (HPA) axis29 and restoration of normal activity with 
resolution of the depressive episode163,270.  Linkage to the microbiota-gut-brain axis was 
found in the form of endocrine studies comparing germ free (GF) mice with specific 
pathogen free (SPF) mice.  GF mice possess no microbiota and have suppressed 
immunological function while their SPF counterparts possess both a normal microbiota 
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as well as normal functioning immune system45,218,219,365.  GF mice were characterized to 
have an exaggerated stress response, similar to that seen during major depressive 
episodes62,269,354.  Inoculating GF mice with normal microbiota from SPF mice led to the 
normalization of HPA axis regulation34,62,160,268.  In disease models, administration of 
Lactobacilli and Bifidobacteria was associated with relief of pain due to stress and 
irritable bowel syndrome5,130,241,320,382.  Additionally, oral administration of low levels of 
gut bacterial pathogen was associated with increased anxiety-like behavior34,147,214.  The 
major modalities of interaction utilized by the microbiota-gut-brain axis are neuronal, 
hormonal, and immunological.  While these processes are often considered as separate 
and distinct for the sake of clarity, physiology relies on the active integration of each of 
these processes in order to maintain stable homeostasis. 
 
1.1.1 Influence of neuronal communication. 
 Neuronal communication within the gut-brain axis can be divided broadly into two 
categories based on the location of the cell body of the innervating neuron.  Extrinsic 
neurons are those whose cell bodies reside within the central nervous system, 
principally the vagal and spinal afferents.  The intrinsic primary afferent neurons (IPANs) 
reside within the gut63.  IPANs form extensive self-reinforcing networks of reflex loops199.  
It is estimated that the IPANs account for an estimated 100 million connections to the 
human gut, in comparison to the 50 thousand connections from the extrinsic neurons127.  
Both the extrinsic neurons and IPANs contribute to maintaining the gastrointestinal 
homeostasis via modulation of complex reflex loops during internal perturbations127.  
While both extrinsic neurons and IPANs transmit information relating to chemical and 
mechanical stimuli, IPANs interact with enteric ganglia to regulate activity via intramural 
reflexes; extrinsic neurons integrate information into mesenteric, spinal, and supraspinal 
reflexes within the central nervous system150,213,298. 
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 Of the extrinsic neurons, those belonging to the vagus nerve are the most well 
studied and understood.  The vagus nerve provides both efferent and afferent 
parasympathetic innervation to the majority of the digestive system, with the exception of 
the most distal aspects of the small intestine, descending colon and rectum which 
receive parasympathetic innervation from the sacral nerves.  Subpopulations of vagal 
afferents terminate in close proximity to endocrine-like cells of the gastrointestinal 
tract139.  Receptors on these neurons have been shown to be responsive to many of the 
small peptides with endocrine-like properties that are secreted by the gut, such as 
peptide YY52,161 and ghrelin83,84.  Expression of these receptors has been found to vary 
based on nutritional status86 as well as by fasting87,94.  It has been hypothesized that 
interaction between the vagus nerve and these small peptides allows for rapid signaling 
of satiety and energy status within the central nervous system83,314,343.   
  Vagal afferents have also been shown to associate with immune cells of 
digestive system28.  These neurons have been shown to a variety of immune cell 
secreted factors, including histamine and inflammatory cytokines345.  Stimulation of the 
vagus nerve by cytokines followed by vagal suppression of cytokine production forms 
the basis for the inflammatory reflex369.  Absence of this vital reflex results in excessive 
innate immune system activity and cytokine toxicity47,384.  The vagus nerve and the 
inflammatory reflex play an important role in suppressing postprandial inflammation that 
naturally develops following high-fat or high-fat and high-carbohydrate meals108,141,156.  
Stimulation of vagal efferents resulted in inhibition of TNF-α production by the liver and 
prevented the development of shock in rats suffering from lethal endotoxemia46.  While 
vagal efferents may act to suppress inflammation, the stimulation of vagal afferents has 
been shown to induce IL-1ß expression within the central nervous system as well as 
stimulate glucocorticoid production via the HPA axis170.  Behaviorally, subdiaphragmatic 
vagotomy has been associated with attenuation of fever225,337, food-motivated behavior49, 
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and taste aversion learning in rodent148.  Within the central nervous system, vagotomy 
has been associated with depletion of hypothalamic norepinephrine secreting neurons117 
and reduced IL-1ß production in response to systemic LPS administration201. 
 
1.1.2 Influence of hormonal communication. 
 Many small peptides with endocrine-like properties are secreted by the gut.  In 
the treatment of type 2 diabetes mellitus, drugs mimicking glucagon like peptide-1 
(GPL1) have been utilized as they increase glucose-induced insulin secretion95,168.   The 
small peptides oxyntomodulin (XON)64, ghrelin185, and peptide YY (PYY)74 plays varying 
roles in modulating satiety and regulating energy homeostasis.  PYY and ghrelin are the 
most well studied of these gut secreted hormone-like peptides.  PYY is released 
postprandially, crosses the blood-brain barrier into the accurate nucleus, and binds to 
the Y2 receptor of neuropeptide Y neurons in the hypothalamus, resulting in inhibition of 
food intake30,312.  Intravenous administration of PYY in both humans and animals has 
been shown to reduce food intake31.  Using functional MRI studies in humans, elevated 
serum PYY was associated with increased activity in corticolimbic and reduced activity in 
homeostatic regions32.  In contrast, low circulating levels of PYY were associated with 
activation of hypothalamic homeostatic regions.  This has led to the hypothesis that 
postprandial PYY level switch food intake regulation from homeostatic to hedonic, 
corticolimbic regions32.   
 Ghrelin is secreted in response to emptying of the stomach, crosses the blood-
brain barrier, and binds to the growth hormone secretagogue rector of the hypothalamic 
ventromedial nucleus and arcuate nucleus27,191,368 where is increases food intake.  
Ghrelin levels increase in the preprandial state and decrease postprandially12,75,374.  In 
humans, ghrelin levels have been observed to correlate with hunger scores in humans73.  
In addition to short-term satiety signaling, ghrelin has been implicated in long-term 
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energy balance.  In rodents, daily administration of ghrelin led to decreased energy 
expenditures, leading to reduced fat utilization373.  Finally, ghrelin is capable of regulating 
growth hormone release independently of its main regulation by pituitary growth-
hormone-releasing hormone188. 
 More broadly, the gut-brain axis interacts with the hypothalamic-pituitary-adrenal 
(HPA) axis.  The HPA axis plays a key role in regulating stress, in addition to modulating 
a diverse set of somatic processes ranging from immune function to mood and emotion 
to energy storage and expenditure317.  In brief, the hypothalamus releases corticotropin-
releasing hormone and vasopressin.  In turn, these stimulate the release of 
adrenocorticotropic hormone from the anterior pituitary which act at the adrenal cortex to 
stimulate the release of glucocorticoid hormones, principally cortisol.  Both PYY and 
ghrelin are hypothesized to generate many of their associate physiological responses by 
influencing the actions of the HPA axis145,169,175,196,347.  Empirically, many of the 
observations for the influence of the microbiota on the gut-brain axis have been via 
modulation of the HPA axis.  For example, germ free animals were found to have 
exaggerated stress responses, in the form of elevated cortisol levels62,269,354.  
Reconstitution of the gut microbiota was associated with a normalization of cortisol 
release in response to stressors34,62,160,268.   
 
1.1.3 Influence of immunological communication. 
 It has been estimated that 70-80% of a human’s immune cells reside within gut-
associated lymphoid tissue.  As the columnar intestinal epithelial cells for a barrier 
between the lumen of the gut and host, specialized lymphoid structures, Peyer’s 
patches, allow for immunological sampling of the luminal space14.  Dendritic cells, 
expressing a wide-range of pattern recognition receptors, are able to extend processes 
into the gut lumen and sample antigens and microorganisms present244.  Vagal afferent 
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processes in close proximity are able to respond to the release of signaling molecules 
released by both mast cell and resident macrtophagers28.  Similarly, the hormones 
secreted by enteroendrocrine cells of the gut are modulated by exposure inflammatory 
signaling molecules, such as cholecystokinin whose secretion is upregulated during gut 
inflammation240.  Likewise, serotonin production by enterochromaffin cells is upregulated 
following exposure to inflammatory signals235.       
 In mice, gastrointestinal inflammation due to Campylobacter jejuni infection has 
been associated with an increase in anxiety-like behavior, even in the absence of a 
systemic inflammatory response215.  Low pathogenic load infections by Citrobacter 
rodentium and C. jejuni were still associated with increased anxiety-like behavior in mice 
despite no significant change in plasma cytokine levels or intestinal inflammation147,214.  
Unsurprisingly, increased gastrointestinal inflammation was associated with a notable 
increase in anxiety-like behavior35,37.  Inoculation with Bifidobacterium longum has been 
shown to have to propensity to ameliorate gastrointestinal pathogen associated anxiety-
like behavior35,37.      
  
1.1.4 The stomach as part of the gut-brain axis. 
 Classically, the “gut” aspect of the microbiota-gut-brain axis has referred to the 
small and large intestines.  Direct neuronal communication between the stomach and 
the brain is primarily mediated via the vagus nerve.  Gastric vagal afferent processes 
have been mapped to the dorsal motor nucleus with additional projections reaching the 
nucleus of the solitary tract340.  Projections to the nucleus of the solitary tract allow for 
both vagovagal reflexes247,313 as well as integration of chemosensory and 
mechanosensory information to the hypothalamus172.  Studies in rats have indicated that 
suppression of vagal afferent signaling blocked ghrelin-induced feeding, secretion of 
growth hormone, and activation of growth hormone-releasing hormone-producing 
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neurons83.  Vagal efferent process release acetylcholine in close proximity to parietal 
cells, stimulating the production and release of gastric acid4.  Hormonally, the stomach 
acts as both a paracrine organ as well as an endocrine organ. As a paracrine organ, the 
G cells of the gastric epithelium secrete gastrin which acts locally on mast to trigger 
histamine release which acts on parietal cells to stimulate the production and secretion 
of gastric acid325.  In turn, gastric acid stimulated D cells of the gastric epithelium to 
produce and secrete somatostatin, which acts to suppress gastric acid production322.  As 
an endocrine organ, the stomach is the major site of ghrelin production and release.  
Ghrelin acts both to induce feeding as well as to promote growth hormone 
release75,188,392.  Both major actions of ghrelin are mediated in the short-term by 
interaction with local receptors present on afferent processes of the vagus nerve83,84.  In 
the long-term, circulating levels of ghrelin act a measure of global energy status for the 
maintenance of homeostasis via interaction with the hypothalamus69,245.  Additionally, the 
stomach is a minor contributor to the production and secretion of leptin20.  Leptin acts 
antagonistically to ghrelin in regards to satiety signaling via the vagus nerve296,297.  
Immunologically, the stomach is host to aspects of the gut-associated lymphoid 
tissue205,238.  The gut-associated lymphoid tissue of the stomach is host predominantly to 
plasma cells and mast cells129,198,397.  However, in the presence of prolonged local 
inflammation, the stomach becomes host to lymphoid follicles, allowing generation of 
new T and B cell populatiuons137,351.  Therefore, it is wholly reasonable to consider the 
stomach an aspect of the gut-brain axis as it is capable of interacting with the brain by 
each of the major modalities of communication that make up the gut-brain axis.  
 
1.2 Systemic and Neuro-Inflammatory Response to Chronic Infection 
 Classically, the hallmarks of the inflammatory process are pain, redness, heat 
swelling and loss of function.  The inflammatory process is a generic, stereotyped, and 
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highly conserved process; as such, it is considered to be an aspect of the innate immune 
response1. Inflammation may be classified as acute or chronic.  Acute inflammation is 
the initial response to tissue insult.  It is characterized by the movement of plasma and 
primarily granulocytes into tissue and serves as one of the primary triggers for tissue 
regeneration273.  Chronic inflammation is characterized by the shift in associated immune 
cells at the site of inflammation toward mononuclear cells and is associated with the 
simultaneous destruction and regeneration of tissues128,338.  Traditionally, inflammation is 
considered a localized process occurring primarily at the foci of insult.  However, in 
cases of widely disseminated insult or excessive chronic inflammation that is not 
properly suppressed, a systemic inflammatory response is generated92.  The systemic 
inflammatory response is characterized by an increase in circulating inflammatory 
cytokines and is considered a risk factor in the development and progression of many 
pathological conditions328.    
 
1.2.1 Development of systemic inflammation. 
 The development of the systemic inflammatory response is complex, situational-
specific process.  Two general pathways have been proposed for the development of 
systemic inflammation: cytokine “spill-over” and dysregulation of immune suppression.  
The “spill-over” hypothesis was largely developed based on observations made during 
recovery from acute respiratory distress syndrome (ARDS)209.  Epidemiologically, the 
ICU mortality of ARDS patients is 60.2%; however, the majority do not die from acute 
respiratory failure but rather from multiple organ failure114,258,349,353.  It has been observed 
that ventilator-induced lung injury leads to localized production of inflammatory 
cytokines, increased alveolar-vascular permeability, and release of cytokines into 
circulation88,179,303,342.  Similar observations have been made in COPD 
patients123,324,360,380.  The presence of systemic inflammation in COPD patients has been 
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associated with the increased risk of developing further complications including weight 
loss85,90, cachexia3,334, osteoporosis3,39, and cardiovascular disease122,167,336.    Upon 
release into circulation, pulmonary derived cytokines were found to result in significant 
cytokine production and release from the liver in a Nf-κB-dependent manner287.  A 
similar process has been proposed to explain the elevated levels of circulating cytokines 
in chronic periodontitis, juvenile idiopathic arthritis and rheumatoid arthritis158.  “Spill-
over” of localized cytokines into circulation driving a pro-inflammatory response from the 
liver has become a leading hypothesis for explaining the growing number of associations 
between chronic periodontitis with cardiovascular disease210. 
   A second proposed mechanism for the development of systemic inflammation is 
the dysregulation of tolerogenic dendritic cells and T-regulatory cells40,223.  Primarily, 
tolerogenic dendritic cells are responsible for maintaining central tolerance by deleting, 
render anergic, or rendering suppressive autoreactive T cells2,10,11.  In peripheral 
circulation, tolerogenic dendritic cells have the additional mode of action to induce the 
differentiation and proliferation of T-regulatory cells2,311.  Exposure to IL-10 is key to the 
development of tolerogenic dendritic cells, and suppression of IL-10 production has been 
associated with the development of systemic inflammatory disorders, such as Crohn’s 
disease359 and rheumatoid arthritis72.  T-regulatory cells act to actively suppress 
activation of the immune system and particularly the inflammatory response178,243.  
Disruptions to the gene encoding FoxP3 are associated with a disruption to the 
differentiation and proliferation of T-regulatory cells7,119.  Such genetic disruptions result 
in a rapidly fatal autoimmune disorder, immune dysregulation polyendocrinopathy 
enteropathy X-linked syndrome (IPEX)80,275,323.  IPEX syndrome is characterized by 
overwhelming systemic inflammation and autoimmunity within the first year of life388.  It 
has been proposed that some pathogens, such as Staphylococcus aureus, attempt to 
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evade immune system by disrupting T-regulatory cell function, ultimately setting the 
stage for the development of toxic shock syndrome364.   
 Ultimately, both of these processes likely contribute to the development of 
systemic inflammation.  The release of inflammatory cytokines from a localized insult 
stimulates the liver to produce and release additional inflammatory cytokines and acute 
phase proteins into circulation.  This inflammatory milieu is characterized by the release 
of potent mediators of inflammation, such as TNF-α, IL-6, and c reactive protein358.  In 
turn, the cytokines drive differentiation and proliferation of immune cells in the spleen 
and lymph nodes357.  Lack of proper suppression by tolerogenic dendritic cells and T-
regulatory cells ultimately allows the development of hemodynamic, metabolic, and 
inflammatory associated changes that can compromise the function of uninvolved 
organs, leading to multiple organ dysfunction300. 
  
1.2.2 Influence of systemic inflammation on health. 
 Systemic inflammation has come to be recognized as a major risk factor in the 
development of many chronic organ dysfunction pathologies.  Most well understood and 
studied is the association between systemic inflammation and cardiovascular 
disease289,370.  In particular, liver-derived c reactive protein has been associated with a 7-
fold increased risk of myocardial infarction310.  Similarly, low-grade systemic 
inflammation, as measured by circulating IL-6 and c reactive protein levels, was found to 
be a predictive factor in the development of type 2 diabetes98.  Additionally, circulating 
inflammatory cytokines were associated with elevated risk of development of diabetic 
complications184,389.  Chronically elevated levels of IL-6 have been implicated to play a 
key role in the development of synovitis and bone erosions characteristic of autoimmune 
joint disease118.   
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 The relationship between inflammation and cancer has been long established89.  
It has estimated that approximately 15% of malignancies can be attributed to 
infections44,200,333,338.  Chronic inflammatory diseases such as rheumatoid arthritis and 
inflammatory bowel disease are associated with cancer development at similar 
frequencies to that associated with p53 mutations395.  The strong associations between 
colon carcinogenesis and ulcerative colitis and Crohn’s disease100-102,387.  Likewise, 
chronic gastritis associated with infection by Helicobacter pylori is the leading cause of 
gastric adenocarcinoma107.  Chronic infection is associated with induced DNA damage, 
which occurs as a result of continuous exposure to reactive oxygen and nitrogen species 
produced as part of the inflammatory response220.  In fact, inflammation induced 
production of macrophage migration inhibitory factor suppresses the transcriptional 
activity of p53, allowing cell proliferation despite inflammation-induced DNA damage171.  
In melanoma, exposure to the chemokine cytokine CXCL1 enhances colony-forming 
activity and cell proliferation21,272,281.  Similarly in breast cancer, exposure to the 
chemokine cytokine CXCL12 is hypothesized to govern the pattern of metastases262.  
The broader implication is that chronic inflammation and exposure to inflammatory 
cytokines plays roles in both the initiation of cancer and its development. 
 
1.2.3 Development of neuro-inflammation. 
 Classically, the central nervous system has been considered an immune 
privileged site with the blood-brain barrier limiting the influence of the peripheral immune 
system on its function.  However, several mechanisms have been proposed to explain 
the development of neuro-inflammation in response to systemic inflammation.  These 
mechanisms include neuronal recognition of inflammatory cytokines by the vagus 
nerve47,156,201 as well as the neurons of the sensory circumventricular organs54,318,341, the 
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active transport of circulating cytokines across the blood-brain barrier99,153,154, and the 
recent discovery of meningeal lymphatic vessels15,211. 
 Vagotomy suppresses brain-mediated responses to systemic administration of 
bacterial endotoxin, particularly by intraperitoneal injection49,133,337,386.  Peripheral 
administration of bacterial endotoxin activates vagal afferent processes, further 
supporting a role for the vagus nerve in signaling peripheral immune system activation in 
the brain135.  Vagal afferent process have been found to express IL-1ra, the receptor for 
the inflammatory cytokine IL-1ß148.  Furthermore, exposure to IL-1ß induces glutamate 
release by vagal afferent processes within the nucleus of the solitary tract234.  The 
sensory circumventricular organs of the vascular organ of the lamina terminalis, the 
subfornical organ, and the area postrema are regions of the central nervous system that 
possess capillaries with a fenestrated epithelium.  Traditionally, the sensory 
circumventricular organs play key roles in monitoring circulating hormones responsible 
for the maintenance of body fluid and cardiovascular homeostasis113,242.  However, 
systemic administration of TNF-α has been observed to lead to pronounced increase in 
the expression of the TNF-receptor, p55, in each of the sensory circumventricular 
organs265.  Similarly, IL-6 mediated signal transduction has been observed379.  However, 
only the sensory circumventricular organ of the area postrema has been observed to be 
directly responsive to circulating IL-1ß106.  Signal transduction from the nucleus of the 
solitary tract76,77,106,329,330,356, in the case of vagal afferents, as well as from the 
circumventricular organs251,326 proceeds to the medial parvocellular division of the 
paraventricular nucleus of the hypothalamus.  Integration of these signaling pathways, 
leads to modulation of the hypothalamus-pituitary-adrenal axis with subsequent release 
of adrenocorticotropic hormone53. 
 Additionally, it has been noted that circulating cytokines may be transported 
across the blood-brain barrier via carrier-mediated transport23,25.  IL-1α and IL-1ß have 
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been found to cross the blood-brain barrier by the same saturatable transporter24.  IL-6 
uses a separate saturatable transporter26.  Transport of TNF-α is mediated by trafficking 
of endothelial TNF receptors283.  Upon entering the central nervous system, transported 
cytokines are able to interact with endogenous expressed receptors.  Within the CNS 
cytokines are capable of acting in sequence, in which one cytokine triggers the synthesis 
and release of one or more additional cytokines, which may themselves further 
propagate the production and release of additional cytokines301.  Additionally, cytokines 
may act in parallel, in which response patterns depend on the cooperative or 
antagonistic influence of multiple cytokines in response to neurophysiology174,302. 
 The recent discovery of meningeal lymphatic vessels provides another potential 
route for the development of neuro-inflammation15,211.  While simplified in comparison to 
lymphatic vessels found elsewhere in the body, these meningeal lymphatic vessels have 
been shown to be capable of transporting T lymphocytes and may provide a more 
conventional route for immune cells to access the central nervous system211. The 
meningeal lymphatic vessels have also been implicated in the draining of interstitial and 
cerebral spinal fluid into the deep cervical lymphatic vessels15.  While the role remains 
largely unexplored, surgical removal of the deep cervical lymph nodes and ligation of the 
vessels is associated cognitive impairment in animal models due to impairment in the 
normal flow of meningeal associated T cells307. 
 
1.2.4 Influence of neuro-inflammation on cognitive health and function. 
 Neuro-inflammatory processes have been implicated to have broad impact on 
cognitive health and function.  Expression of IL-1, IL-2, IL-6, and TNF-α have been 
shown to play various roles in disease-associated cognitive dysfunction116,143,263,335.  The 
constellation of nonspecific behavioral changes that accompany illness, such as 
depression, lethargy, weakness, malaise, disinterest, and inability to concentrate, are 
14 
 
collectively referred to as “sickness behavior”.  Together, with the fever response, these 
behavioral changes constitute a highly organized strategy to fight infection157.  Cytokines 
with neuro-stimulatory effects have been associated with reduced memory 
performance116,207 and have been suggested to play key roles in the development of 
neuropsychiatric disorders, such as schizophrenia and depression221,222,263,335,346.  IL-1 
and TNF-α are responsible for modulating sleep patterns during disease-associated 
sleep disturbances194,195.  Production of IL-1ß in the nucleus of the solitary tract as 
mediated by the vagus nerve in response to peripheral LPS administration results in 
change to the hypothalamic thermal set point, inducing fever316.  While vagotomy blocks 
development of the fever in response to LPS administration, it does not inhibit fever in 
response to peripheral IL-6 administration189.  In animal models, intraperitoneal 
administration of LPS was found to in the upregulation of IL-1ß production within the 
central nervous system376,379 with an associated effect on the inhibition of neurogenesis 
with the hippocampus255.  It has been hypothesized that neurogenesis within the 
hippocampus plays a key role in the consolidation of memory.  Therefore, neuro-
inflammation has been proposed as a potential contributor to the development of 
Alzheimer’s Disease, Lewy Body Dementia, and AIDS Dementia Complex50,91,217.  Low 
levels of neuro-inflammation due to IL-1α, TNF-α, and IL-6 production associated with 
obesity have been associated with the development of anxiety-like behavior and 
impairment of spatial memory in mice93.  In humans, a growing body of evidence has 
associated neuro-inflammation with elevated risk of neurodegenerative disease and 
depression173.  
  
1.3  Helicobacter pylori and Human Health 
 The early history of scientific inquest into the nature of Helicobacter pylori is one 
of originating in antiquity and still unfolding in modern science.  Hippocrates provided the 
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first written description of gastritis systems with Avicenna noting that relationship 
between onset of gastric pain and mealtime183.  Gastric ulcers would be first formally 
observed by Marcellus Donatus of Mantua in the late 16th century377 and described by 
Matthew Baillie in the late 18th century183.  In 1812, François-Joseph-Victor Broussais 
was the first to note that acute gastritis, if untreated, had the potential to develop into a 
chronic condition59.  Bottcher and Letulle found bacteria at the floor of ulcers and were 
the first to hypothesize that gastric ulcer were caused by bacteria in 1875266.  In 1889, 
Walery Jaworski observed spiral shaped bacteria in gastric washings and suggested that 
they were responsible for the development of gastric ulcers and gastric cancer190.  In 
1939, Abraham Stone Freedberg pioneered the first studies into identifying a bacterial 
cause of gastric ulcers but ceased his work due to pressure from his superiors352.  In 
1954, Edward Pamler published his finding that no viable bacteria are found in the 
human stomach, which becomes the accepted dogma for gastroenterologists282.  In 
1983, Robin Warren and Barry Mashall first published their observation that half of 
patients undergoing gastroscopy showed gastric epithelial colonization by a previously 
undescribed curved Gram negative bacillus173.  Later, Warren and Marshall positively 
associate bacterial colonization with gastritis and peptic ulceration232.  In an attempt to 
address detractors, Marshall would publish the results of self-induced infection by 
cultured H. pylori with relief of gastritis brought about by antibiotic mediated eradication 
of the infection96,233.  Brenden Drumm and colleagues published the first definitive 
evidence that H. pylori was a specific pathogen and causative agent of gastritis.  In 
1994, the World Health Organization’s International Agency for Research on Cancer 
classified H. pylori as a Group I carcinogen based on the growing body of evidence for 
its role in gastric adenocarcinoma56.   
 Similarly, the evolution history of H. pylori also originates in antiquity and 
continues today.  Based on genetic data, the association between H. pylori and 
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humanity can be traced back to at least the last great migration of humanity out of Africa, 
roughly 65,000 years ago111,112,208.  As a human specific pathogen, it is not surprising 
that the coevolution between H. pylori and its human host has blurred the distinction 
between pathogen and commensal43.  It has been suggested that prior to the advent of 
widespread antibiotic usage that H. pylori was a universal inhabitant of the human 
stomach41.  Such an intimate and ubiquitous association has led to the proposal that 
human gastric physiology evolved to maintain normal homeostasis in the presence of 
chronic H. pylori infection.  The rise in gastroesophageal reflux disease, Barrett’s 
esophagitis, esophageal cancer in populations where chronic H. pylori infection is 
decreasing in prevalence104.  The protective relationship between chronic H. pylori 
infection and gastroesophageal reflux disease and its sequelae is hypothesized to result 
from gastric atrophy reducing acid production187,394.  It has also been proposed that 
modulations of the human immune system chronic H. pylori infection may also provide 
some level of protection against the development of childhood asthma and diarrheal 
disease319.  
Finally, it is the ubiquitous nature of chronic H. pylori infection that grants it such 
a potential for impacting human health.  It is estimated that approximately 50% of 
humans worldwide are chronically infected by H. pylori51,228,362.  A clear disparity in the 
prevalence of infection has been noted in that the carriage rate of H. pylori between 
affluent and non-affluent nations.  In “developing” nations the incidence rate of H. pylori 
infection is estimated at 10-20% of the population per year, resulting in carriages rates of 
80-100%51.  However, in “developed” nations, the incidence rate is estimated at 0.5% of 
the population per year with a total carriage rates of 10-30%285.  Even within “developed” 
nations a disparity is observed in that prevalence rates among populations with lower 
socioeconomic standing approach those seen in “developing” nations227-229.  As such, H. 
17 
 
pylori infection represents a potential additional burden on these already vulnerable 
populations. 
 
1.3.1 Helicobacter pylori and gastric health. 
 The influence of H. pylori on long-term gastric health is perhaps the most well 
studied aspect of this pathogen.  The hallmark of the interaction between H. pylori and 
its human host is the development of a superficial gastritis affecting the epithelial 
mucousa162,288,306,371.  Neutrophilic infiltration of the lamina propria and epithelial glands 
is the most common histological finding during H. pylori infection288.  However, the 
presence of other immune cells, such as lymphocytes, monocytes and macrophages, 
eosinophils, and plasma cell are commonly observed in chronically infected 
individuals288.  Associated plasma cell populations in the gastric tissue have been found 
to secrete sIgA309. Of T cell populations present during chronic H. pylori infection, CD8+ 
cells are often overrepresented284.  Active chronic infection is associated with a depletion 
of mucus from the epithelial cell surface348, despite increased mucus production70.  In a 
proportion of infected individuals, glandular atrophy develops due to loss of epithelial cell 
populations110. 
 H. pylori does not invade the gastric epithelium but rather colonizes the 
overlaying mucus layer159.  However, a fraction of H. pylori cells are able to directly 
adhere to the gastric epithelium via the use of adhesin-like protein203.  Despite its lack of 
invasiveness, H. pylori is capable of inducing a robust inflammatory reaction, which is 
hypothesized to be related to its secretory activities.  The urease of activity of H. pylori 
produces ammonia, which is a known pro-inflammatory insult to epithelial cells383.  
Additionally, H. pylori actively secrete cytotoxic factors, such as vacuolating cytotoxin A 
(VacA), which also produce an inflammatory response66,203.  VacA induces massive 
vacuolation in epithelial cell lines65.  There is no close homolog of vacA present in other 
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Helicobacter species or in other bacteria68, suggesting a potential importance in specific 
interactions between H. pylori and the human stomach.  Pores formed by VacA allow the 
egress of anions and urea from epithelial cell177,366.  Release of urea from epithelial cells 
may be beneficial to H. pylori as urea hydrolysis by urease protects against gastric 
acidity.  In mice, oral administration of VacA has been associated with ulcer formation67.  
Significant allelic variation  has been observed in VacA, with certain allele types 
associated with elevated risk in development of gastric disease16,17.  Likewise, the cag 
pathogenicity island is associated with increased risk for the development of both peptic 
ulcer disease71,271 as well as gastric adenocarcinoma375.  The cag pathogenicity island 
encodes for a type IV secretion system, by which bacterial cells in close association with 
host cells are able to inject macromolecules into the host cell375.  The most well studied 
effector protein of the cag pathogenicity island, CagA, interacts with SHP-2164 to 
influence spreading, migration, and adhesion of epithelial cells396.  Additionally, CagA 
interacts with Grb2 to activate the Ras/MEK/ERK pathway, leading to cell scattering and 
proliferation250.  Like vacA, no homologs are known for cagA in either other Helicobacter 
species or in other bacteria, indicating yet another evolved human specific interaction.   
 Chronic H. pylori infection is met with a robust innate and adaptive immune 
response, manifested by continuous epithelial cell cytokine release and gastric mucosal 
infiltration of neutrophils, macrophages, and lymphocytes18,71,291.  The mucosal cytokine 
profile implies a predominantly Th1 mediated inflammatory response22.  H. pylori gastritis 
reduces gastric somatostatin levels260, which in turn results in hypergastrinemia as a 
result of the loss in negative regulation204.   Elevated gastrin levels act on 
enterochromaffin-like and parietal cells, leading to greater acid secretion103.  Chronically 
elevated gastrin levels have the additional effect of promoting proliferation of parietal 
cells103,144.  Increased delivery of acid to the duodenum induces gastric metaplasia which 
is subsequently colonized by H. pylori with resultant inflammation and ulceration155,182,277.  
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As chronic gastritis spreads from the gastric antrum to corpus, histamine release by 
enterochromaffin-like cells is inhibited which further inhibits secretion of gastric acid by 
parietal cells33.  Reduced gastric acid secretion further enhancing gastrin production, 
which while failing to increase acid production continues to provide a proliferative 
stimulus292,293.  Continued proliferation and inflammation lead to progressive loss of 
gastric glands, and such atrophic changes alongside continued cell proliferation lead to 
markedly increased risk of development of gastric ulceration and gastric 
adenocarcinoma197,291. 
 
1.3.2 Helicobacter pylori and extra-gastric health. 
 Much like the early studies seeking to link H. pylori infection to the development 
of gastric disease, the hypothesis that chronic H. pylori infection influences extra-gastric 
health has also generated controversy.  A number of studies have reported associations 
between H. pylori infection and cardiovascular diseases.  A higher prevalence of chronic 
H. pylori infection has been observed in patients suffering from ischemic heart 
disease81,246.  Magnitude of anti-H. pylori antibody titer has been positively correlated 
with risk of death by myocardial infarction6,294.  Interestingly, infection by cag 
pathogenicity island positive strains of H. pylori was found in significantly higher 
prevalence in ischemic stroke patients after controlling for other demographic 
variables226,299.  However, large epidemiology studies, relying only on seropositivity data 
have found only minimal evidence for an association between H. pylori seropositivity and 
risk of myocardial infarction38,315,393.  Seropositivity has been associated with a significant 
increase in adenomatous polyps and reduction in normal colonoscopy findings in human 
patients, suggesting a link between H. pylori infection and colorectal cancer252.  
Interestingly, hypergastrinemia has been hypothesized as a possible contributing factor 
in the development of colorectal cancer124,252.  Hematologically, chronic H. pylori 
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infection has been well established as a major risk factor in the development of 
autoimmune idiopathic thrombocytopenic pupura132,165,186,381.  Anti-CagA antibodies have 
been found to recognize two distinct platelet antigen in purpura patients but only one in 
normal subjects, suggesting that the intersection between molecular mimicry on the part 
of H. pylori and immune system predisposition determine the risk of developing this 
autoimmune disease131.  Several studies have suggested a link between chronic H. 
pylori infection and idiopathic iron-deficiency anemia, though the mechanism remains 
unknown125,355.  Likewise, H. pylori infection has been associated with elevated risk of 
developing preeclampsia during pregnancy; although, the mechanistic link remains 
highly specualtive305,378.  Conversely, H. pylori infection appears to confer a degree of 
protection against the development of Th2 mediated diseases, such as atopy55,239 and 
asthma60,78.   Interestingly, the most commonly hypothesized link between chronic H. 
pylori infection and extra-gastric health is the interaction between the bacterium and the 
host’s immune system. 
 
1.3.3 Modulation of the immune response by Helicobacter pylori. 
 As H. pylori establishes a chronic infection that has the propensity to persist 
throughout the host’s life, it is not unsurprising that H. pylori has evolved mechanisms by 
which it interacts with the immune system to allow it to evade clearance.  Little is known 
about the acute phase of H. pylori infection, except that there is a rapid recognition by 
the host in the form of both an innate and adaptive immune response290.  However, the 
chronic stages of H. pylori infection are characterized by continual activation of the 
immune response to the extent that antibody titers may remain consistently elevated for 
decades295.   
 H. pylori evades the immune response by a wide range of adaptations.  While the 
innate immune system naturally responds to bacterial flagella via recognition by TLR5, 
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the flagella of H. pylori is not stimulatory9,140,202.  Similarly, TLR9 naturally recognizes the 
unmethylated DNA commonly found in bacterial pathogens but not the highly methylated 
DNA of H. pylori280,331.  The Lipid A component of H. pylori LPS has mutated in such a 
way that it is anergenic and does not stimulate epithelial cell TLR419.  In cell culture 
studies, VacA has been shown the block phagosome maturation in macrophages400, 
inhibit antigen presentation in T cells254 and inhibit T cell proliferation136.  Molecular 
mimicry of gastric epithelial fucosylated antigens further limits the adaptive host 
response390.Perhaps, H. pylori’s most effective evasion of the immune system is its 
survival as a chronic pathogen without tissue invasion.  The bulk of H. pylori cells 
resides in the mucus layer and lumen of the stomach385, placing them beyond the reach 
of most immune effectors.   
 However, a proportion of H. pylori cells maintain an intimate association with the 
gastric epithelium and H. pylori derived products are able to cross the epithelial 
barrier224.  This results in activation of both the innate and adaptive arms of the immune 
system290.  H. pylori infection is met with a predominantly Th1 mediated inflammatory 
response22.  While an extracellular, toxin-producing bacterial infection is more often met 
with a predominantly Th2 mediated B cell activation and antibody production, animal 
studies have suggested that a predominant Th1 mediated immune response is 
appropriate to control H. pylori infection121,253.  While a Th1 mediated immune response 
is appropriate for control of H. pylori infection, the inflammatory component of the Th1 
mediated response is a major contributing factor in the development of H. pylori 
associated gastric pathogenesis121,151,253,344. 
 Systemically, chronic H. pylori infection is associated with several shifts in the 
composition of immune cell populations.  Most well understood is the induction of a 
polarization of Th1 and Th2 cell populations toward a predominantly Th1 
phenotype22,79,367.  Production of INF-γ promotes T cell differentiation into the Th1 
22 
 
phenotype, which will, in turn, produce additional INF-γ establishing a Th1 dominant 
microenvironment while inhibiting IL-2 production and suppressing differentiation into the 
Th2 phenotype249.  Based on its interference with calcineurin signaling, it has been 
hypothesized that VacA intoxication suppresses Th2 differentiation and activity by 
inhibiting IL-2 transcription136.  Currently, a great deal of focus has been placed on the 
immune polarizing abilities of the neutrophil-activating protein (NAP) of H. pylori256,327.  
NAP is chemiotactic for neutrophils and stimulates a high production of oxygen 
radicals8,109.  NAP has been shown to be able to cross the endothelial barrier efficiently 
and promote leukocyte adhesion and extravasation into infected tissue109,304,327.  In 
tissue, NAP is able to activate mast cells to release TNF-α257 as well as IL-12 and IL-23 
release from neutrophils, monocytes, and dendritic cells8.  This particular milieu of 
cytokines exerts a strong polarizing effect on the differentiation of naïve T cells toward 
the Th1 phenotype267,278,372.  Conversely, impairment of TLR signaling has been 
associated with the generation of semimature dendritic cells166,181,276.  These poorly 
immunogenic dendritic cells act to maintain peripheral immune tolerance through 
induction of anergy and deletion in autoreactive T cells230.  Additionally, these 
semimature dendritic cells lead to the differentiation and proliferation of CD4+FoxP3+ T 
regulatory cells (Treg cells)13.  The Treg cells act against T cell mediated immunity 
through the production of IL-10 as well as by direct suppression of memory T cell 
responses212,308.  It is hypothesized that the generation of these Treg cell populations 
during H. pylori infection is responsible for the observed protective effect that chronic H. 
pylori infection has in regard to  the risk of development of asthma13,276.   
 
1.3.4 Helicobacter pylori and cognitive health. 
 Very few studies have examined the influence of chronic H. pylori infection on 
cognitive health and development.  In mice, chronic H. pylori infection has been 
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associated with changes in feeding behavior that persisted following eradication of the 
infection36.  It was hypothesized that H. pylori associated changes in satiety signaling 
may not completely resolve following eradication of infection.  In an elderly Greek cohort, 
H. pylori infection has been associated with reduced performance on the Mini Mental 
State Examination with successful eradication associated with improvement192,193.  It was 
hypothesized that H. pylori associated atrophic gastritis led to the development of 
vitamin B12 deficiency which allowed the elevation of circulating homocysteine levels 
resulting in mild neuro-inflammation193.  Finally, a negative association was observed 
between H. pylori seropositivity and IQ score in school aged children in an Israeli 
cohort261.  The observed effect was found to be independent of socioeconomic and 
nutritional status, eliminating the two most commonly cited variables for detrimental 
cognitive effects.   
 
1.3.5 Helicobacter pylori as part of the microbiota-gut-brain axis. 
 It has been proposed that H. pylori colonization and chronic infection of the 
human stomach was “universal” throughout most of human evolution42,112,142.  As the 
stomach meets the criteria for consideration as a member of the gut-brain axis, it is 
reasonable to consider how H. pylori may modulate signaling along the gut-brain axis as 
a member of the resident microbiota.  In mice, H. pylori infection has been associated 
with vagus nerve mediated alteration in feeding behavior36.  Action by local secreted 
inflammatory cytokines in response to H. pylori on the vagus nerve result in alteration of 
sympathetic tone of the stomach as well as activate the hypothalamus-pituitary-adrenal 
axis105, resulting in vagus nerve mediated suppression of inflammation58,264.  These 
vagus nerve mediated alterations to homeostasis are hypothesized to be key plays in 
the protective aspect of chronic H. pylori infection in regard to the gastroesophageal 
reflux disease339.  Hormonally, H. pylori infection is associated with impairment of ghrelin 
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production176,279,361.  Eradication of H. pylori infection has been observed to result in an 
increase in ghrelin production and secretion by the gastric mucousa176,274.  As ghrelin 
levels influence the production and secretion of growth hormone, H. pylori mediated 
alteration of ghrelin levels has been proposed as a potential mechanistic link in the 
association of H. pylori infection and height reduction in children248,286.  Similarly, as 
reduced ghrelin levels are hypothesized to play an important role in the development of 
polycystic ovary syndrome146,259,332, it has been proposed that reduction of ghrelin levels 
during H. pylori infection contribute to the finding of an association between this disorder 
of the reproduction system and gastric infection231,398,399.  Immunologically, H. pylori 
engages in seemingly paradoxical activity.  In generation of a Th1 polarizing response, 
chronic infection leads to the development of a pro-inflammatory state22,79,367.  In turn, 
Th1 polarization leads to suppression of Th2 mediated immune activity249.  
Simultaneously, chronic H. pylori infection is associated with the generation and 
proliferation of Treg cell populations, which act to suppress the pro-inflammatory 
activity181.  These modulations of the adaptive immune response are hypothesized to 
result in the observed protective effect that chronic H. pylori infection has against the 
development of asthma, atopy, and allergies13,276. 
 
1.4 Gaps in Knowledge 
 H. pylori has been well described as a gastric pathogen, capable of establishing 
a chronic infection, inducing a long-term superficial gastritis, and increasing the risk of 
developing gastric disease.  However, the influence of H. pylori on extra-gastric health 
remains controversial and poorly understood.  Seropositivity to H. pylori has been 
epidemiologically associated with increased levels of circulating inflammatory markers.  
However, such association studies are unable to address whether H. pylori is truly the 
causative agent of the observed changes in inflammatory markers, or, more importantly, 
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if curing of active H. pylori infection leads to a normalization of circulating inflammatory 
markers.  A second gap in knowledge is the determination of whether chronic H. pylori 
infection is capable of inducing a neuro-inflammatory response.  It has been shown that 
chronic systemic inflammation has the potential to generate an inflammatory response 
within the central nervous system.  While a few researchers have speculated that 
chronic H. pylori infection may indeed induce a mild neuro-inflammatory state, such 
hypotheses are based solely on conjecture due to the limitations in gathering tissue 
samples from human subjects.  The final gap in knowledge is whether chronic H. pylori 
infection is associated with detrimental changes in cognitive health.  As chronic neuro-
inflammation has been shown to negatively influence cognitive health, it is not 
unreasonable to propose that, if chronic H. pylori induces a neuro-inflammatory 
response, chronic H. pylori infection may negatively impact cognition.  In order to 
evaluate these gaps in knowledge, a chronic animal model of H. pylori infection was 
developed in Sprague-Dawley rats, the influence of H. pylori infection on systemic 
inflammatory markers as well as neuro-inflammatory markers was monitored through 
time, the immunomodulatory influence of H. pylori was examined for its role in the 
development of extra-gastric inflammation, and cognitive behavioral studies were 
conducted to evaluate the influence of chronic H. pylori infection on cognition. 
 
1.5 Significance of this Study 
Altogether, these studies will address fundamental gaps in knowledge in the 
study of Helicobacter pylori and its influence on extra-gastric health.  More broadly, 
these studies have to potential to increase the understanding of the influence that 
chronic infection has on the immune response and, in turn, how changes in the immune 
response are able to influence health at a systemic level.  From a public health stand 
point, emphasis and focus has shifted toward attempting to address risks factors of late 
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life disease, rather than wait for the manifestation of symptoms.  As systemic 
inflammation is a known risk factor in the development of many late life chronic illnesses, 
this work offers to shed light into the rate and mechanism by which systemic 
inflammation is established in response to a chronic bacterial infection. In the study of H. 
pylori infection, these studies offer insight into the earliest stages of chronic infection 
where data on the effects of chronic infection are incredibly scarce.  These studies seek 
to address the long-standing question of whether chronic H. pylori infection has the 
potential to negatively impact the health of infected individuals who do not eventually 
develop gastric disease.  Demonstrating that chronic H. pylori infection does indeed “set 
the stage” for the development of chronic systemic will provide long sought confirmation 
of large scale epidemiology studies.  Furthermore, these studies provide a model for 
evaluating the influence of chronic H. pylori infection in a manner which more closely 
recapitulates the natural course of infection.  It has been shown that most chronic H. 
pylori infections begin in early childhood and persist throughout life without direct 
medical intervention.  The period of early childhood development presents a particularly 
vulnerable period in development where perturbations may leave behind lasting, if not 
permanent, negative effects.  The influence of H. pylori infection on this period of life is 
only beginning to be evaluated by researchers, and the animal model developed as part 
of these studies offers great potential in gaining understanding into the influence of H. 
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Chapter 2: Establishment of a rat based animal model of chronic Helicobacter 
pylori infection 
2.1 Introduction 
 As H. pylori has evolved as a human specific pathogen, development of effective 
animal models that recapitulate the natural history of chronic H. pylori infection has been 
challenging.  The first animal models for H. pylori infection relied on the use of germ-free 
piglets14,26 as these animals possess gastric physiology similar to humans13,18,28.  
Ferrets, colonized by Helicobacter mustelae, were used as the first animal model to 
demonstrate gastric ulceration19.  Most animal studies have utilized rodent, specifically 
mouse, models of infection as strains of H. pylori that have been identified which are 
capable of stable colonization35,55.  However, much current research has utilized the 
Mongolian gerbil as infection results in the rapid development of ulceration and cancer in 
these animals23,55.  Rat-based animal models have been utilized sparingly in H. pylori 
research.  However, those few studies demonstrate several key benefits seen in the use 
of rats over other rodent models.  Establishment of chronic infection in rats was possible 
with minimal adaptation of H. pylori5,32,33,45. Chronic infection in rats was observed to 
result in the colonization of the upper foveolar cells of gastric antrum32, which more 
closely resembles the colonization pattern seen in humans29 in comparison to the 
corpus-antrum transition colonization seen in other rodent models30.        
 The early stages of natural infection by H. pylori are the least understood aspects 
of infection.  It is hypothesized that chronic H. pylori infection is typically established 
during early childhood56 and that young children (aged 0 to 5 years) appear to be 
particularly vulnerable to infection by H. pylori24,50.  Decline in the prevalence of chronic 
H. pylori infection has been associated with the rise of gastric esophageal reflux 
disease15,17,22,27,34,42,53, obesity20,25,57 and even asthma2,7,8,11.  In affluent nations, H. pylori 
prevalence is in decline, which may be at least partially explained by the absence H. 
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pylori associated modulation of physiology6.  As many of these pathophysiologies have 
their root during early childhood development, it may be hypothesized that the 
establishment of chronic H. pylori during early development may influence extra-gastric 
health in ways not observed with infection established during adulthood.   
   
2.2 Materials and Methods 
Animal care. All experiments involving the use of live vertebrate animals were 
conducted with the approval of the University of Illinois at Urbana-Champaign 
Institutional Animal Care and Use Committee (IACUC).  Rat populations were composed 
of male Sprague-Dawley rats (Envigo, formerly Harlan Laboratories, Indianapolis, IN).  
Mouse populations were composed of male C57BL\6J mice (Jackson Laboratory, Bar 
Harbor, ME).  Animals were single housed with 12 h light-dark cycle, mean temperature 
of 22.1°C, humidity of 50%, and allowed food and water ad libitum.   
 
Bacterial strains. H. pylori G27 (cag PAI+, vacA s1/m1; NCTC 13282), 26695 (cag 
PAI+, vacA s1/m1; ATCC 700392), and 60190 (cag PAI+, vacA s1/m1; ATCC 49503) 
were cultured in bisulfite-free Brucella broth (BSFB) supplemented with 5% fetal bovine 
serum (Sigma Aldrich, St. Louis, MO) and vancomycin 5 µg/ml (Sigma Aldrich), on a 
rotary platform shaker for 48 h at 37°C, under 5% CO2 and 10% O2.  H. pylori 
transposon interruption mutants47, G27 (vacA::Tn7), G27 (cagA::Tn7), G27 (cagY::Tn7), 
and G27 (napA::Tn7), were kind gifts from Nina Salama (Fred Hutchinson Cancer 
Research Center, Seattle, WA).   
 
Determination of antibiotic susceptibility.  All strains were tested for susceptibility to 
the pharmacological agents used in standard H. pylori eradication therapy.  In brief, H. 
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pylori strains were plated onto Columbia Blood Agar (Thermo Fisher) supplemented with 
7% defibrinated sheep’s blood (Thermo Fisher).  Additional Columbia Blood Agar plates 
were supplemented with either 50 µg/mL lansoprazole (Sigma Aldrich), 0.12 µg/mL 
amoxicillin (Sigma Aldrich), 0.25 µg/mL clarithromycin (Sigma Aldrich), or the 
combination of all three pharmaceutical agents.  Thresholds for determining 
susceptibility for amoxicillin and clarithromycin were based on published standards for 
determination of antibiotic susceptibility in clinical settings48. 
 
Determination of mid-log phase growth time.  Mid-log phase times for H. pylori strain 
G27, 26695, and 60190 were determined empirically by growth curve measurements.  In 
brief, low passage frozen culture stocks were revitalized in BSFB media supplemented 
with 5% fetal bovine serum (Sigma Aldrich, St. Louis, MO) and vancomycin 5 µg/ml 
(Sigma Aldrich) 96 h at 37°C, under 5% CO2 and 10% O2.  500 mL flasks of BSFB 
media supplemented with 5% fetal bovine serum were inoculated with 1 mL of full grown 
stationary culture.  Cultures were incubated on a rotary platform shaker for 36 h at 37°C, 
under 5% CO2 and 10% O2.  OD600 was measured at 90 minute intervals and cell 
density confirmed by dilution plating on Columbia Blood Agar (Thermo Fisher, Hanover 
Park, IL) supplemented with 7% defibrinated sheep’s blood (Thermo Fisher), 10 µg/ml 
vancomycin (Sigma Aldrich), 5 µg/ml trimethoprim (Sigma Aldrich), 5 µg/ml cefsulodin 
(Sigma Aldrich), and 5 µg/ml amphotericin B (Sigma Aldrich).  Motility and cellular 
morphology were evaluated for each time point by phase contrast microscopy.  Growth 
curves were plotted from resulting data and mid-log phase determined for each H. pylori 
strain. 
 
Rodent adaptation of H. pylori strains.  Male Sprague-Dawley rats (Envigo), aged 19-
21 days, were orally fed 3.75 mg/kg lansoprazole (Sigma Aldrich) suspended in 20% 
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sucrose solution once daily for 7 days.  On days 3 and 5 of treatment, animals received 
0.5 ml of mid-log phase H. pylori culture diluted to 2x107 cells/ml (active H. pylori 
infection) or 0.5 ml of sterile BSFB media (mock infected controls) by oral gavage using 
a 20 G disposable feeding needle (Thermo Fisher).  Inoculum dosage was estimated by 
disposable hemocytometer (inCYTO, Seonggeo-gil, South Korea).  Dilution was 
confirmed by serial dilution and spread plating on Columbia Blood Agar (Thermo Fisher) 
supplemented with 7% defibrinated sheep’s blood (Thermo Fisher), 10 µg/ml 
vancomycin (Sigma Aldrich), 5 µg/ml trimethoprim (Sigma Aldrich), 5 µg/ml cefsulodin 
(Sigma Aldrich), and 5 µg/ml amphotericin B (Sigma Aldrich) incubated for 5 days at 
37ºC under microaerophilic conditions (5% CO2, 10% O2).  7 days following competition 
of lansoprazole treatment, animals were euthanized and stomachs collected by 
necropsy.  Stomach tissue was grossly chopped into ~1 cm2 pieces using sterile razor 
blades and vigorously washed in 5 mL sterile BSFB media for 10 min.  Resulting 
stomach wash was cultured on Columbia Agar (Thermo Fisher) supplemented with 7% 
defibrinated sheep’s blood, vancomycin 10 mg/ml (Sigma Aldrich), trimethoprim 5 mg/ml 
(Sigma Aldrich), cefsulodin 5 mg/ml (Sigma Aldrich), and amphotericin B 5 mg/ml 
(Sigma Aldrich) for 5 days at 37ºC under microaerophilic conditions (5% CO2, 10% O2).  
Presumptive H. pylori colonies (oxidase +, catalase +, urease +, and motile curved bacilli 
under phase contrast microscopy) were colony purified 3 times.  10 purified isolates 
were combined and the adaptation process repeated.  Final rodent adapted H. pylori 
strains were confirmed by 16S rRNA gene sequencing. 
 
Establishment of H. pylori infections. Male Sprague-Dawley rats (Envigo), aged 19-
21 days, were orally fed 3.75 mg/kg lansoprazole (Sigma Aldrich) suspended in 20% 
sucrose solution once daily for 7 days.  On days 3 and 5 of treatment, animals received 
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0.5 ml of mid-log phase H. pylori G27 culture diluted to 2x107 cells/ml (active H. pylori 
infection) or 0.5 ml of sterile BSFB media (mock infected controls) by oral gavage using 
a 20 G disposable feeding needle (Thermo Fisher).  Inoculum dosage was estimated by 
hemocytometer and verified by CFU plating.  Length of infection (2-, 8-, or 25-weeks) 
was defined as the number of weeks following competition of lansoprazole treatment 
prior to euthanasia and tissue collection.  The weights of all animals were recorded on a 
weekly basis. 
 
Inoculum influence on bacterial load.  Male Sprague-Dawley rats (Envigo) aged 19-
21 infected with rat-adapted H. pylori G27 culture diluted to 2x102, 2x103, 2x104, 2x105, 
2x106, 2x107 cells/ml (active H. pylori infection) or 0.5 ml of sterile BSFB media (mock 
infected controls) by oral gavage as described previously.  Animals were infected for 8 
weeks prior to euthanasia and collection of tissues.  Animal population consisted of a 
single animal for each inoculum dosage. 
 
Determination of bacterial load. Stomach tissue was roughly chopped into 1 cm2 
pieces and washed vigorously in sterile BSFB media for 10 minutes.  Resulting wash 
serially diluted and plated onto Columbia Agar (Thermo Fisher) supplemented with 7% 
defibrinated sheep’s blood, 10 µg/mL vancomycin (Sigma Aldrich), 5 µg/mL trimethoprim 
(Sigma Aldrich), 5 µg/mL cefsulodin (Sigma Aldrich), and 5 µg/mL amphotericin B 
(Sigma Aldrich).  Plates were incubated for 5 days at 37ºC under microaerophilic 
conditions (5% CO2, 10% O2).  Stomach tissue was blotted dry using sterile gauze and 




Active H. pylori infection time series.  Male Sprague-Dawley rats (Envigo) aged 19-21 
days were orally fed lansoprazole 3.75 mg/kg (Sigma Aldrich) once daily for 7 days.  On 
day 3 and 5 of treatment, animals received 0.5 ml of mid-log phase H. pylori G27 culture 
diluted to 2x107 cells/ml (active H. pylori infection) or 0.5 ml of sterile BSFB media (mock 
infected controls).  Inoculum dosage was estimated by hemocytometer and verified by 
CFU plating.  Length of infection (2-, 8-, and 26-weeks) was defined as the number of 
weeks following competition of lansoprazole treatment prior to euthanasia and tissue 
collection.  Each time point experiment consisted of 3 independent replicates composed 
of 6 animals (3 actively infected and 3 mock infected).   
 
Eradication of active H. pylori infection studies. Male Sprague-Dawley rats (Envigo) 
aged 19-21 days were orally fed lansoprazole 3.75 mg/kg (Sigma Aldrich) once daily for 
7 days.  On day 3 and 5 of treatment, animals received 0.5 ml of mid-log phase H. pylori 
G27 culture diluted to 2x107 cells/ml (active H. pylori infection) or 0.5 ml of sterile BSFB 
media (mock infected controls).  Inoculum dosage was estimated by hemocytometer and 
verified by CFU plating.  Animals underwent H. pylori eradication therapy 13 weeks after 
completion of lansoprazole treatment administered as part of the inoculation procedures.  
In brief, animals received eradication therapy consisting of 3.75 mg/kg lansoprazole 
(Sigma Aldrich), 2.25 mg/kg clarithromycin (Sigma Aldrich), and 4.5 mg/kg amoxicillin 
(Sigma Aldrich) suspended in 30% sucrose solution orally twice daily for 10 days.  
Animals were then allowed to remain uninfected for an additional 13 weeks after 
completing eradication therapy prior to euthanasia and collection of tissue.  Prior 
infection by H. pylori was confirmed by Instant-View H. pylori Rapid Test seropositivity 
assay (Alpha Scientific, Poway, CA) on plasma samples.  The experimental animal 
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population consisted of 3 independent replicates composed of 6 animals (3 actively 
infected and 3 mock infected). 
 
Mouse infection studies.  Male C57BL\6J mice (Jackson Laboratory, Bar Harbor, ME) 
aged 6 weeks were orally fed lansoprazole 3.75 mg/kg (Sigma Aldrich) once daily for 7 
days.  On day 3 and 5 of treatment, animals received 0.2 ml of mid-log phase H. pylori 
G27 culture diluted to 5x107 cells/ml (active H. pylori infection) or 0.2 ml of sterile BSFB 
media (mock infected controls).  Inoculum dosage was estimated by hemocytometer and 
verified by CFU plating.  Animals were infected for 8 weeks prior to euthanasia and 
collection of tissues.  The experimental animal population consisted of 3 actively infected 
animals and 3 mock infected animals. 
 
H. pylori virulence factor mutant infection studies.  Male Sprague-Dawley rats 
(Envigo) aged 19-21 days were orally fed lansoprazole 3.75 mg/kg (Sigma Aldrich) once 
daily for 7 days.  On day 3 and 5 of treatment, animals received 0.5 ml of mid-log phase 
rat-adapted H. pylori G27 (vacA::Tn7), H. pylori  G27 (cagA::Tn7), H. pylori  G27 
(cagY::Tn7), or H. pylori  G27 (napA::Tn7) culture diluted to 2x107 cells/ml (active H. 
pylori infection) or 0.5 ml of sterile BSFB media (mock infected controls).  Inoculum 
dosage was estimated by hemocytometer and verified by CFU plating.  Each infection 
study using a mutant H. pylori strain was conducted a single independent block of 3 
mock infected animals and 3 actively infected animals. 
 
Terminal collection of tissue samples. At experimental end points, whole stomach 
tissue, liver, spleen and brain tissues along with large volume blood samples were 
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collected.  In brief, animals were placed under surgical plane anesthesia by 
intraperitoneal administration of 100 mg/kg ketamine (Med Vet International, Mettawa, 
IL) and 10 mg/kg xylazine hydrochloride (Sigma Aldrich).  Cardiovascular function was 
stabilized by intramuscular injection of 0.05 mg/ml atropine sulfate (Med Vet 
International).  The animal’s abdominal and thoracic cavities were opened and cardiac 
puncture blood draw conducted via the left ventricle using a 19 G needle.  Collected 
blood was immediately transferred to EDTA anti-coagulated blood collection tubes 
(Becton, Dickinson, and Company, Franklin Lake, NJ).  A 4-0 silk braided suture (MYCO 
Medical, Apex, NC) was used to tie a loop around the duodenum just inferior to the 
pyloric sphincter. The stomach was then cut free of the gastrointestinal tract just inferior 
to the suture and just superior to cardiac sphincter.  The stomach was immediately 
placed in in cold PBS prior to processing.  Whole liver, spleen and brain tissue were 
collected by necropsy and placed into cold PBS prior to processing.   
 
Sample processing.  Blood samples were centrifuged 10 min at 1500 x g at room 
temperature to separate plasma.  Plasma was centrifuged a second time for 10 min at 
2000 x g at room temperature to remove platelets.  Plasma was aliquoted at 200 µL and 
stored at -20°C until assayed.  200 mg pieces of liver and spleen tissue as well as the 
cerebellum and hippocampus from brain tissue were sterilely collected from whole tissue 
and frozen at -20°C.  Stomachs were opened along the lesser curvature and thin strips 
representing the greater curvature of the stomach were collected and set aside for 
histology.  Remaining gastric tissue was processed for determining bacterial load.  After 
washing for bacterial load determination, 200 mg of gastric tissue was collected and 




Preparation of whole tissue protein lysates.  200 mg of gastric tissue was 
mechanically homogenized using mortar and pestle with the aid of liquid nitrogen.  
Homogenized tissue was suspended in 2 mL of RIPA buffer (Thermo Fisher) 
supplemented proteinase inhibitor cocktail (Thermo Fisher).  Cells were lysed on ice with 
gentle shaking for 3 hr.  Unlysed tissues and lipid fraction were removed by 
centrifugation at 1500 x g for 15 min at 4°C.  Total protein concentration for tissue 
lysates was determined by BCA assay (Thermo Fisher).  Tissue lysates were aliquoted 
at 200 µL and frozen at -20°C until assayed. 
 
Gastric histology. Strips of stomach tissue along the greater curvature from the gastric 
cardia through the pylorus were collected using sterile scalpel blade.  Strips of tissue 
were fixed in Carnoy’s fixative prior to embedding in paraffin wax.  Paraffin embedded 
tissue was sectioned at 7 µm and stained by standard H&E procedures.  Slides were 
digitized at 40X magnification using a Hamamatsu NanoZoomer slide scanner 
(Hamamatsu, Bridgewater, NJ).  
 
Cytokine quantification.    Tissue lysate was diluted to 500 µg/ml to standardize the 
amount of protein assayed across sample.  Cytokine quantification was determined by 
quantitative ELISA for TNF-α (Eagle Bioscience, Nashua, NH), IL-6 (Eagle Biosciences), 
and CRP (Sigma Aldrich) according to manufacturer’s directions.   
 
Statistical analysis.  Bacterial growth curves and animal weights were evaluated by 
non-linear regression analysis.  Bacterial load was evaluated by one-way ANOVA with 
Tukey’s correction for multiple comparisons.  Cytokine levels from active infection time 
series were evaluated by two-way ANOVA of H. pylori infection status and length of 
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infection with Tukey’s correction for multiple comparisons.  Eradication studies and 
mouse studies were evaluated using a 2-tailed distribution, paired t test.  Cytokine levels 
from transposon insertion H. pylori infection studies were evaluated by two-way ANOVA 
of H. pylori infection status and H. pylori strain. An alpha level of 0.05 was used as a 
threshold for statistical significance and all error bars represent standard error of the 
mean (SEM). Graphpad Prism (version 6.01) was used for all statistical analyses.  
 
2.3  Results 
 
2.3.1 Characterization of H. pylori growth in culture media.  
 Previous reports have shown that mid-log phase, actively growing H. pylori 
cultures have the highest potential to establish chronic infection during experimentally 
induced infection.  To determine the appropriate conditions for culturing H. pylori for use 
in animal infections, growth curve experiments were conducted using three different 
strains of H. pylori: G27, 60190, and 26695.  OD600 and CFU per mL were monitored at 
90 minute intervals for a period of 72 hr.  Resulting data were plotted and growth curves 
analyzed by non-linear regression using the Boltzmann sigmoidal formula (Figure 2.1).  
Evaluation of change in OD600 through time revealed that each of the three strains of H. 
pylori (G27, 26695, and 60190) possess similar growth rates.  The “slope” variables for 
each curve were not significantly different (p = 0.68), indicating comparable rates of 
exponential growth among the strains of H. pylori.  However, the “Top” variable for H. 
pylori 26695 was found to be significantly lower (ANOVA p < 0.01; Tukey’s pairwise test 
p = 0.02) than that of strains G27 and 60190, indicating that strain 26695 produces a 
lower cell density upon reaching stationary phase. 
 As H. pylori is known to enter a non-culturable, non-infective coccoid state when 
under culturing stress (e.g. high cell density), viable cell counts were determined by 
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spread plating with cell density enumerated as CFU per mL.  Again, the “slope” values 
were not found to vary significantly (p = 0.45) among the three strains of H. pylori.  
Additionally, the “Top” variable for H. pylori 26695 was found to be significantly lower 
(ANOVA p < 0.01; Tukey’s pairwise test p < 0.01) than that of strains G27 and 60190, 
further supporting that strain 26695 produces a lower cell density upon reaching 
stationary phase. 
 Evaluation of motility and cellular morphology by phase contrast revealed an 
increasing proportion of non-motile, coccoid shaped H. pylori cells through time.  Prior to 
48 hrs, few to no coccoid shaped H. pylori were observed in collected samples.  
Between 48 and 60 hrs, the proportion of non-motile, coccoid H. pylori rises to 
approximately 10% of the collected samples.  Between 60 and 72 hours, the proportion 
of non-motile, coccoid H. pylori increases to approximately 20% of the collected samples 
in strains G27 and 60190.  In H. pylori 26695 the proportion of observed non-motile, 
coccoid cells rises to approximately 35% between 60 and 72 hours of growth.  This 
elevation in proportion of cells undergoing transition into coccoid morphology potentially 
explains the difference in stationary phase cell density observed among the strains as 
coccoid cells are typically biochemically inactive and non-culturable.  Based on these 
data, a period of growth of 36 hours was selected for all H. pylori cultures which would 
be used for infection studies. 
 
2.3.2 Generation of a rat-adapted strain of H. pylori. 
 Rat-adapted strains of H. pylori were generated for every strain used in infection 
studies.  To create more amenable conditions for colonization of the gastric epithelium, 
the proton pump inhibitor lansoprazole was administered orally to animals at 3.75 mg/kg 
for 7 days during the inoculation procedure.  Animals were inoculated with H. pylori by 
oral gavage of approximately 1 x 107 cells on day 3 and 5 of lansoprazole treatment.  
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The dosage of H. pylori culture was selected based on previous studies of H. pylori 
infection in rats32.  One week following the completion of lansoprazole treatment, 
animals were euthanized and their stomachs collected for culturing.  H. pylori was 
cultured from the animals’ stomachs using H. pylori selective media (Columbia agar 
supplemented with 7% sheep’s blood, 10 µg/mL vancomycin, 5 µg/mL trimethoprim, 5 
µg/mL cefsulodin, and 5 µg/mL amphotericin B).  Resulting colonies were determined to 
be H. pylori by evaluation under phase contrast microscopy (motile, curved bacilli) and 
biochemical evaluation for catalase, oxidase, and urease activity.  Ten independent H. 
pylori colonies were purified by repeated streak plating and pooled.  A second 
adaptation passage was conducted using this culture.  Following re-purification of H. 
pylori from the stomachs of the second set of animals, strain identity was confirmed by 
sequencing of the 16S rRNA gene.  The H. pylori cultures resulting from this second 
passage were utilized as the rat-adapted strains for all subsequent infection studies. 
 
2.3.3 Influence of oral gavage cell density on bacterial load. 
 To determine the influence of oral gavage cell density may have on the course of 
infection, bacterial load was determined following 8 weeks of active H. pylori G27 
infection initiated by inoculums ranging from 1 x 102 to 1 x 107 cells.  Following 
euthanasia, collected stomachs were roughly chopped using sterile razor blades and 
washed vigorously in sterile liquid media to free H. pylori cells from the tissue.  The 
resulting stomach wash was serially diluted and plated for determination of CFU per mL.  
To account for variance in animal size, CFU numbers were normalized by mass of the 
stomach tissue utilized. 
 The resulting bacterial loads (Figure 2.2) revealed that bacterial load of H. pylori 
G27 after 8 weeks of active infection was not influenced by the cell density of the 
inoculum used in the oral gavages.  Previous studies have estimated that the gastric 
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transit time in juvenile rat pups is approximately 30 minutes43,54.  As such, it is 
reasonable to hypothesize that the majority of H. pylori delivered by oral gavage is 
unable to colonize the gastric epithelium prior to being lost to the lower gastrointestinal 
tract were it is unable to survive.  The consistency of the bacterial loads suggests that H. 
pylori growth is limited by available niche space and likely exists in an equilibrium in 
which the natural motility of the stomach removes cells at a rate commensurate with 
replacement by active growth of the bacteria. 
 Based on these data, it may be preliminarily estimated that the ID50 for H. pylori 
G27 under these experimental conditions is 1 x 103 cells.  Previous studies have 
suggested that the ID50 for rodents is 1 x 104 cells32,33.  However, these studies did not 
utilize a strain of H. pylori that was adapted to rodents by passaging or proton pump 
inhibitor treatment to aid in successful colonization of the gastric epithelium.   
 
2.3.4 H. pylori infection in Sprague-Dawley rats leads to establishment of 
reproducibly stable bacterial loads. 
 Active H. pylori infection studies were conducted in a time series system with 
infections lasting 2, 8, and 26 weeks.  Infection length was determined to have begun at 
the completion of lansoprazole administration.  Bacterial load was determined for each 
actively infected animal (Figure 2.3).  To account for variance in size among animals, 
bacterial load numbers were normalized by the mass of the stomach tissue utilized in 
culturing.  A significant trend of increasing bacterial load is observed through time 
(ANOVA: p < 0.01; Tukey’s pairwise comparisons: p < 0.01 for all comparisons).  It is 
hypothesized that this trend in increasing bacterial load results from changes in the 
available niche space that H. pylori is able to access as the animals grow. 
 To evaluate whether these observations regarding bacterial load during H. pylori 
infection were strain specific, the bacterial loads from 8-week infection studies utilizing 
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H. pylori strains 26695 and 60190 were determined and compared to those of H. pylori 
G27 (Figure 2.4).  Consistent with prior growth curve analyses, H. pylori 26695 resulted 
in a significantly lower bacterial load (ANOVA: p < 0.01; Tukey’s pairwise comparisons: p 
< 0.01) than strains G27 and 60190.  The data indicate that the trajectory of chronic H. 
pylori infection may be subtlety influenced by the strain of bacteria despite each strain 
possessing the same major virulent factors. 
 
2.3.5 Chronic H. pylori infection in Sprague-Dawley rats is associated with 
histological changes in gastric tissue consistent with those observed during 
human infection. 
 To determine if chronic H. pylori G27 infection in Sprague-Dawley rats resulted in 
comparable changes in gastric tissue to those observed during human infection, 
histological slides of gastric tissue were prepared for both mock and actively infected 
animals.  Evaluation of gastric tissue from adult animals after 26 weeks of infection 
(Figure 2.5A) revealed the presence of a mild, superficial gastritis.  Consistent with 
chronic H. pylori infection in humans prior to the onset of late-life gastric pathology, 
parietal cell hyperplasia is prominently observed in the mid-section of the gastric pits 
(Figure 2.5B).  Expansion of chief, G and enterochromaffin-like cell population is 
observed in the basal region of the gastric pit (Figure 2.5C).  Additionally, the infiltration 
of immune cell populations, predominantly mononuclear cells, is observed in the 
submucosa of actively-infected animals (Figure 2.5D). 
 These data demonstrate that chronic H. pylori in Sprague-Dawley rats 
recapitulates many of the key histological hallmark correlating with pathophysiological 
changes associated with chronic H. pylori infection in humans.  Development of mild 
dysplasia of the luminal aspects of the gastric epithelium due to inflammatory insult is a 
common finding in gastric biopsies of humans that are chronically infected with H. pylori 
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but have not yet progressed to ulcer disease or gastric adenocarcinoma.   Hyperplasia of 
parietal, chief, G, and enterochromaffin-like cell populations occurs partially as a 
consequence of H. pylori secreted urease raising the pH of the gastric lumen, resulting 
in physiological compensation by expansion of parietal cell populations.  Additionally, 
inflammation associated with H. pylori results in physiologic suppression of acid 
secretion by parietal cells, resulting in the expansion of modulatory chief, G, and 
enterochromaffin-like cells which secrete additional factors leading to the proliferation of 
parietal cell populations.    
 
2.3.6 H. pylori infection in Sprague-Dawley rats is associated with increased levels 
of inflammatory markers in gastric tissue. 
 Gastric levels of TNF-α, IL-6 and CRP were measured by high sensitivity ELISA 
from whole tissue lysates.  Differences were recorded as the fold difference between 
mock infected control animals and actively infected animals (2-way ANOVA: H. pylori 
status p-value: <0.0001, 61.8% of total variation; Length of infection p-value: <0.0001, 
18.9% of total variation; Figure 2.6).  The greatest degree of elevated inflammatory 
markers was observed at the 2-week time point.  It is hypothesized that this observation 
is the result of the acute phase of the immunological response to infection.    The 
magnitude of elevated inflammatory markers is markedly reduced between the 2- and 8-
week time points (Pairwise comparison by Tukey’s p-value: <0.0001).  Elevated levels of 
TNF-α and IL-6 remain consistent and non-significantly different between 8- and 26-
week time points.  However, CRP levels show a significant reduction between 8- and 26-
week time points.  Together these observations are indicative of the switch in the 
immunological response from the acute phase toward the chronic phase.  As both TNF-α 
and IL-6 are hypothesized to be produced and secreted locally within the tissue, the 
maintenance of stably elevated levels between 8- and 26-week time points is supportive 
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of the transition from acute to chronic immunological response.  As CRP is 
predominantly produced and secreted by the liver, it is hypothesized that the ongoing 
reduction of the magnitude of elevated CRP levels is related to the broader adaptation of 
the immune system toward a chronic inflammatory state. 
 To evaluate whether the observed elevation in gastric inflammatory markers was 
strain specific, 8-week infection studies were conducted using H. pylori 26695 and 
60190.  Similar to observed difference is bacterial load, H. pylori 26695 was associated 
with marginally lower levels of elevated inflammatory markers while H. pylori 60190 was 
associated with marginally higher level of elevated inflammatory markers in comparison 
to those observed during infection studies utilizing H. pylori G27 (Figure 2.7).  These 
data indicate that strain specific variation in elevated gastric inflammatory markers does 
indeed exist.  However, the degree of variation in elevation among these three type 
strains is marginal when considered from a biological context.  As such, these data lend 
support to a “universal” inflammatory response to H. pylori strains which possess the 
s1/m1 allele of vacA as well as the cag pathogenicity island, which are associated with 
heightened risk of developing gastric disease36,41,44,46. 
 
2.3.7 Eradication of H. pylori infection in Sprague-Dawley rats leads to resolution 
of increased inflammatory markers. 
 To assess whether active H. pylori infection was the etiological agent responsible 
for the observed elevation in inflammatory markers, eradication studies were conducted 
such that animals were inoculated with either sterile media (mock infected control 
animals) or H. pylori G27 culture (H. pylori cleared animals).  13 weeks after inoculation, 
all animals received oral eradication therapy consisting of lansoprazole (3.75 mg/kg), 
clarithromycin (2.25 mg/kg), and amoxicillin (4.5 mg/kg), twice daily for ten days. 
Sensitivity of the rat adapted strain of H. pylori G27 to the antibiotics was confirmed by 
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determination of minimum inhibitory concentration in agreement with accepted treatment 
guidelines49.  Animals were then allowed to “recover” for 13 weeks prior to the collection 
of tissue samples.  Clearance of infection was determined by the inability to culture H. 
pylori from the stomachs of animals which were inoculated with live culture.  Prior 
infection in these animals was confirmed by serology testing for the presence of anti-H. 
pylori antibodies.  Measurement of inflammatory markers from gastric tissue revealed no 
significant difference between mock infected and H. pylori cleared animals (Figure 2.8).  
These data support the inference that H. pylori infection was the causative agent of the 
observed elevation of gastric inflammatory markers.   
 
2.3.8 H. pylori infection in C57BL\6 mice leads to a similar but blunted pattern of 
increased levels of inflammatory markers.   
 To determine if the observed elevation in inflammatory markers was the result of 
host species specific interactions, 8-week infection studies were conducted utilizing 
C57BL\6 mice.  Animals were infected utilizing the rat-adapted strain of H. pylori G27 
according to the same inoculation procedure utilized in rat studies.  However, the 
animals utilized in these mouse infections were 6-week old, fully matured animals as 
opposed to juvenile pups in rat studies.   
 Following euthanasia and tissue collection, bacterial load was determined to be 
8000 ± 1200 CFU/mg of gastric tissue.  This bacterial load was significantly lower than 
that observed in Sprague-Dawley rats (p value: <0.01).  Two possible hypotheses may 
explain this observation.  Firstly, the gastric tissue of C57BL\6 mice may be less 
amenable to the growth of the rat-adapted strain of H. pylori G27; or, secondly, the 
stomachs of C57BL\6 mice may present H. pylori with reduced niche space as the 
gastric epithelium accounts for less tissue per unit mass in mice than in rats.  
Regardless, successful infection was observed in each inoculated animal. 
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 Measurement of inflammatory markers from whole tissue lysate prepared from 
the animals’ stomachs revealed a similar pattern of elevated levels of TNF-α, IL-6, and 
CRP in infected animals relative to mock infected animals as was seen in Sprague-
Dawley rats (Figure 2.9).  However, the magnitude of elevation was significantly 
reduced in infected mice in comparison to infected Sprague-Dawley rats (2-way ANOVA 
p value: <0.01, p values for pairwise comparison of individual inflammatory markers 
between infected C57BL\6 mouse vs infected Sprague-Dawley rat by Tukey’s pairwise 
comparison: <0.01 for all comparisons).  This observation of reduced inflammatory 
response in C57BL\6 mice has been noted in other studies utilizing gastrointestinal 
bacterial pathogens39.  These data support the inference that the observed elevation in 
gastric inflammatory markers is not the result of species specific physiology but rather 
can be attributed to active infection by H. pylori.  Additionally, these data indicate that the 
degree of inflammation observed during H. pylori infection is influenced by the host 
physiological response. 
 
2.3.9 Absence of prominent H. pylori virulence factors has only minor influence on 
H. pylori associated gastric inflammation. 
 To determine the influence of prominent H. pylori associated virulence factors, 8-
week long infections studies were conducted utilizing rat-adapted strains of transposon 
interruption mutants of H. pylori G2747: H. pylori G27 (vacA::Tn7), H. pylori  G27 
(cagA::Tn7), H. pylori  G27 (cagY::Tn7), or H. pylori  G27 (napA::Tn7).  These mutants 
were selected as they represent virulence factors commonly cited as predictive in the 
pathological outcome of chronic H. pylori infections.  The pore forming secreted bacterial 
toxin VacA has been linked to elevated risk in development of gastric disease3,4.  VacA 
is has been shown to elicit an inflammatory response in cell culture based 
experiments9,31.  Similarly, the cag pathogenicity island is associated with increased risk 
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for the development of both peptic ulcer disease10,40 as well as gastric 
adenocarcinoma52.  The most well studied effector protein of the cag pathogenicity 
island, CagA, interacts with SHP-221 to influence spreading, migration, and adhesion of 
epithelial cells58.  Additionally, CagA interacts with Grb2 to activate the Ras/MEK/ERK 
pathway, leading to cell scattering and proliferation37.  The CagY protein forms the 
sheath12,51 of the type IV secretion system used to inject macromolecules, such as 
CagA, into the host cell52.  Neutrophil-activating protein (NapA) of H. pylori is 
chemotactic for neutrophils and stimulates a high production of oxygen radicals1,16.  It is 
able to activate mast cells to release TNF-α38 as well as IL-12 and IL-23 release from 
neutrophils, monocytes, and dendritic cells1. 
 All transposon interruption mutants resulted in significantly reduced bacterial load 
in comparison to wildtype H. pylori G27 (ANOVA p value: <0.01; all pairwise 
comparisons vs wildtype by Tukey’s pairwise comparison test p values: <0.01; Figure 
2.10).  As comparisons of bacterial load among the transposon interruption mutants was 
not significant, this reduction in bacterial load is likely attributable to the influence of the 
transposon interruptions.  However, as the fold difference in bacterial load is only 
approximately 1.8, it is likely that this reduction in bacterial load has only negligible 
impact on the course of inflammation generated by chronic infection. 
 Comparisons in the magnitude of elevated inflammatory markers from gastric 
tissue revealed that transposon interruption of these virulence factors resulted in only 
minor changes in gastric inflammation (Figure 2.11).  Lack of functional vacA, cagA, or 
cagY genes was not associated with a significant change in magnitude of the measured 
inflammatory markers.  However, lack of a functional napA gene was associated with a 
small but significant decrease in the magnitude of all three measured inflammatory 
markers.  These data support the hypothesis that vacA as well as the cag pathogenicity 
island represent human specific adaptations that do not play major roles in the course of 
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infection in non-human animal models.  As the gastric immune infiltrate is composed 
more predominantly of eosinophils rather than neutrophils, the true impact of the 
absence of a functional napA gene may not be accurately portrayed in rodent infections.   
  
2.4 Discussion 
 Here, a Sprague-Dawley rat based model for chronic H. pylori infection has been 
developed.  As H. pylori infection is hypothesized to begin during the earliest stages of 
life, protocols were established to allow for inoculation of animals shortly post-weaning.  
Based on histological assessment of gastric tissue, infected animals recapitulate many 
of the hallmark tissue adaptations that occur during chronic H. pylori infection prior to the 
development of clinical gastric disease, such as increasing immune cell infiltration and 
the development of glandular hyperplasia.  Direct evaluation of inflammatory markers 
confirms that chronic H. pylori results in marked gastritis.  Interestingly, these studies 
suggest that the transition from acute inflammation to chronic inflammation occurs 
between 2 and 8 weeks in these animals with elevated inflammatory markers remaining 
stable between 8 and 26 weeks of infection.   
 Only minor differences were observed in infections utilizing different strains of H. 
pylori, indicating that this animal model may be robust to strain specific genetic variance 
among pathogenic H. pylori strains.  In comparing elevated levels of inflammatory 
markers between Sprague-Dawley rats and C57BL\6 mice, mice showed a similar 
pattern of elevated inflammatory markers; however, the magnitude of elevation was 
markedly reduced in mice compared to rats.  This is likely due to C57BL\6 mice having a 
blunted inflammatory response following exposure to gastrointestinal bacterial 
pathogens.  However, it does indicate the elevation of inflammatory markers is not 
unique to Sprague-Dawley rats.   
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In infection studies utilizing H. pylori G27 strains in which major virulence factors 
have been transposon interrupted, lack of VacA or aspects of the cag pathogenicity 
island had no significant impact on the levels of inflammation observed during infection.  
These findings support the hypothesis that these particular virulence factors are human 
specific factors that may not play a major role in H. pylori infection in rodents.  Lack of 
NapA was associated with a minor but significant decrease in TNF-α and IL-6 in gastric 
tissue but not CRP.  This indicates that NapA may serve as a minor player in the 
localized inflammatory response within the stomach but may not contribute to any 
systemic effect.       
 As most efforts in developing animal models for H. pylori infection have focused 
heavily on recapitulating the late-life clinical stages of disease, understanding of the 
early stages of chronic infection has been limited.  These data lay the groundwork for an 
animal model which may prove beneficial for addressing questions relating to the early 
stages of chronic H. pylori infection. Furthermore, the development of a rat-based model 
of chronic H. pylori infection provides a tool amenable to evaluating many of the extra-
gastric influences of H. pylori infection, such as cognitive and nutritional health, as rat-
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Figure 2.1. Growth curve characteristics of H. pylori strains utilized in infection 
studies.  Growth curves (n=3 for each strain) for H. pylori strains G27 (a and b), 60190 
(c and d), and 26695 (e and f) were determined using bisulfite-free Brucella broth under 
microaerophilic conditions.  Samples were collected every 90 minutes and OD600(a,c 
and e) and CFU/mL (b, d, and f) were measured.  Curves were generated by non-linear 
regression according to the Boltzmann sigmoidal formula.  Dotted lines correspond to 
the 95% confidence interval for each trend line.  Statistical evaluation of the curves 
found no significant difference in the “slope” parameters, indicating that growth rate did 
not vary significantly among the evaluated strains.  However, the “top” parameter for H. 
pylori 26695 was significantly lower (ANOVA p < 0.01; Tukey’s pairwise test p = 0.02) 
than that observed for strain G27 and 60190, indicating that strain 26695 reaches lower 
cell density at stationary phase.  Based on these data, inoculation cultures were grown 
for 36 hours prior to use in oral gavage of animals to ensure that actively growing mid-
log phase culture was used.           
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Figure 2.2. Bacterial load following 8-week long infection established by varying 
inoculums.  To determine the influence of inoculation dosage on bacterial load, 8-week 
long infections (n = 1 animal per dosage with 3 technical replicates of bacterial load per 
animal) were established using varying inoculums of H. pylori G27.  No infection was 
observed in the animal inoculated with 102 cells of H. pylori.  Negligible differences were 
observed in bacterial load from animals that received 103 – 107 cells of H. pylori.  These 
data suggest that H. pylori bacterial load during chronic infection is not influenced by the 
initial inoculum dosage.  Interestingly, these data suggest that H. pylori exists in an 
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Figure 2.3. Time series of bacterial load observed following 2-, 8-, and 26-week 
long H. pylori G27 infections.  Whole stomach tissue was cut into 1 cm2 pieces and 
washed vigorously in sterile media prior to plating on H. pylori selective medium 
(Columbia Blood Agar supplemented with vancomycin (10 µg/mL), trimethoprim (5 
µg/mL), cefsulodin (5 µg/mL), and amphotericin B (5 µmg/mL)). Bacterial load was 
calculated as number of CFU per mg of gastric tissue. Each filled circle represents the 
bacterial load of an individual animal (n=9 for each time point). Data were collected 
across 3 independent experiments, each with 3 infected animals. Resulting data were 
pooled when no significant difference was detected by ANOVA (p values: 2 weeks = 0.6, 
8 weeks = 0.3, 26 weeks = 0.4).  The horizontal line corresponds to the mean bacterial 
load at each time point. Statistical evaluation by ANOVA (p < 0.01) and Tukey’s multiple 
comparison test (p values reported above each comparison) supported a trend of 
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Figure 2.4. Influence of H. pylori strain on bacterial load following 8-week long 
infections.  Whole stomach tissue was cut into 1 cm2 pieces and washed vigorously in 
sterile media prior to plating on H. pylori selective medium (Columbia Blood Agar 
supplemented with vancomycin (10 µg/mL), trimethoprim (5 µg/mL), cefsulodin (5 
µg/mL), and amphotericin B (5 µg/mL)). Bacterial load was calculated as number of CFU 
per mg of gastric tissue. Each filled circle represents the bacterial load of an individual 
animal (n = 3 for each H. pylori strain).  The horizontal line corresponds to the mean of 
the bacterial load. Statistical evaluation by ANOVA (p < 0.01) and Tukey’s multiple 
comparison test (p values reported above significant comparisons) indicate that H. pylori 






Figure 2.5. Chronic H. pylori G27 infection in Sprague-Dawley rats recapitulates 
many of the histological hallmarks associated with chronic infection in humans 
prior to the onset of clinical disease. Hematoxylin and eosin Y stained histological 
slides prepared from rat gastric tissue following 26-week long H. pylori G27 infections.  
Sections were taken along the greater curvature of the stomach at the corpus-antrum 
transition zone.  Sections are oriented with the luminal side of the tissue on the left and 
serosal side to the right.  Overview of the total sections (A) demonstrates the 
appearance of healthy, non-inflamed tissue in the mock-infected animal in comparison to 
actively infected animal, characterized by dysplasia of the luminal edge as well as 
hyperplasia of the underlying glandular cell populations.  Inset images depict the 
presence of parietal cell hyperplasia (B) as well as chief, G, and enterochromaffin-like 
cell hyperplasia (C) in the actively infect animals in comparison to mock-infected.  The 
final inset image (D) demonstrates the infiltration of immune cell populations, 
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Figure 2.6. Measurement of inflamamtory markers from gastric tissue following H. 
pylori G27 infection. Quantitative ELISA based assessment of the degree of change of 
levels of TNF-α, IL-6, and CRP during H. pylori G27 infection.  H. pylori associated 
changes in inflammatory markers is reported as fold difference between actively infected 
animals relative to matched mock-infected animals.  Data were collected across 3 
independent experiments, each utilizing 3 mock-infected and 3 actively infected animals. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white bars) were averaged and rendered relative 
to match mock-infected animals. The height of each bar corresponds to the mean 
difference between inflammatory markers, and the error bars correspond to the standard 
error of the mean. Data were statistically evaluated by 2-way ANOVA (p values: H. pylori 
status: < 0.01, length of infection: < 0.01, and interaction: < 0.01 for each inflammatory 
marker) with comparisons between matched mock-infected and actively infected animals 
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Figure 2.7. Comparison of gastric inflammatory markers following 8-week long H. 
pylori infections utilizing strains G27, 60190, and 26695. Quantitative ELISA based 
assessment of the degree of change of levels of TNF-α, IL-6, and CRP during H. pylori 
infection utilizing strains G27, 60190, and 26695.  H. pylori associated changes in 
inflammatory markers is reported as fold difference between actively infected animals 
relative to matched mock-infected animals.  Data were collected utilizing 3 mock-infected 
and 3 actively infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively infected animals (white bars) were 
averaged and rendered relative to match mock-infected animals. The height of each bar 
corresponds to the mean difference between inflammatory markers, and the error bars 
correspond to the standard error of the mean. Data were statistically evaluated by 
ANOVA (p value: < 0.01) with comparisons between H. pylori strains by Tukey’s multiple 
comparison test (p values reported above each comparison).  
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Figure 2.8. Measurement of inflamamtory markers from gastric tissue following 
eradication of H. pylori G27 infection. Quantitative ELISA based assessment of the 
degree of change of levels of TNF-α, IL-6, and CRP following eradication of H. pylori 
G27 infection.  In eradication studies (d), 13-week infections were carried out in 
Sprague-Dawley rats utilizing H. pylori G27, followed by an eradication regimen 
(lansoprazole (3.75 mg/kg), clarithromycin (2.25 mg/kg), and amoxicillin (4.5 mg/kg) 
administered orally, twice daily for 10 days). After 13 weeks following eradication 
regimen, tissue samples were collected and inflammatory markers measured by 
quantitative ELISA.  H. pylori associated changes in inflammatory markers is reported as 
fold difference between actively infected animals relative to matched mock-infected 
animals.  Data were collected across 3 independent experiments, each utilizing 3 mock-
infected and 3 actively infected animals. Results from mock-infected animals (black 
bars) were averaged and normalized to 1. Results from actively infected animals (white 
bars) were averaged and rendered relative to match mock-infected animals. The height 
of each bar corresponds to the mean difference between inflammatory markers, and the 
error bars correspond to the standard error of the mean. significant differences were not 
observed in levels of TNF-α, IL-6, or CRP, indicating that inflammatory marker levels 
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Figure 2.9. Measurement of gastric inflammatory markers in C57BL\6 mice 
following 8-weel long H. pylori G27 infections. Quantitative ELISA based assessment 
of the degree of change of levels of TNF-α, IL-6, and CRP during H. pylori infection in 
C57BL\6.  H. pylori associated changes in inflammatory markers is reported as fold 
difference between actively infected animals relative to matched mock-infected animals.  
Data were collected utilizing 3 mock-infected and 3 actively infected animals. Results 
from mock-infected animals (black bars) were averaged and normalized to 1. Results 
from actively infected animals (white bars) were averaged and rendered relative to 
match mock-infected animals. The height of each bar corresponds to the mean 
difference between inflammatory markers, and the error bars correspond to the standard 
error of the mean. Data were statistically evaluated by student’s t-test (p values reported 
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Figure 2.10. Measurement of bacterial load from 8-week long infections utilizing 
transposon interuption mutant of H. pylori G27. Whole stomach tissue was cut into 1 
cm2 pieces and washed vigorously in sterile media prior to plating on H. pylori selective 
medium (Columbia Blood Agar supplemented with vancomycin (10 µg/mL), trimethoprim 
(5 µg/mL), cefsulodin (5 µg/mL), and amphotericin B (5 µg/mL)). Bacterial load was 
calculated as number of CFU per mg of gastric tissue. Each filled circle represents the 
bacterial load of an individual animal (n = 3 for each H. pylori strain).  The horizontal line 
corresponds to the mean of the bacterial load. Statistical evaluation by ANOVA (p < 
0.01) and Tukey’s multiple comparison test (p values reported above significant 
comparisons) indicate that mutant strains of H. pylori G27 resulted in significantly lower 
bacterial load in comparison to wildtype.  As no significant difference was observed 
among the transposon interruption mutants, this difference is likely attributable to the 
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Figure 2.11. Comparison of gastric inflammatory markers following 8-week long H. 
pylori infections utilizing transposon interruption mutants of vacA, cagA, cagY, 
and napA. Quantitative ELISA based assessment of the degree of change of levels of 
TNF-α, IL-6, and CRP during H. pylori infection utilizing strains transposon interruption 
mutants of prominent virulence factors.  H. pylori associated changes in inflammatory 
markers is reported as fold difference between actively infected animals relative to 
matched mock-infected animals.  Data were collected utilizing 3 mock-infected and 3 
actively infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively infected animals (white bars) were 
averaged and rendered relative to match mock-infected animals. The height of each bar 
corresponds to the mean difference between inflammatory markers, and the error bars 
correspond to the standard error of the mean. Data were statistically evaluated by 2-way 
ANOVA (p value: < 0.01) with comparisons between wildtype H. pylori G27 and the 
transposon interruption mutant strains by Tukey’s multiple comparison test (p values 
reported above each comparison).  Disruption of the napA gene was associated with a 
small by significant decrease in the magnitude of elevation of the measured 
inflammatory markers in gastric tissue.
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Chapter 3: Systemic inflammatory response to chronic Helicobacter pylori 
infection 
3.1 Introduction 
Chronic systemic inflammation is characterized by the elevation of circulating 
inflammatory markers and is associated elevated risk in the development and 
progression of many multi organ-system dysfunctions1,8,10,11,28,29,31.  Two hypotheses 
have been put forward to explain the development of systemic inflammation as a result 
of localized infection.  The first, termed cytokine “spill-over” describes the entrance into 
circulation of local produced inflammatory cytokines through inflammation mediated 
permeabilization of the vasculature9,17,26,32.  The second is loss of normal immune 
suppressive activity by tolerogenic dendritic cells and T regulatory cells35.  Both 
processes are associated with the rise in circulating pro-inflammatory markers, such as 
TNF-α, IL-6 and c reactive protein34. 
Epidemiological studies have suggested an association between chronic H. pylori 
infection and systemic inflammation13,22,24,38.  Specifically, H. pylori seropositivity has 
been associated with elevated circulating of the acute phase protein, c reactive protein 
(CRP)12,15,16,18,19.  These findings have led to the proposal that chronic H. pylori infection 
may increase the risk of death by myocardial infarction3,25 as elevated circulating CRP 
levels are associated with increased risk of myocardial infarction7,14,27.  Additionally, 
chronic H. pylori infection has been associated with polarization of Th1 and Th2 cell 
populations toward the pro-inflammatory Th1 phenotype4,6,36.    
 To evaluate the role of chronic H. pylori infection in the development of systemic 
inflammation inflammatory markers were quantified from liver, spleen, and plasma 
samples form 2-, 8- and 26-week long H. pylori G27 infection studies.  Eradication 
studies were utilized to evaluate the causal relationship between active H. pylori 
infection and systemic inflammation.  Finally, the role of T cell populations in the 
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development of H. pylori associated systemic inflammation were evaluated by T cell 
phenotyping to determine the degree systemic immune cell population modulation that 
occurs during chronic H. pylori infection and by conducting infection studies conducted in 
athymic rats. 
 
3.2 Materials and Methods 
Animal care. All experiments involving the use of live vertebrate animals were 
conducted with the approval of the University of Illinois at Urbana-Champaign 
Institutional Animals Care and Use Committee (IACUC).  Rat populations were 
composed of male Sprague-Dawley rats (Envigo, formerly Harlan Laboratories, 
Indianapolis, IN).  Mouse populations were composed of male C57BL\6J mice (Jackson 
Laboratory, Bar Harbor, ME).  Animals were single housed with 12 h light-dark cycle, 
mean temperature of 22.1°C, humidity of 50%, and allowed food and water ad libitum. 
 
Active H. pylori infection time series. To evaluate systemic inflammation, liver, spleen 
and plasma tissue were collected at the time of euthanasia by necropsy from the animal 
populations described in Chapter 2.  In brief, these animal populations consisted 2-, 8-, 
and 26-week infection studies, each composed of 3 independent blocks which, in turn, 
were each composed of 3 mock infected animals and 3 actively infected animals.  
 
Eradication of active H. pylori infection studies. To evaluate systemic inflammation, 
liver, spleen and plasma tissue were collected at the time of euthanasia by necropsy 
from the animal populations described in Chapter 2.  In brief, this animal population was 
composed of 3 independent blocks which, in turn, were each composed of 3 mock 
infected animals and 3 actively infected animals.  Animals were infected for 13 weeks; 
then, both mock infected and actively infected animals underwent eradication therapy.  
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All animals were allowed to remain uninfected for an additional 13 weeks prior to 
euthanasia and collection of tissues. 
 
Mouse infection studies.  To evaluate systemic inflammation, liver, spleen and plasma 
tissue were collected at the time of euthanasia by necropsy from the animal population 
described in Chapter 2.  In brief, this animal population consisted of an 8-week infection 
study, composed of 3 mock infected animals and 3 actively infected C57BL\6 mice. 
 
LPS induced systemic inflammation.  To provide a point of comparison to induced 
systemic inflammation, Sprague Dawley rats received weekly intraperitoneal injections of 
500 µg/kg purified E. coli LPS (Sigma Aldrich, St. Louis MO) dissolved in PBS or the 
equivalent volume of PBS on a weekly basis for 8 weeks.  Following completion of 
exposure experiment animals were euthanized and stomach, liver, spleen, and plasma 
collected for the measurement of inflammatory markers.  Due to the extreme distress 
resulting from this exposure experiment in the experimental animal population, the 
animal population was limited in size to one LPS exposed animal and one PBS exposed 
animal. 
 
Naproxen induced gastritis.  To determine if gastritis in the absence of active H. pylori 
infection is sufficient to cause systemic inflammation, animal studies were conducted in 
which Sprague-Dawley rats received either naproxen (80 mg/kg; Sigma Aldrich) 
suspended in PBS or the equivalent amount of PBS once weekly for 8 weeks.  Following 
completion of exposure experiment animals were euthanized and stomach, liver, spleen, 




Athymic rat infection studies.  To evaluate the role of T cell populations in H. pylori 
associated inflammation, 8-week long infection studies were conducted utilizing male 
Foxn1rnu/rnu rats (Envigo) aged 20-21 days.  Animals were infected with H. pylori as 
previously described.  The animal population consisted of 3 actively infected animals 
and 3 mock infected animals.  Following completion of exposure experiment animals 
were euthanized and stomach, liver, spleen, and plasma collected for the measurement 
of inflammatory markers.   
 
Terminal collection of tissue samples. Tissue samples were collected as described in 
Chapter 2.  In brief, animals were placed under surgical anesthesia, and terminal blood 
collection was conducted by cardiac puncture.  Stomach, liver, spleen and brain tissues 
were collected by necropsy immediately following euthanasia of the animal. 
 
Sample processing.  Collected tissue samples were processed as described in Chapter 
2.  In brief, plasma samples were prepared from whole blood and stored at -20°C until 
assayed.  Remaining tissues were stored at -20°C until processed for preparation of 
whole tissue protein lysates. 
 
Preparation of whole tissue protein lysates.  200 mg of gastric tissue was 
mechanically homogenized using mortar and pestle with the aid of liquid nitrogen.  
Homogenized tissue was suspended in 2 mL of RIPA buffer (Thermo Fisher) 
supplemented proteinase inhibitor cocktail (Thermo Fisher).  Cells were lysed on ice with 
gentle shaking for 3 hr.  Unlysed tissues and lipid fraction were removed by 
centrifugation at 1500 x g for 15 min at 4°C.  Total protein concentration for tissue 
lysates was determined by BCA assay (Thermo Fisher).  Tissue lysates were aliquoted 




Cytokine quantification.    Tissue lysate was diluted to 500 µg/ml to standardize the 
amount of protein assayed across sample.  Cytokine quantification was determined by 
quantitative ELISA for TNF-α (Eagle Bioscience, Nashua, NH), IL-6 (Eagle Biosciences), 
and CRP (Sigma Aldrich) according to manufacturer’s directions.   
 
T cell population phenotyping.  To evaluate changes in circulating T cell populations, 
8-week long infection studies were conducted utilizing H. pylori G27.  The experimental 
population consisted of 5 mock infected Sprague-Dawley rats and 5 actively infected 
rats.  Following completion of exposure experiment animals were euthanized and whole 
blood collected by cardiac puncture.  Buffy coat immune lymphocytes were purified from 
fresh whole blood differential centrifugation using Histopaque (Sigma Aldrich) and 
Accuspin separation tubes (Sigma Aldrich).  Immune cells were cultured in RPMI 1640 
(Sigma Aldrich) supplemented with 10% FBS (Sigma Aldrich).  Immune cells were 
activated by exposure to PMA 50 ng/ml (Sigma Aldrich) and ionomycin 1 µg/ml (Sigma 
Aldrich) in the presence of GoligiStop (BD Biosciences, Franklin Park, NJ) for 4 hours.  
Following fixation and permeabilization, cells were labeled with fluorchrome-conjugated 
mAbs against CD4 (W/325; BioLegend, San Diego, CA), INF-γ (DB-1; BioLegend), IL-4 
(OX-81; BioLegend), IL-17A (eBio17B7; Affymetrix, Santa Clara, CA), and FoxP3 (150D; 
BioLegend).  Cells were analyzed using a BD FACS Canto II flow cytometer (BD 
Biosciences) and FCS Express 5 (BD Biosciences).  Th1/Th2 ratio was determined as 
the proportion of CD4+ cells that were exclusively INF-γ+ (Th1) or IL-4+ (Th2).  
Th17/Treg ratio was determined as the proportion of CD4+ cells that were exclusively IL-
17A+ (Th17) or FoxP3+ (Treg). 
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Statistical analysis.  Cytokine levels from active infection time series were evaluated by 
two-way ANOVA of H. pylori infection status and length of infection with Tukey’s 
correction for multiple comparisons.  Eradication studies, mouse studies, heat killed H. 
pylori studies, E. coli K12 studies, naproxen induced gastritis studies, athymic rat H. 
pylori infection studies, and T cell phenotyping studies were evaluated using a 2-tailed 
distribution, paired t test.  Cytokine levels from transposon insertion H. pylori infection 
studies were evaluated by two-way ANOVA of H. pylori infection status and H. pylori 
strain. An alpha level of 0.05 was used as a threshold for statistical significance and all 
error bars represent standard error of the mean (SEM). Graphpad Prism (version 6.01) 
was used for all statistical analyses.  
  
3.3  Results 
 
3.3.1 H. pylori infection in Sprague-Dawley rats is associated with increased levels 
of inflammatory markers in liver, spleen, and plasma tissue. 
 Utilizing tissue samples collected as part of the 2-, 8-, and 26-week long H. pylori 
G27 time series, TNF-α, IL-6, and CRP were assayed from liver, spleen, and plasma by 
quantitative ELISA.    At 2-weeks post inoculation, liver levels of TNF-α (Figure 3.1) 
were found to be 17.5 fold elevated in H. pylori infected animals relative to mock-infected 
animals.  These elevated levels decreased to 8.5-fold at 8 weeks and 7.6-fold at 26 
weeks post inoculation (ANOVA p value: < 0.001; Pairwise comparison 2-weeks vs 8-
/26-weeks by Tukey’s p value < 0.001).  Elevated levels of IL-6 in the liver (Figure 3.1) 
were on average 19.5-fold higher in H. pylori infected animals than in mock infected with 
no significant difference between time points.  Elevated levels of CRP in the liver (Figure 
3.1) were 86.5-fold elevated in H. pylori infected at 2-weeks post-inoculation, decreased 
to 34.1-fold elevated at 8-weeks, and further decreased to 13.4-fold elevation at 26-
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weeks (ANOVA p value: < 0.001; p values for all pairwise comparisons by Tukey’s: 
<0.001).   
In the spleen, TNF-α levels were found to be elevated on average 8.7-fold during 
H. pylori infection across all time points with no significant difference between time 
points (Figure 3.2).  Similarly, IL-6 levels were found to the elevated by 5.8-fold on 
average during H. pylori infection across all time points with no significant difference 
between time points (Figure 3.2).  Spleen associated CRP levels (Figure 3.2) showed a 
trend of decreasing elevation through time with 28.4-fold elevation at 2-weeks, 8.1-fold 
at 8-weeks, and 5.1-fold elevation at 26-weeks post inoculation (ANOVA p value: < 
0.001; p values for all pairwise comparisons by Tukey’s: <0.001).   
Plasma levels of TNF-α (Figure 3.3) were observed to be 18.8-fold elevated at 2-
weeks post inoculation with a minor reduction to 16.6-fold elevated at 8-weeks and 14.5-
fold elevated at 26 weeks (ANOVA p value: < 0.001; p values for all pairwise 
comparisons by Tukey’s: <0.001).  Plasma levels of IL-6 (Figure 3.3) were on average 
3.6-fold elevated across all time points with no significant difference between time 
points.  Similarly, plasma levels of CRP (Figure 3.3) were on average 4.2-fold elevated 
across all time points with no significant difference between time points.  These data 
show a strong association between chronic H. pylori infection and stable elevation of 
circulating inflammatory markers with involvement of the liver, spleen, and plasma. 
To assess whether H. pylori associated systemic inflammation was the result of 
strain-specific interactions, 8-week infection studies carried out utilizing H. pylori 60190 
and 26695 likewise showed elevated levels of inflammatory markers in circulating 
plasma, as well as the liver and spleen (Figure 3.4).  No significant difference was 
observed in the fold elevation of TNF-α (p value ANOVA: plasma: 0.4990, liver: 0.9997, 
spleen: 0.9728) or IL-6 among G27, 60190, and 26695 (p value ANOVA: plasma: 
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0.8967, liver: 0.8846, spleen: 0.7329).  H. pylori 60190 was associated with minor but 
significant increase in elevation in plasma (p value ANOVA: < 0.001; Pairwise 
comparison 60190 vs G27/26695 by Tukey’s p value = 0.003), liver (p value ANOVA: 
0.001; Pairwise comparison 60190 vs G27/26695 by Tukey’s p value = 0.008), and 
spleen (p value ANOVA: 0.001; Pairwise comparison 60190 vs G27/26695 by Tukey’s p 
value = 0.001) CRP levels in comparison to G27 and 26695.  These data indicate that 
strain specific variation of H. pylori may have little influence on H. pylori associated 
systemic inflammation. 
 
3.3.2 Eradication of H. pylori infection in Sprague-Dawley rats leads to resolution 
of increased levels of inflammatory markers. 
In eradication studies, systemic inflammatory markers were found to have 
returned to normal baseline levels following eradication of chronic H. pylori infection 
(Figure 3.5).  These data are strongly indicative that not only is active H. pylori infection 
responsible for initiation of the systemic inflammatory response but is also required for 
maintaining the systemic inflammatory response.   
 
3.3.3 H. pylori infection in C57BL\6 mice leads to a similar but blunted pattern of 
increased levels of inflammatory markers. 
 To determine if the observed systemic inflammatory response associated with H. 
pylori infection was species-specific, inflammatory markers were measured from liver, 
spleen, and plasma samples collected from C57BL\6 mice which had been infected with 
H. pylori G27 for 8 weeks.  As was seen in gastric tissue, a similar pattern of elevated 
inflammatory markers was observed in mice as was seen in Sprague-Dawley rats 
(Figure 3.6).  Additionally, as was seen in gastric tissue, the magnitude of elevation of 
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the measured cytokines was reduced in mice relative to rats by approximately 2-fold.  
These data support the hypothesis that the observed elevation of systemic inflammatory 
markers is not species-specific; however, the data do suggest that the degree of 
systemic inflammation associated with chronic H. pylori infection is potentially influenced 
by the host species. 
 
3.3.4 H. pylori associated systemic inflammatory profile is markedly different than 
that associated with systemic administration of LPS. 
  To assess the degree of gastritis induced by chronic H. pylori infection to that 
seen during sepsis, we conducted animal studies in which animals received either mock 
treatment with sterile saline or once weekly intraperitoneal injection of purified E. coli 
LPS (500 µg/kg).  H. pylori could not be recovered from the stomachs of animals at the 
conclusion of these studies.  Measurement of gastric inflammatory markers revealed 
12.4-fold higher levels of TNF-α, 13.9-fold higher levels of IL-6, and 58.3-fold higher 
levels of CRP in comparison to those observed following 8 weeks of H. pylori infection 
(Figure 3.7). 
Weekly administration of LPS induced extremely elevated systemic inflammatory 
markers (Figure 3.7).  LPS administration was associated with a 4.4-fold higher 
elevation of plasma TNF-α, 11-fold high elevation of plasma IL-6, and 9.6-fold higher 
elevation of plasma CRP than was observed during chronic H. pylori infection.  In the 
liver, LPS administration was associated with 13.8-fold higher elevation of TNF-α, 3.5-
fold higher elevation of IL-6, and 2.1-fold higher elevation of CRP than was seen during 
chronic H. pylori infection.  In the spleen, LPS was associated with 17.2-fold higher 
elevation of TNF-α, 17.6-fold higher elevation IL-6, and 8.9-fold higher elevation of CRP 
than was seen during chronic H. pylori infection.  These data help to place H. pylori 
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associated systemic inflammatory response in a broader context of severity.  LPS 
administration more closely resembles the degree of inflammation associated with acute 
infection and sepsis; however, the increased levels of inflammatory markers observed 
during chronic H. pylori infection are markedly milder.   
 
3.3.5 Administration of heat killed H. pylori or E. coli K12 is not associated with 
elevated levels of inflammatory markers. 
To assess the necessity of active H. pylori infection in inducing the observed 
elevated inflammatory markers, infection studies were conducted utilizing heat-killed H. 
pylori G27.  Bacteria were heat killed in such a way as to render them unculturable in 
liquid BSFB media or on Columbia blood agar plates but prevent lysis of bacterial cells 
as determined by phase contrast microscopy.  H. pylori could not be recovered from the 
stomachs of animals 8 weeks post-inoculation.  Measurement of gastric and systemic 
inflammatory markers found no significant elevation between mock control animals and 
those that received heat-killed H. pylori culture (Figure 3.8).  To determine that the 
observed elevation of inflammatory markers was not due to perturbation of the normal 
gut microflora by inoculation by addition of bacterial culture, infection studies were 
conducted utilizing E. coli K12.  H. pylori could not be recovered from the stomachs of 
animals 8-week post-inoculation.  Measurement of gastric and systemic inflammatory 
markers found no significant difference between mock control animals and those that 
received active E. coli culture (Figure 3.9).  As a whole, these data support the finding 
that active H. pylori infection is necessary for observation of elevated inflammatory 
markers and that a perturbation of the gut microflora by inoculation with an innocuous 
bacterial species is not sufficient to induce the observed elevation in inflammatory 




3.3.6 Naproxen-induced gastritis is not associated with the development of 
systemic inflammation. 
  To assess if gastritis in the absence of H. pylori infection was sufficient to 
induce systemic inflammation, gastritis was chemically induced by once weekly oral 
gavage of high dose naproxen (80 mg/kg) for 8 weeks. This approach has been 
previously shown to induce neutrophilic associated ulceration of the gastric 
epithelium21,39. H. pylori could not be recovered from the stomachs of animals at the 
conclusion of these studies.  Measurement of inflammatory markers revealed 4-fold 
higher levels of TNF-α (P < 0.0001), 4.5-fold higher IL-6 (P < 0.0001), and 6.9-fold 
higher CRP (P < 0.0001) elevation in comparison to those observed following 8 weeks of 
H. pylori infection (Figure 3.10).  These data indicate that the increased levels of 
inflammatory markers associated with chronic H. pylori infection are milder in 
comparison to those observed during ulceration or sepsis.    
     While gastritis associated with high dose oral administration of naproxen was 
significantly greater than that observed during chronic H. pylori infection, it was not 
associated with an elevation of systemic inflammatory markers (Figure 3.10).  Naproxen 
administration was associated with a minor but significantly elevation of liver 
inflammatory markers.  This observation is in agreement with other studies that have 
found the high dose naproxen administration is associated mild level of hepatotoxicity2,5.  
Ultimately, these data support the conclusion that H. pylori associated systemic 
inflammation is dependent on active H. pylori infection and not simply a downstream 




3.3.7 Absence of T cell populations is associated with a lack of systemic 
inflammation during chronic H. pylori infection. 
As previous experiments suggested that H. pylori associated modulation of the 
immune system, especially of T cell populations, may be a key factor in determining the 
course of associated systemic inflammation, infection experiments were conducted 
utilizing athymic rats to assess the course of H. pylori associated inflammation in the 
absence of T cell populations.  In congruence with athymic mouse studies20,37, gastric 
inflammation was highly attenuated in athymic rats during 8 weeks of H. pylori G27 
infection (Figure 3.11) showing only 4.5-fold elevation of TNF-α and 4.3-fold elevation of 
IL-6.  CRP levels were not found to be elevated in gastric tissue, further supporting the 
conclusion that while CRP may be detected in other tissues, liver and adipose tissue 
require interaction with immune cell populations to produce and secrete this acute phase 
protein.  Inflammatory markers measured from plasma, liver and spleen were not found 
to be significantly different from those observed during mock infection.  These data 
further support the finding that H. pylori associated systemic inflammation is dependent 
on immune cells populations absent in athymic rats. 
 
3.3.8 Chronic H. pylori infection is associated with modulation of circulating T cell 
populations. 
Previous studies have suggested that chronic H. pylori infection manifests an 
immunomodulatory influence on the cell populations of the adaptive immune 
system23,30,33.  To assess the degree of immune system modulation, we examined 
changes in the Th1:Th2 and Th17:Treg ratios following 8 weeks of chronic infection by 
H. pylori G27.  The Th1:Th2 ratio increased by 1.6-fold (Figure 3.12), indicating a 
significant increase in Th1 cells relative to antagonistic Th2 cells.  The Th17:Treg ratio 
decreased by 11.3-fold (Figure 3.12), indicating a significant increase in the generation 
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of Treg cells during H. pylori infection.  Together, these data add a measure of nuance to 
the immunological response to chronic H. pylori infection in that while a Th1 polarization 
favors a pro-inflammatory state, a Treg polarization favors tolerance and suppression of 
inflammation. These seemingly contradictory processes suggest that H. pylori 
associated modulation of the immune system plays a key role in both inducing 
inflammation but also maintaining inflammation at low levels throughout chronic 
infection. 
 
3.3.9 Absence of prominent H. pylori virulence factors has negligible influence on 
H. pylori associated systemic inflammation. 
 To evaluate the potential influence of major H. pylori virulence factors on H. pylori 
associated systemic inflammation, inflammatory markers were quantified by ELIA from 
liver, spleen, and plasma collected from animals follow 8-week long H. pylori infection 
studies utilizing the transposon interruption mutants described in Chapter 2 (Figure 
3.13).  In tissue collected from infected animals, no significant difference in elevated 
inflammatory markers was observed in each of the examined tissues.  These data 
indicate that VacA, the cag pathogenicity island, and NapA have limited influence on the 
development of H. pylori associated systemic inflammation in Sprague-Dawley rats.  As 
both VacA and the cag pathogenicity island have been proposed to function in a human-
specific context, some caution must be exercised in direct application of these findings to 
natural human infection.   
 
3.4 Discussion 
 Chronic systemic inflammation is characterized by the long term presence of 
elevated levels of circulating inflammatory markers.    The presence of chronic systemic 
inflammation has been associated with elevated risk of multi-organ system dysfunction 
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and increased risk of the development of disease.  Epidemiological studies have 
suggested a potential association between H. pylori seropositivity and elevated 
circulating inflammatory markers.  Direct evaluation of markers of systemic inflammation 
as well as eradication studies support the hypothesis that chronic H. pylori infection is an 
etiological agent of systemic inflammation.  Furthermore, the trend of decreasing 
inflammatory markers in the liver and spleen support the hypothesis that the immune 
response shifts from acute phase to chronic phase sometime between 2 and 8 weeks of 
chronic infection. 
 Similar to gastric inflammation, only negligible differences in elevated 
inflammatory markers were observed during infection studies utilizing different strains of 
H. pylori.  Likewise, infection studies in C57BL\6 mice resulted in a similar pattern of 
elevated inflammatory markers as was observed in rats; however, the overall magnitude 
was reduced in C57BL\6 mice relative to Sprague-Dawley rats.  These findings further 
support the hypothesis that host background plays a role in the severity of inflammation 
associated with chronic H. pylori infection.   
 Lack of a systemic inflammatory response to heat killed H. pylori or E. coli K12 
support the hypothesis that active H. pylori infection is necessary for the observed 
patterns of elevated inflammatory markers and that administration of bacterial products 
or disruption of the normal gut microflora by an innocuous bacterial species in not 
sufficient to generate the observed changes in systemic inflammation.  Additionally, the 
lack of systemic inflammatory response to naproxen-induced gastritis indicates that 
gastritis alone is not sufficient to generate the observed pattern of elevated inflammatory 
markers. 
 T cell populations appear to be key mediators in H. pylori associated systemic 
inflammation as their absence abrogates the elevation of systemic inflammatory markers 
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in infection studies utilizing athymic rats.  Furthermore, T cell phenotyping following H. 
pylori infection indicates that chronic H. pylori infection is associated with modulation of 
both the Th1:Th2 and the Th17:Treg cell populations.  Polarization of the Th1:Th2 ratio 
toward pro-inflammatory Th1 populations is hypothesized to be a key aspect in the 
development of H. pylori associated systemic inflammation while polarization of the 
Th17:Treg ratio toward tolerogenic Treg populations is hypothesized to result in 
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Figure 3.1. H. pylori G27 infection is associated with elevated inflammatory 
markers in liver tissue.  Quantitative ELISA based assessment of the degree of 
change of levels of TNF-α, IL-6, and CRP from liver during H. pylori G27 infection.  H. 
pylori associated change in inflammatory markers is reported as fold difference between 
actively infected animals relative to mock-infected animals. Data were collected across 3 
independent experiments, each utilizing 3 mock-infected and 3 actively infected animals. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white bars) were averaged and rendered relative 
to mock-infected animals. The height of each bar corresponds to the mean difference 
between inflammatory markers, and the error bars correspond to the standard error of 
the mean. Data were statistically evaluated by 2-way ANOVA (p values: H. pylori status: 
< 0.01, length of infection: < 0.01, and interaction: < 0.01 for each inflammatory marker) 
with comparisons between mock-infected and actively infected animals by Tukey’s 
multiple comparison test (p values reported above each comparison). A significant 
decrease in TNF-α elevation was observed between 2- and 8-week long infections as 
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Figure 3.2. H. pylori G27 infection is associated with elevated inflammatory 
markers in spleen.  Quantitative ELISA based assessment of the degree of change of 
levels of TNF-α, IL-6, and CRP from spleen during H. pylori G27 infection.  H. pylori 
associated change in inflammatory markers is reported as fold difference between 
actively infected animals relative to mock-infected animals. Data were collected across 3 
independent experiments, each utilizing 3 mock-infected and 3 actively infected animals. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white bars) were averaged and rendered relative 
to mock-infected animals. The height of each bar corresponds to the mean difference 
between inflammatory markers, and the error bars correspond to the standard error of 
the mean. Data were statistically evaluated by 2-way ANOVA (p values: H. pylori status: 
< 0.01, length of infection: < 0.01, and interaction: < 0.01 for each inflammatory marker) 
with comparisons between mock-infected and actively infected animals by Tukey’s 
multiple comparison test (p values reported above each comparison). A minor but 
significant decrease in TNF-α elevation was observed between 8- and 26-week long 
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Figure 3.3. H. pylori G27 infection is associated with elevated inflammatory 
markers in plasma.  Quantitative ELISA based assessment of the degree of change of 
levels of TNF-α, IL-6, and CRP from plasma during H. pylori G27 infection. H. pylori 
associated change in inflammatory markers is reported as fold difference between 
actively infected animals relative to mock-infected animals. Data were collected across 3 
independent experiments, each utilizing 3 mock-infected and 3 actively infected animals. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white bars) were averaged and rendered relative 
to mock-infected animals. The height of each bar corresponds to the mean difference 
between inflammatory markers, and the error bars correspond to the standard error of 
the mean. Data were statistically evaluated by 2-way ANOVA (p values: H. pylori status: 
< 0.01, length of infection: < 0.01, and interaction: < 0.01 for each inflammatory marker) 
with comparisons between mock-infected and actively infected animals by Tukey’s 
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Figure 3.4.  Comparison of the degree of systemic inflammation associated with 
various H. pylori strains following 8-week long infections.  Quantitative ELISA 
based assessment of the degree of change of levels of TNF-α, IL-6, and CRP during H. 
pylori infection utilizing strains G27, 60190, and 26695.  H. pylori associated changes in 
inflammatory markers is reported as fold difference between actively infected animals 
relative to matched mock-infected animals.  Data were collected utilizing 3 mock-infected 
and 3 actively infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively infected animals (white bars) were 
averaged and rendered relative to match mock-infected animals. The height of each bar 
corresponds to the mean difference between inflammatory markers, and the error bars 
correspond to the standard error of the mean. Data were statistically evaluated by 
ANOVA (p value: < 0.01) with comparisons between H. pylori strains by Tukey’s multiple 
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Figure 3.5. Eradication of H. pylori infection results in the return of elevated 
inflammatory markers to baseline levels.  Quantitative ELISA based assessment of 
the degree of change of levels of TNF-α, IL-6, and CRP following eradication of H. pylori 
G27 infection.  In eradication studies, 13-week infections were carried out in Sprague-
Dawley rats utilizing H. pylori G27, followed by an eradication regimen (lansoprazole 
(3.75 mg/kg), clarithromycin (2.25 mg/kg), and amoxicillin (4.5 mg/kg) administered 
orally, twice daily for 10 days). After 13 weeks following eradication regimen, tissue 
samples were collected and inflammatory markers measured by quantitative ELISA.  H. 
pylori associated changes in inflammatory markers is reported as fold difference 
between actively infected animals relative to mock-infected animals.  Data were 
collected across 3 independent experiments, each utilizing 3 mock-infected and 3 
actively infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively infected animals (white bars) were 
averaged and rendered relative to mock-infected animals. The height of each bar 
corresponds to the mean difference between inflammatory markers, and the error bars 
correspond to the standard error of the mean. Significant differences were not observed 
in levels of TNF-α, IL-6, or CRP, indicating that inflammatory marker levels returned to 
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Figure 3.6. Measurement of systemic inflammatory markers in C57BL\6 mice 
following 8-week long H. pylori G27 infections.  Quantitative ELISA based 
assessment of the degree of change of levels of TNF-α, IL-6, and CRP during H. pylori 
infection in C57BL\6.  H. pylori associated changes in inflammatory markers is reported 
as fold difference between actively infected animals relative to matched mock-infected 
animals.  Data were collected utilizing 3 mock-infected and 3 actively infected animals. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white bars) were averaged and rendered relative 
to match mock-infected animals. The height of each bar corresponds to the mean 
difference between inflammatory markers, and the error bars correspond to the standard 
error of the mean. Data were statistically evaluated by student’s t-test (p values reported 
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Figure 3.7. Gastric and systemic inflammatory marker profile of chronic H. pylori 
G27 infection is markedly different than that of acute systemic inflammation 
induced by LPS.  Sprague-Dawley rats were administered LPS (500 μg/kg) by 
intraperitoneal injection once weekly for 8 weeks prior to quantitative ELISA based 
assessment of the degree of change in levels of TNF-α, IL-6, and CRP. LPS associated 
change in inflammatory markers is reported as fold difference between LPS-treated 
animals relative to mock-treated animals. The experiment was performed one time with 
each bar corresponding to the mean of 3 technical replicates. The error bars correspond 
to the standard error of the mean. Results from mock-treated animals (black bars) were 
averaged and normalized to 1. Results from LPS-treated animals (white bars) were 
averaged and rendered relative to mock-treated animals. Data gathered from 8-week H. 
pylori G27 infection studies (as reported previously) are shown to the right of LPS data 
as a means of comparing H. pylori associated changes in inflammatory markers 
to those seen during LPS treatment.  As LPS studies were limited to treatment groups 
comprised of a single animal each for humane reasons, statistical testing was not 
conducted due to small sample size.   
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Figure 3.8.  Inflammatory profile generated following exposure to heat killed H. 
pylori G27. Sprague-Dawley rats were inoculated with 1x107 cells of heat killed H. pylori 
G27 in similar manner to active infection studies. 8 weeks after completion of 
inoculations, tissue samples were collected and inflammatory markers measured by 
quantitative ELISA. The experiment was performed one time with each bar 
corresponding to the mean of 3 technical replicates. Results from mock-infected animals 
(black bars) were averaged and normalized to 1. Results from actively infected animals 
(white and gray bars) were averaged and rendered relative to mock-infected animals. 
The height of each bar corresponds to the mean fold difference in inflammatory markers, 
and the error bars correspond to the standard error of the mean. Significant differences 
were not observed, indicating that exposure to H. pylori products is not sufficient to 
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Figure 3.9.  Inflammatory profile generated following exposure to E. coli K12. 
Sprague-Dawley rats were inoculated with 1x107 cells of E. coli K12 in similar manner to 
active infection studies. 8 weeks after completion of inoculations, tissue samples were 
collected and inflammatory markers measured by quantitative ELISA. The experiment 
was performed one time with each bar corresponding to the mean of 3 technical 
replicates. Results from mock-infected animals (black bars) were averaged and 
normalized to 1. Results from actively infected animals (white and gray bars) were 
averaged and rendered relative to mock-infected animals. The height of each bar 
corresponds to the mean fold difference in inflammatory markers, and the error bars 
correspond to the standard error of the mean. Significant differences were not observed, 
indicating that exposure to an innocuous bacterium is not sufficient to recapitulate the 
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Figure 3.10.  Chemically induced gastritis is not associated with the development 
of systemic inflammation.  Gastritis was artificially induced in Sprague-Dawley rats by 
weekly administration of naproxen (80 mg/kg) by oral gavage. The experiment was 
performed one time utilizing 3 mock-treated and 3 naproxen-treated animals. Results 
from mock-treated animals (black bars) were averaged and normalized to 1. Results 
from naproxen-treated animals (white bars) were averaged and rendered relative to 
matched mock-treated animals. The height of each bar corresponds to the fold 
difference in inflammatory markers, and the error bars correspond to the standard error 
of the mean. Statistical evaluation by student’s t-test indicated that naproxen treatment 
was associated with a robust elevation of inflammatory markers in gastric tissue (p 
values reported above relevant comparisons) as well as a significant elevation of 
inflammatory markers in hepatic tissue (p values reported above relevant comparisons). 
These data indicate that naproxen induced gastritis is associated with slight elevation of 
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Figure 3.11.  Absence of T cell populations prevents the development of systemic 
inflammation in response to chronic H. pylori infection. Quantitative ELISA based 
assessment of the degree of change of levels of TNF α, IL-6, and CRP following 8-week 
infections in athymic FoxN1rnu/rnu rats utilizing H. pylori G27. The experiment was 
performed one time utilizing 3 mock infected and 3 actively infected for each strain. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white and gray bars) were averaged and 
rendered relative to mock-infected animals. The height of each bar corresponds to the 
mean fold difference in inflammatory markers, and the error bars correspond to the 
standard error of the mean. Statistical evaluation by student’s t-test indicated that 
chronic H. pylori infection was associated with an increase in gastric TNF-α and IL-6. All 
other comparison between mock-infected and actively infected animals were not 
significant, indicating that T cell populations are required for the development of H. pylori 
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Figure 3.12. H. pylori infection modulates populations of circulating T cells.  T cell 
phenotyping was conducted on Sprague-Dawley rats that had been either mock-infected 
or actively infected with H. pylori G27 after 8-weel long infections.  Whole blood was 
collected by terminal cardiac puncture and circulating lymphocytes purified by differential 
centrifugation.  T cell populations were quantified by flow cytometry with immune-
fluorescent labeling for Th1, Th2, Th17, and Treg cell types.  The experiment was 
performed one time utilizing 5 mock-infected and 5 H. pylori G27 infected animals.  The 
Th1/Th2, Th1/Th17, and Th17/Treg ratios were calculated for each animal.  Each circle 
corresponds to the ratio calculated for an individual animal.  The longer bar corresponds 
to the mean, and the error bars correspond to the standard error of the mean.  Data 
were statistically evaluated by student’s t test, and p values are reported above 
significant comparisons.  These data suggest that H. pylori modulates the immune 
response both toward a pro-inflammatory state (elevated Th1/Th2 ratio) and 
simultaneously toward a tolerogenic state (depressed Th17:Treg ratio).  
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Figure 3.13.  Major H. pylori virulence factors do not play a major role in the 
development of H. pylori associated systemic inflammation.  Quantitative ELISA 
based assessment of the degree of change of levels of TNF-α, IL-6, and CRP during H. 
pylori infection utilizing transposon interruption mutants of prominent virulence factors.  
H. pylori associated changes in inflammatory markers are reported as fold difference 
between actively infected animals relative to matched mock-infected animals.  Data were 
collected utilizing 3 mock-infected and 3 actively infected animals. Results from mock-
infected animals (black bars) were averaged and normalized to 1. Results from actively 
infected animals (white bars) were averaged and rendered relative to mock-infected 
animals. The height of each bar corresponds to the mean fold difference between 
inflammatory markers, and the error bars correspond to the standard error of the mean. 
Data were statistically evaluated by 2-way ANOVA (p value: 0.41 - .68) and no 
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Chapter 4: Neuro-inflammatory response to chronic Helicobacter pylori infection 
4.1 Introduction 
 While the central nervous system has been considered an immune privileged site 
with the blood-brain barrier limiting the influence of the peripheral immune system on its 
function, several mechanisms have been proposed to explain the development of neuro-
inflammation in response to systemic inflammation.  These mechanisms include 
neuronal recognition of inflammatory cytokines by the vagus nerve3,12,20 as well as the 
neurons of the sensory circumventricular organs4,25,28, the active transport of circulating 
cytokines across the blood-brain barrier7,10,11, and the recent discovery of meningeal 
lymphatic vessels1,21.  Expression of IL-1, IL-2, IL-6, and TNF-α have been shown to play 
various roles in disease-associated cognitive dysfuntion8,9,23,27.  The constellation of 
nonspecific behavioral changes that accompany illness, such as depression, lethargy, 
weakness, malaise, disinterest, and inability to concentrate, are collectively referred to 
as “sickness behavior”13.   
 The role of chronic H. pylori infection in the development of neuro-inflammation 
has only been speculated in an extremely small number of studies.  These studies which 
noted improvements in cognition in elderly dementia6,15,18 and Alzheimer Disease16,17,19,26 
patients following eradication of active H. pylori infection.  In these studies, neuro-
inflammation arising from elevated circulating level of homocysteine as a result of 
vitamin B12 deficiency was attributed to atrophic gastritis.  However, no direct evaluation 
of neuro-inflammation was undertaken as part of these studies. 
 To evaluate the role of chronic H. pylori infection in the development of systemic 
inflammation inflammatory markers were quantified from hippocampal and cerebellar 
samples from 2-, 8- and 26-week long H. pylori G27 infection studies.  Eradication 
studies were utilized to evaluate the causal relationship between active H. pylori 
infection and neuro-inflammation.  Finally, the role of T cell populations in the 
136 
 
development of H. pylori associated neuro-inflammation were evaluated by conducting 
infection studies conducted in athymic rats. 
 
4.2 Materials and Methods 
Animal care. All experiments involving the use of live vertebrate animals were 
conducted with the approval of the University of Illinois at Urbana-Champaign 
Institutional Animals Care and Use Committee (IACUC).  Rat populations were 
composed of male Sprague-Dawley rats (Envigo, formerly Harlan Laboratories, 
Indianapolis, IN).  Mouse populations were composed of male C57BL\6J mice (Jackson 
Laboratory, Bar Harbor, ME).  Animals were single housed with 12 h light-dark cycle, 
mean temperature of 22.1°C, humidity of 50%, and allowed food and water ad libitum. 
 
Active H. pylori infection time series. To evaluate neuro-inflammation, hippocampal 
and cerebellar tissues were collected at the time of euthanasia by necropsy from the 
animal populations described in Chapter 2.  In brief, these animal populations consisted 
2-, 8-, and 26-week infection studies, each composed of 3 independent blocks which, in 
turn, were each composed of 3 mock infected animals and 3 actively infected animals.  
 
Eradication of active H. pylori infection studies. To evaluate neuro-inflammation, 
hippocampal and cerebellar tissue were collected at the time of euthanasia by necropsy 
from the animal populations described in Chapter 2.  In brief, this animal population was 
composed of 3 independent blocks which, in turn, were each composed of 3 mock 
infected animals and 3 actively infected animals.  Animals were infected for 13 weeks; 
then, both mock infected and actively infected animals underwent eradication therapy.  
All animals were allowed to remain uninfected for an additional 13 weeks prior to 




Mouse infection studies.  To evaluate neuro-inflammation, hippocampal and cerebellar 
tissue were collected at the time of euthanasia by necropsy from the animal population 
described in Chapter 2.  In brief, this animal population consisted of an 8-week infection 
study, composed of 3 mock infected animals and 3 actively infected C57BL\6 mice. 
 
LPS induced systemic inflammation.  To provide a point of comparison to induced 
systemic inflammation, hippocampal and cerebellar tissue were collected at the time of 
euthanasia by necropsy from the animal population described in Chapter 3.  In brief, 
Sprague Dawley rats received weekly intraperitoneal injections of 500 µg/kg purified E. 
coli LPS (Sigma Aldrich, St. Louis MO) dissolved in PBS or the equivalent volume of 
PBS on a weekly basis for 8 weeks.  Due to the extreme distress resulting from this 
exposure experiment in the experimental animal population, the animal population was 
limited in size to one LPS exposed animal and one PBS exposed animal. 
 
Naproxen induced gastritis.  To determine if gastritis in the absence of active H. pylori 
infection is sufficient to cause neuro-inflammation, hippocampal and cerebellar tissue 
were collected at the time of euthanasia by necropsy from the animal population 
described in Chapter 3.  In brief, this animal population consisted of 3 Sprague-Dawley 
rats that received naproxen (80 mg/kg; Sigma Aldrich) suspended in PBS and 3 
Sprague-Dawley rats that received the equivalent amount of PBS once weekly for 8 
weeks.   
 
Athymic rat infection studies.  To evaluate the role of T cell populations in H. pylori 
associated neuro-inflammation, hippocampal and cerebellar tissue were collected at the 
time of euthanasia by necropsy from the animal population described in Chapter 3.  In 
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brief, 8-week long infection studies were conducted utilizing male Foxn1rnu/rnu rats 
(Envigo) aged 20-21 days.  The animal population consisted of 3 actively infected 
animals and 3 mock infected animals. 
 
Indomethacin anti-inflammatory blockade.  To evaluate the role of systemic 
inflammation on the development of neuro-inflammation, animal infection studies were 
conducted utilizing a low dose indomethacin (Sigma Aldrich) anti-inflammatory blockade.  
All animals in the experimental population received indomethacin (2.5 mg/kg) 
administered via intraperitoneal injection, morning and evening each day throughout the 
course of the infection study beginning on the first day of lansoprazole administration.  In 
mice this dose has been shown to be sufficient to block neuro-inflammation associated 
with systemic LPS administeration22.  The experimental animal population consisted of 3 
Sprague-Dawley rats that were actively infected with H. pylori G27 as described 
previously and 3 Sprague-Dawley rats that were mock-infected using sterile bisulfite free 
Brucella broth as described previously.  Eight week after the competition of the 
inoculation protocol, animals were euthanized and stomach, liver, spleen, blood, and 
brain tissues collected for further analyses. 
 
Terminal collection of tissue samples. Tissue samples were collected as described in 
Chapter 2.  In brief, animals were placed under surgical anesthesia, and terminal blood 
collection was conducted by cardiac puncture.  Stomach, liver, spleen and brain tissues 
were collected by necropsy immediately following euthanasia of the animal. 
 
Sample processing.  Collected tissue samples were processed as described in Chapter 
2.  In brief, plasma samples were prepared from whole blood and stored at -20°C until 
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assayed.  Remaining tissues were stored at -20°C until processed for preparation of 
whole tissue protein lysates. 
 
Preparation of whole tissue protein lysates.  200 mg of gastric tissue was 
mechanically homogenized using mortar and pestle with the aid of liquid nitrogen.  
Homogenized tissue was suspended in 2 mL of RIPA buffer (Thermo Fisher) 
supplemented proteinase inhibitor cocktail (Thermo Fisher).  Cells were lysed on ice with 
gentle shaking for 3 hr.  Unlysed tissues and lipid fraction were removed by 
centrifugation at 1500 x g for 15 min at 4°C.  Total protein concentration for tissue 
lysates was determined by BCA assay (Thermo Fisher).  Tissue lysates were aliquoted 
at 200 µL and frozen at -20°C until assayed. 
 
Cytokine quantification.    Tissue lysate was diluted to 500 µg/ml to standardize the 
amount of protein assayed across sample.  Cytokine levels was determined by 
quantitative ELISA for TNF-α (Eagle Bioscience, Nashua, NH), IL-6 (Eagle Biosciences), 
and CRP (Sigma Aldrich) according to manufacturer’s directions.   
 
Statistical analysis.  Cytokine levels from active infection time series were evaluated by 
two-way ANOVA of H. pylori infection status and length of infection with Tukey’s 
correction for multiple comparisons.  Eradication studies, mouse studies, heat killed H. 
pylori studies, E. coli K12 studies, naproxen induced gastritis studies, athymic rat H. 
pylori infection studies, and indomethacin anti-inflammatory blockade studies were 
evaluated using a 2-tailed distribution, paired t test.  Cytokine levels from transposon 
insertion H. pylori infection studies were evaluated by two-way ANOVA of H. pylori 
infection status and H. pylori strain. An alpha level of 0.05 was used as a threshold for 
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statistical significance and all error bars represent standard error of the mean (SEM). 
Graphpad Prism (version 6.01) was used for all statistical analyses.  
 
4.3  Results 
 
4.3.1 H. pylori infection in Sprague-Dawley rats is associated with increased levels 
of inflammatory markers in hippocampal and cerebellar tissue.  
To assess the relationship between H. pylori infection and neuro-inflammation, 
hippocampal (Figure 4.1) and cerebellar (Figure 4.2) tissues were collected as part of 
the H. pylori G27 infection time series.  These tissues were selected as their functional 
roles have been shown to have increased sensitivity to inflammatory inhibition2,5,14,24,29,30.  
As was observed both gastrically and systemically, 2-week infection time points were 
associated with the highest levels of increased TNF-α and CRP.  Two-way ANOVA 
analysis (2-way ANOVA: H. pylori status p value <0.0001, 70.9% of total variation; 
Length of infection p value <0.0001, 14.3% of total variation) with subsequent testing by 
Tukey’s multiple pairwise test (p value <0.0001 for all comparisons) supported a trend of 
decreasing TNF-α levels in hippocampal tissue through time during chronic H. pylori 
infection.  However, in cerebellar tissue, TNF-α levels remain non-significantly changed 
between 8- and 26-week time points (2-way ANOVA: H. pylori status p value <0.0001, 
94.6% of total variation; Length of infection p value <0.0001, 2.5% of total variation with 
subsequent testing by Tukey’s multiple pairwise test p value <0.0001 for comparisons of 
2-weeks vs 8- or 26-weeks).  In both, hippocampal (2-way ANOVA: H. pylori status p 
value <0.0001, 90.4% of total variation; Length of infection p value = 0.02, 1.2% of total 
variation) and cerebellar (2-way ANOVA: H. pylori status p value <0.0001, 94.3% of total 
variation; Length of infection p value = 0.01, 0.8% of total variation) tissue, elevated 
levels of IL-6 remain non-significantly different among time points.  Elevated levels of 
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CRP showed a pattern of decreasing magnitude through time in both hippocampal (2-
way ANOVA: H. pylori status p value <0.0001, 60.9% of total variation; Length of 
infection p value <0.0001, 19.1% of total variation with subsequent testing by Tukey’s 
multiple pairwise test p value <0.0001 for all comparisons) and cerebellar (2-way 
ANOVA: H. pylori status p value <0.0001, 60.1% of total variation; Length of infection p 
value <0.0001, 19.2% of total variation with subsequent testing by Tukey’s multiple 
pairwise test p value <0.0001 for all comparisons) tissue. These data indicate that 
chronic H. pylori infection is associated with elevated markers of neuro-inflammation in 
the hippocampus and the cerebellum.  Furthermore, these data support a model in 
which highly potent inflammatory markers are reduced in degree of elevation through 
time during chronic H. pylori infection.  However, IL-6, a key mediator of the neuro-
inflammatory response remains stably elevated throughout chronic infection. 
To determine if the neuro-inflammatory response was a commonality among 
different strains of H. pylori, the levels of inflammatory markers from hippocampal and 
cerebellar tissue were examined following 8 weeks of infection by H. pylori strains G27, 
60190, and 26695 (Figure 4.3).  Elevated levels of TNF-α and IL-6 were not found to 
vary significantly among the three strains.  Hippocampal levels of CRP during infection 
by H. pylori 60190 were found to significantly elevated in comparison to those seen 
during 26695 infection (p value = 0.04) while all other comparisons regarding CRP 
elevation were not significant.  These data indicate that specific strain of H. pylori is not a 





4.3.2 Eradication of H. pylori infection in Sprague-Dawley rats leads resolution of 
increased levels of inflammatory markers. 
To determine the causality between chronic H. pylori infection and associated 
elevated neuro-inflammatory markers, hippocampal and cerebellar tissue was examined 
following eradication therapy (Figure 4.4).  Levels of TNF-α, IL-6, and CRP associated 
with hippocampal and cerebellar tissue from H. pylori cured animals were not 
significantly different from those seen in mock-infected animals.  These data further 
indicate that chronic H. pylori is the causative agent of the observed neuro-inflammation, 
and that once eradicated, elevated levels of neuro-inflammatory markers return to 
baseline levels. 
 
4.3.3 H. pylori infection in C57BL\6 mice leads to a similar but blunted pattern of 
increased inflammatory markers. 
 To determine if the observed neuro-inflammatory response associated with H. 
pylori infection was species-specific, inflammatory markers were measured from 
hippocampal and cerebellar samples collected from C57BL\6 mice which had been 
infected with H. pylori G27 for 8 weeks.  As was seen in gastric tissue, a similar pattern 
of elevated inflammatory markers was observed in mice as was seen in Sprague-Dawley 
rats (Figure 4.5).  Additionally, as was seen in gastric and systemic inflammation, the 
magnitude of elevation of the measured cytokines was reduced in mice relative to rats 
by approximately 2.5- to 1.3-fold.  These data support the hypothesis that the observed 
elevation of neuro-inflammatory markers is not species-specific; however, the data do 
suggest that the degree of neuro-inflammation associated with chronic H. pylori infection 




4.3.4 H. pylori associated neuro-inflammatory profile is markedly different than 
that associated with systemic administration of LPS. 
LPS administration was associated with a 7.8-fold higher elevation of 
hippocampal and 11-fold higher elevation of cerebellar TNF-α levels in comparison to 
those observed during H. pylori G27 infection (Figure 4.6).  Likewise, IL-6 levels were 
found to be 14.4-fold higher in hippocampal tissue and 12.3-fold higher in cerebellar 
tissue.  CRP levels were found to only be 1.9-fold higher in the hippocampus and 1.6-
fold higher in the cerebellum.  These data further demonstrate the reduced magnitude of 
H. pylori associated neuro-inflammation in comparison to that which would be seen 
during acute infection or sepsis. 
 
4.3.5 Administration of heat killed H. pylori or E. coli K12 is not associated with 
elevated inflammatory markers. 
To assess the necessity of active H. pylori infection in inducing the observed 
elevated inflammatory markers, infection studies were conducted utilizing heat-killed H. 
pylori G27.  Measurement of hippocampal and cerebellar inflammatory markers found no 
significant elevation between mock control animals and those that received heat-killed H. 
pylori culture (Figure 4.7).  To determine that the observed elevation of inflammatory 
markers was not due to perturbation of the normal gut microflora by inoculation by 
addition of bacterial culture, infection studies were conducted utilizing E. coli K12.  
Measurement of hippocampal and cerebellar inflammatory markers found no significant 
difference between mock control animals and those that received active E. coli culture 
(Figure 4.8).  As a whole, these data support the finding that active H. pylori infection is 
necessary for observation of elevated inflammatory markers and that a perturbation of 
the gut microflora by inoculation with an innocuous bacterial species is not sufficient to 




4.3.6 Naproxen-induced gastritis is not associated with the development of neuro-
inflammation. 
 Naproxen associated gastritis was not associated with a neuro-inflammatory 
response (Figure 4.9).  These data support the conclusion that the neuro-inflammatory 
response observed during chronic H. pylori infection is not simply a downstream 
consequence of gastritis.  
 
4.3.7 Absence of T cell populations is associated with a lack of neuro-
inflammatory response during chronic H. pylori infection. 
No significant elevation in hippocampal or cerebellar inflammatory markers was 
observed in tissue collected from athymic rats following 8-week long H. pylori G27 
infections (Figure 4.10).  These data further support the finding that H. pylori associated 
neuro-inflammation is dependent on immune cell populations absent in athymic rats. 
 
4.3.8 Inhibition of the systemic inflammatory response by indomethacin blocks 
the development of H. pylori associated neuro-inflammation. 
 To determine if inhibition of the systemic inflammatory response influence the 
development of neuro-inflammation in response to chronic H. pylori infection, 8-week 
long infection studies were conducted in which both actively infected and mock infected 
animals received twice daily intraperitoneal administration of low dose indomethacin (2.5 
mg/kg).  Following euthanasia of animals, inflammatory markers were evaluated from 
stomach, liver, spleen, plasma, hippocampus, and cerebellum tissues (Figure 4.11).  
Surprisingly, low dose indomethacin administration was observed to block H. pylori 
associated inflammation at all levels.  While these data are in agreement with the 
hypothesis that H. pylori associated neuro-inflammation is related to the systemic 
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inflammatory response, the total abrogation of H. pylori associated inflammation limits 
the conclusions that can be drawn from these data. 
 
4.3.9 Absence of prominent H. pylori virulence factors has negligible influence on 
H. pylori associated neuro-inflammation. 
 To evaluate the potential influence of major H. pylori virulence factors on H. pylori 
associated systemic inflammation, inflammatory markers were quantified by ELIA from 
liver, spleen, and plasma collected from animals follow 8-week long H. pylori infection 
studies utilizing the transposon interruption mutants described in Chapter 2 (Figure 
4.12).  In tissue collected from infected animals, no significant difference in elevated 
inflammatory markers was observed in any of the examined tissues.  These data 
indicate that VacA, the cag pathogenicity island, and NapA have limited influence on the 
development of H. pylori associated systemic inflammation in Sprague-Dawley rats.  As 
both VacA and the cag pathogenicity island have been proposed to function in a human-
specific context, some caution must be exercised in direct application of these findings to 
natural human infection.   
 
4.4 Discussion 
 Neuro-inflammation is characterized by the presence of elevated levels of 
inflammatory markers within the central nervous system.  The presence of neuro-
inflammation has been associated with behavioral changes and the development of 
detrimental cognitive effects.  These data support the hypothesis that chronic H. pylori 
infection is associated with the development of low grade neuro-inflammation.  Data 




 As was seen in gastric and systemic inflammation, only negligible differences in 
elevated inflammatory markers were observed during infection studies utilizing different 
strains of H. pylori.  Likewise, infection studies in C57BL\6 mice resulted in a similar 
pattern of elevated inflammatory markers as was observed in Sprague-Dawley rats.  
However, the overall magnitude of elevation was reduced in C57BL\6 mice relative to 
Sprague-Dawley rats, indicating that severity of H. pylori associated inflammation may 
be modulated by the host background. 
 Lack of neuro-inflammatory response to either heat killed H. pylori of E. coli K12 
support the hypothesis that the observed change sin neuro-inflammation are not the 
result of brief exposure to bacterial products or disruption of the normal gut microflora by 
an innocuous bacterial species, but rather result from active H. pylori infection of the 
stomach.  Furthermore, the absence of a neuro-inflammatory response in athymic rats 
indicates the likely role of the systemic inflammatory in the development of neuro-
inflammation in response to chronic H. pylori infection. 
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Figure 4.1. Chronic H. pylori infection is associated with elevated inflammatory 
markers in hippocampal tissue.  Quantitative ELISA based assessment of the degree 
of change of levels of TNF-α, IL-6, and CRP from hippocampus during H. pylori G27 
infection.  H. pylori associated change in inflammatory markers is reported as fold 
difference between actively infected animals relative to mock-infected animals. Data 
were collected across 3 independent experiments, each utilizing 3 mock-infected and 3 
actively infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively infected animals (white bars) were 
averaged and rendered relative to mock-infected animals. The height of each bar 
corresponds to the mean difference between inflammatory markers, and the error bars 
correspond to the standard error of the mean. Data were statistically evaluated by 2-way 
ANOVA (p values: H. pylori status: < 0.01, length of infection: < 0.01, and interaction: < 
0.01 for each inflammatory marker) with comparisons between mock-infected and 
actively infected animals by Tukey’s multiple comparison test (p values reported above 
each comparison). A significant trend in decreasing in TNF-α and CRP elevation was 
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Figure 4.2. Chronic H. pylori infection is associated with elevated inflammatory 
markers in cerebellar tissue.  Quantitative ELISA based assessment of the degree of 
change of levels of TNF-α, IL-6, and CRP from cerebellum during H. pylori G27 infection.  
H. pylori associated change in inflammatory markers is reported as fold difference 
between actively infected animals relative to mock-infected animals. Data were collected 
across 3 independent experiments, each utilizing 3 mock-infected and 3 actively infected 
animals. Results from mock-infected animals (black bars) were averaged and 
normalized to 1. Results from actively infected animals (white bars) were averaged and 
rendered relative to mock-infected animals. The height of each bar corresponds to the 
mean difference between inflammatory markers, and the error bars correspond to the 
standard error of the mean. Data were statistically evaluated by 2-way ANOVA (p 
values: H. pylori status: < 0.01, length of infection: < 0.01, and interaction: < 0.01 for 
each inflammatory marker) with comparisons between mock-infected and actively 
infected animals by Tukey’s multiple comparison test (p values reported above each 
comparison). A significant trend in decreasing in CRP elevation was observed between 
2-, 8-, and 26-week long infections.  Additionally, a significant decrease in TNF-α was 
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Figure 4.3. Comparison of the degree of neuro-inflammation associated with 
various H. pylori strains following 8-week long infections.  Quantitative ELISA 
based assessment of the degree of change of levels of TNF-α, IL-6, and CRP during H. 
pylori infection utilizing strains G27, 60190, and 26695.  H. pylori associated changes in 
inflammatory markers is reported as fold difference between actively infected animals 
relative to matched mock-infected animals.  Data were collected utilizing 3 mock-infected 
and 3 actively infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively infected animals (white bars) were 
averaged and rendered relative to match mock-infected animals. The height of each bar 
corresponds to the mean difference between inflammatory markers, and the error bars 
correspond to the standard error of the mean. No significant difference was observed in 
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Figure 4.4. Eradication of H. pylori infection results in the return of elevated 
inflammatory markers to baseline levels.  Quantitative ELISA based assessment of 
the degree of change of levels of TNF-α, IL-6, and CRP following eradication of H. pylori 
G27 infection.  In eradication studies, 13-week infections were carried out in Sprague-
Dawley rats utilizing H. pylori G27, followed by an eradication regimen (lansoprazole 
(3.75 mg/kg), clarithromycin (2.25 mg/kg), and amoxicillin (4.5 mg/kg) administered 
orally, twice daily for 10 days). After 13 weeks following eradication regimen, tissue 
samples were collected and inflammatory markers measured by quantitative ELISA.  H. 
pylori associated changes in inflammatory markers is reported as fold difference 
between actively infected animals relative to mock-infected animals.  Data were 
collected across 3 independent experiments, each utilizing 3 mock-infected and 3 
actively infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively infected animals (white bars) were 
averaged and rendered relative to mock-infected animals. The height of each bar 
corresponds to the mean difference between inflammatory markers, and the error bars 
correspond to the standard error of the mean. Significant differences were not observed 
in levels of TNF-α, IL-6, or CRP, indicating that inflammatory marker levels returned to 
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Figure 4.5. Measurement of systemic inflammatory markers in C57BL\6 mice 
following 8-week long H. pylori G27 infections.  Quantitative ELISA based 
assessment of the degree of change of levels of TNF-α, IL-6, and CRP during H. pylori 
infection in C57BL\6.  H. pylori associated changes in inflammatory markers is reported 
as fold difference between actively infected animals relative to matched mock-infected 
animals.  Data were collected utilizing 3 mock-infected and 3 actively infected animals. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white bars) were averaged and rendered relative 
to match mock-infected animals. The height of each bar corresponds to the mean 
difference between inflammatory markers, and the error bars correspond to the standard 
error of the mean. Data were statistically evaluated by student’s t-test (p values reported 
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Figure 4.6. Neuro-inflammatory marker profile of chronic H. pylori G27 infection is 
markedly different than that of acute systemic inflammation induced by LPS.  
Sprague-Dawley rats were administered LPS (500 μg/kg) by intraperitoneal injection 
once weekly for 8 weeks prior to quantitative ELISA based assessment of the degree of 
change in levels of TNF-α, IL-6, and CRP. LPS associated change in inflammatory 
markers is reported as fold difference between LPS-treated animals relative to mock-
treated animals. The experiment was performed one time with each bar corresponding 
to the mean of 3 technical replicates. The error bars correspond to the standard error of 
the mean. Results from mock-treated animals (black bars) were averaged and 
normalized to 1. Results from LPS-treated animals (white bars) were averaged and 
rendered relative to mock-treated animals. Data gathered from 8-week H. pylori G27 
infection studies (as reported previously) are shown to the right of LPS data as a means 
of comparing H. pylori associated changes in inflammatory markers to those seen during 
LPS treatment.  As LPS studies were limited to treatment groups comprised of a single 
animal each for humane reasons, statistical testing was not conducted due to small 
sample size.  
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Figure 4.7.  Inflammatory profile generated following exposure to heat killed H. 
pylori G27. Sprague-Dawley rats were inoculated with 1x107 cells of heat killed H. pylori 
G27 in similar manner to active infection studies. 8 weeks after completion of 
inoculations, tissue samples were collected and inflammatory markers measured by 
quantitative ELISA. The experiment was performed one time with each bar 
corresponding to the mean of 3 technical replicates. Results from mock-infected animals 
(black bars) were averaged and normalized to 1. Results from actively infected animals 
(white and gray bars) were averaged and rendered relative to mock-infected animals. 
The height of each bar corresponds to the mean fold difference in inflammatory markers, 
and the error bars correspond to the standard error of the mean. Significant differences 
were not observed, indicating that exposure to H. pylori products is not sufficient to 
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Figure 4.8.  Inflammatory profile generated following exposure to E. coli K12. 
Sprague-Dawley rats were inoculated with 1x107 cells of E. coli K12 in similar manner to 
active infection studies. 8 weeks after completion of inoculations, tissue samples were 
collected and inflammatory markers measured by quantitative ELISA. The experiment 
was performed one time with each bar corresponding to the mean of 3 technical 
replicates. Results from mock-infected animals (black bars) were averaged and 
normalized to 1. Results from actively infected animals (white and gray bars) were 
averaged and rendered relative to mock-infected animals. The height of each bar 
corresponds to the mean fold difference in inflammatory markers, and the error bars 
correspond to the standard error of the mean. Significant differences were not observed, 
indicating that exposure to an innocuous bacterium is not sufficient to recapitulate the 
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Figure 4.9.  Chemically induced gastritis is not associated with the development of 
neuro-inflammation.  Gastritis was artificially induced in Sprague-Dawley rats by 
weekly administration of naproxen (80 mg/kg) by oral gavage. The experiment was 
performed one time utilizing 3 mock-treated and 3 naproxen-treated animals. Results 
from mock-treated animals (black bars) were averaged and normalized to 1. Results 
from naproxen-treated animals (white bars) were averaged and rendered relative to 
matched mock-treated animals. The height of each bar corresponds to the fold 
difference in inflammatory markers, and the error bars correspond to the standard error 
of the mean. No significant difference was observed in the levels of inflammatory 
markers between naproxen treated and mock treated animals. These data indicate that 
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Figure 4.10.  Absence of T cell populations prevents the development of systemic 
inflammation in response to chronic H. pylori infection. Quantitative ELISA based 
assessment of the degree of change of levels of TNF α, IL-6, and CRP following 8-week 
infections in athymic FoxN1rnu/rnu rats utilizing H. pylori G27. The experiment was 
performed one time utilizing 3 mock infected and 3 actively infected for each strain. 
Results from mock-infected animals (black bars) were averaged and normalized to 1. 
Results from actively infected animals (white and gray bars) were averaged and 
rendered relative to mock-infected animals. The height of each bar corresponds to the 
mean fold difference in inflammatory markers, and the error bars correspond to the 
standard error of the mean. No significant difference was observed in the level of 
inflammatory markers between actively infected and mock infected animals, indicating 
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Figure 4.11.  Indomethacin anti-inflammatory blockade prevent H. pylori 
associated inflammatory response.  To evaluate the influence of the systemic 
inflammatory response on the development of the neuro-inflammatory response, 8-week 
infection studies were conducted in which all member of the experimental animal 
population received low dose indomethacin (2.5 mg/kg) twice daily by intraperitoneal 
injection.  The experiment was performed one time utilizing 3 mock-treated and 3 
actively-infected animals. Results from mock-infected animals (black bars) were 
averaged and normalized to 1. Results from actively-infected animals (white bars) were 
averaged and rendered relative to mock-infected animals. The height of each bar 
corresponds to the fold difference in inflammatory markers, and the error bars 
correspond to the standard error of the mean. No significant difference was observed in 
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Figure 4.12.  Major H. pylori virulence factors do not play a major role in the 
development of H. pylori associated neuro-inflammation.  Quantitative ELISA based 
assessment of the degree of change of levels of TNF-α, IL-6, and CRP during H. pylori 
infection utilizing strains transposon interruption mutants of prominent virulence factors.  
H. pylori associated changes in inflammatory markers is reported as fold difference 
between actively infected animals relative to matched mock-infected animals.  Data were 
collected utilizing 3 mock-infected and 3 actively infected animals. Results from mock-
infected animals (black bars) were averaged and normalized to 1. Results from actively 
infected animals (white bars) were averaged and rendered relative to mock-infected 
animals. The height of each bar corresponds to the mean difference between 
inflammatory markers, and the error bars correspond to the standard error of the mean. 
Data were statistically evaluated by 2-way ANOVA (p value: 0.23 - .51) and no 
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Chapter 5: Influence of chronic Helicobacter pylori infection on cognition 
5.1 Introduction 
Expression of inflammatory cytokines within the central nervous system has been  
shown to play various roles in disease-associated cognitive dysfuntion12,14,37,46.  The 
development of aspects of sickness-like behavior has been tied to IL-1, IL-6 and TNF-α 
levels24,25,42.  Inflammatory cytokines have been linked to elevated risk in the 
development of a wide range of neuropsychiatric disorder, ranging from schizophrenia to 
depression to dementia5,7,26-28,37,46,48.   
 In mice, chronic H. pylori infection was associated with abnormal changes in 
feeding pattern which persisted post-eradication, indicating that chronic H. pylori 
infection may result in permanent alterations to gut-brain pathways1.  Several studies 
have proposed an association between Alzheimer Disease associated dementia23 with 
eradication of active infection associated with improvement in survival20 and cognitive 
performance21,22.  It was hypothesized that H. pylori associated atrophic gastritis led to 
the development of vitamin B12 deficiency which allowed the elevation of circulating 
homocysteine levels resulting in mild neuro-inflammation22.  A negative association was 
observed between H. pylori seropositivity and IQ score in school aged children in an 
Israeli cohort36.  The observed effect was found to be independent of socioeconomic and 
nutritional status, eliminating the two most commonly cited variables for detrimental 
cognitive effects.  Finally, in an epidemiological study among US adults, H. pylori 
seropositivity was associated with reduced performance during cognitive testing2. 
To evaluate the influence of chronic H. pylori infection on cognition, cognitive 
behavioral testing was conducted after 26-week long H. pylori G27 infection studies.  
Eradication studies were utilized to evaluate the reversibility of any cognitive effect 
associated with chronic H. pylori infection.  Cognitive behavioral testing was conducted 
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in collaboration with Dr. Joshua M. Gulley’s research group at the University of Illinois at 
Urbana-Champaign.  
 
5.2 Materials and Methods 
Animal care. All experiments involving the use of live vertebrate animals were 
conducted with the approval of the University of Illinois at Urbana-Champaign 
Institutional Animals Care and Use Committee (IACUC).  Rat populations were 
composed of male Sprague-Dawley rats (Envigo, formerly Harlan Laboratories, 
Indianapolis, IN).  Animals were single housed with 12 h light-dark cycle, mean 
temperature of 22.1°C, humidity of 50%, and allowed food and water ad libitum. 
 
Establishment of H. pylori infections. Male Sprague-Dawley rats (Envigo), aged 19-
21 days, were orally fed 3.75 mg/kg lansoprazole (Sigma Aldrich) suspended in 20% 
sucrose solution once daily for 7 days.  On days 3 and 5 of treatment, animals received 
0.5 ml of mid-log phase H. pylori culture diluted to 2x107 cells/ml (active H. pylori 
infection) or 0.5 ml of sterile BSFB media (mock infected controls) by oral gavage using 
a 20 G disposable feeding needle (Thermo Fisher).  Inoculum dosage was estimated by 
hemocytometer and verified by CFU plating.  Length of infection (26-weeks) was defined 
as the number of weeks following competition of lansoprazole treatment prior to 
euthanasia and tissue collection.  The experimental animal population consisted of 12 H. 
pylori G27 infected animals and 12 mock-infected animals. 
 
Eradication of active H. pylori infection. Male Sprague-Dawley rats (Envigo), aged 
19-21 days, were orally fed 3.75 mg/kg lansoprazole (Sigma Aldrich) suspended in 20% 
sucrose solution once daily for 7 days.  On days 3 and 5 of treatment, animals received 
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0.5 ml of mid-log phase H. pylori culture diluted to 2x107 cells/ml (active H. pylori 
infection) or 0.5 ml of sterile BSFB media (mock infected controls) by oral gavage using 
a 20 G disposable feeding needle (Thermo Fisher).  Inoculum dosage was estimated by 
hemocytometer and verified by CFU plating.  All animals assigned to the eradication 
studies underwent H. pylori eradication therapy 13 weeks after competition of 
lansoprazole treatment administered as part of the inoculation procedures.  In brief, 
animals received eradication therapy consisting of 3.75 mg/kg lansoprazole (Sigma 
Aldrich), 2.25 mg/kg clarithromycin (Sigma Aldrich), and 4.5 mg/kg amoxicillin (Sigma 
Aldrich) suspended in 30% sucrose solution orally twice daily for 10 days.  Animals were 
then allowed to remain cleared of H. pylori infection for an additional 13 weeks. 
 
Behavioral testing.  H. pylori infected rats and controls underwent tests for anhedonia 
(Saccharin preference test), exploratory activity (open-field test), and cognition (object 
location and T-maze tasks).  These were given in succession and occurred over a period 
of 16 days.  For the saccharin preference test, rats were given 24-hr free access in their 
home cage to two identical 100 mL glass sipper tubes, one containing 0.025% saccharin 
solution and the other containing water. On the next day, both liquids were replenished 
and the tubes were returned to the cage with their positions reversed; rats then had free 
access to the tubes for another 24 hr. The tubes were weighed before and after 
consumption each day.  For the open-field test, rats were placed in one of four open-top 
circular chambers (60cm in diameter x 60cm high) located next to each other. Rats 
received a series of two, 10 min open-field tests where they could freely explore the 
open-field; tests were separated by a 60-min break in the home cage.  Activity was 
recorded and analyzed using AnyMaze software (Stoelting; Wood Dale, IL). All 
chambers were wiped down with 70% ethanol solution between sessions to prevent 
cross-contamination. At the end of the day, each chamber was sanitized with 10% 
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bleach and then chambers were rinsed with 70% ethanol.  For the object location test, 
rats were returned to the circular chambers and two identical objects (13cm x 7.5cm x 
7.5cm glass mason jars with handles, filled halfway with black glass beads) were 
attached to the chamber floor with Velcro.  Rats were allowed to interact with the jars 
freely during a 5-min sample phase after which they were returned to their home cage. 
During this time the jars were cleaned with ethanol and the position of one of the jars 
was changed. After 60-min elapsed, rats were returned to the chamber for a 3-min test 
phase where interaction with the moved and unmoved jars was assessed. After each 
test, all chambers and objects were thoroughly wiped down with bleach and ethanol in 
the same manner as in the open-field task.   
For the T-maze task, rats’ body weights were reduced to 85% of their free-fed 
weight across a 7-day period by limiting their daily food ration.  Next, animals received 2 
days of habituation in one of two identical T-mazes (Maze Engineers, Glenview, IL; 
dimensions: arms: 65cm x 10cm x 15cm, starting runway: 95cm x 10cm x 15cm). During 
habituation each arm of the maze was baited with a sucrose pellet (Bioserv, #F06233; 
Frenchtown, NJ) and rats were allowed to freely explore both of the arms and the 
starting runway for 5 min. Next rats received daily “choice” training sessions consisting 
of 20 trials where both arms were baited during 50% of trials. For each trial, rats were 
removed from their home cage and placed at the base of the starting runway. Trials 
terminated when rats either chose an arm (all 4 paws in the arm), attempted to leave the 
maze, or 60 sec elapsed. If rats did not make a choice, or if they failed to investigate the 
recessed pellet receptacle after making a choice, the trial was scored as an error. Rats 
were trained to a criterion of ≤ 5 errors in a single session and were required to complete 
at least two choice training sessions before moving on to response training.  For 
response training, only one arm (e.g., right) was baited during each trial and the position 
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of the baited arm was constant during every trial in a session (but randomly assigned to 
each rat). Trials where rats chose the baited arm were scored as correct, while trials 
where the rat chose the other arm were scored as incorrect.  During the first response 
training session, criterion was met once an animal made ten correct choices in a row (60 
trials maximum/day). The day after meeting criterion, rats received the first of two 
reversal tests. For the first test, the previously unbaited arm (e.g., left) was baited and 
rats completed 60 trials, regardless of performance.  On the next day, rats received an 
additional response training session that terminated after they met a criterion of 10 
consecutive correct responses. The second reversal test was performed on the next day 
wherein the position of the baited arm was changed to the opposite arm and rats 
completed 60 trials.  
 
Terminal collection of tissue samples. At experimental end points, whole stomach 
tissue, liver, spleen and brain tissues along with large volume blood samples were 
collected.  In brief, animals were placed under surgical plane anesthesia by 
intraperitoneal administration of 100 mg/kg ketamine (Med Vet International, Mettawa, 
IL) and 10 mg/kg xylazine hydrochloride (Sigma Aldrich).  Cardiovascular function was 
stabilized by intramuscular injection of 0.05 mg/ml atropine sulfate (Med Vet 
International).  Animal’s abdominal and thoracic cavity were opened and cardiac 
puncture blood draw conducted via the left ventricle using a 19 G needle.  Collected 
blood was immediately transferred to EDTA anti-coagulated blood collection tubes 
(Becton, Dickinson, and Company, Franklin Lake, NJ).  A 4-0 silk braided suture (MYCO 
Medical, Apex, NC) was used to tie a loop around the duodenum just inferior to the 
pyloric sphincter. The stomach was then cut free of the gastrointestinal tract just inferior 
to the suture and just superior to cardiac sphincter.  The stomach was immediately 
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placed in in cold PBS prior to processing.  Whole liver, spleen and brain tissue were 
collected by necropsy and placed into cold PBS prior to processing.   
 
Sample processing.  Blood samples were centrifuged 10 min at 1500 x g at room 
temperature to separate plasma.  Plasma was centrifuged a second time for 10 min at 
2000 x g at room temperature to remove platelets.  Plasma was aliquoted at 200 µL and 
stored at -20°C until assayed.  200 mg pieces of liver and spleen tissue as well as the 
cerebellum and hippocampus from brain tissue were sterilely collected from whole tissue 
and frozen at -20°C.  Stomachs were opened along the lesser curvature and thin strips 
representing the greater curvature of the stomach were collected and set aside for 
histology.  Remaining gastric tissue was processed for determining bacterial load.  After 
washing for bacterial load determination, 200 mg of gastric tissue was collected and 
frozen at -20°C. 
 
Determination of bacterial load. Stomach tissue was roughly chopped into 1 cm2 
pieces and washed vigorously in sterile BSFB media for 10 minutes.  Resulting wash 
serially diluted and plated onto Columbia Agar (Thermo Fisher) supplemented with 7% 
defibrinated sheep’s blood, 10 µg/mL vancomycin (Sigma Aldrich), 5 µg/mL trimethoprim 
(Sigma Aldrich), 5 µg/mL cefsulodin (Sigma Aldrich), and 5 µg/mL amphotericin B 
(Sigma Aldrich).  Plates were incubated for 5 days at 37ºC under microaerophilic 
conditions (5% CO2, 10% O2).  Stomach tissue was blotted dry using sterile gauze and 
weighed.  Bacterial load was then determined as CFU per mg of stomach tissue. 
 
Preparation of whole tissue protein lysates.  200 mg of frozen tissue was 
mechanically homogenized using mortar and pestle with the aid of liquid nitrogen.  
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Homogenized tissue was suspended in 2 mL of RIPA buffer (Thermo Fisher) 
supplemented proteinase inhibitor cocktail (Thermo Fisher).  Cells were lysed on ice with 
gentle shaking for 3 hr.  Unlysed tissues and lipid fraction were removed by 
centrifugation at 1500 x g for 15 min at 4°C.  Total protein concentration for tissue 
lysates was determined by BCA assay (Thermo Fisher).  Tissue lysates were aliquoted 
at 200 µL and frozen at -20°C until assayed. 
 
Cytokine quantification.    Tissue lysate was diluted to 500 µg/ml to standardize the 
amount of protein assayed across sample.  Cytokine quantification was determined by 
quantitative ELISA for TNF-α (Eagle Bioscience, Nashua, NH), IL-6 (Eagle Biosciences), 
and CRP (Sigma Aldrich) according to manufacturer’s directions.   
 
Statistical analysis.  Cytokine levels from active infection studies and eradication 
studies were evaluated by two-way ANOVA of H. pylori infection status and tissue type 
with Tukey’s correction for multiple comparisons.  Saccharin preference, open field 
behavior, and T-maze testing were evaluated by 3-way ANOVA for H. pylori status, 
eradication therapy exposure, and testing session with Tukey’s (open field behavior) or 
Sidak’s (T-maze) multiple comparison test.  Object location test was evaluated by paired 
student’s t test.  An alpha level of 0.05 was used as a threshold for statistical 
significance and all error bars represent standard error of the mean (SEM). Graphpad 





5.3  Results 
 
5.3.1 Confirmation of H. pylori associated inflammation in cognitive experimental 
population.  
 Bacterial load from Sprague-Dawley rats actively infected with H. pylori G27 was 
determined following euthanasia of the animals after completion of cognitive behavioral 
testing (Figure 5.1).  Bacterial load observed in the cognitive experimental population 
was comparable to that previously observed during inflammation studies.  No H. pylori 
colonies were recovered from mock-infected animals.  In the cognitive experimental 
population that underwent eradication therapy, no H. pylori colonies could be recovered 
from H. pylori cleared or mock-infected animals.  However, H. pylori cleared animals 
tested positive for the presence of circulating anti-H. pylori antibodies while mock-
infected animals tested negative, indicating the prior infection did occur in H. pylori 
cleared animals. 
 Inflammatory markers were measured from stomach, liver, spleen, plasma, 
hippocampus, and cerebellum tissue collect by necropsy.  Actively infected animals were 
found to have a pattern of elevated inflammatory markers similar to those observed in 
previous 26-week long infection studies (Figure 5.2).  In animals assigned to the 
eradication studies, inflammatory markers in H. pylori cleared animals were found to be 
non-significantly different in comparison to those observed in mock-infected animals 
(Figure 5.3).   
 
5.3.2 Chronic H. pylori infection is not associated with anhedonia. 
As cognitive behavioral testing is reliant upon reward seeking behavior, animals 
were evaluated for anhedonia in response to sweet taste.  Performance on the saccharin 
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preference test was unaffected by either H. pylori infection or by eradication of the 
infection with antibiotics (Figure 5.4; all p > 0.1).  
 
5.3.3 H. pylori eradication therapy in mock-infected rodents is associated with 
increased open field behavior. 
Open field behavior was utilized to evaluate general locomotor activity levels and 
anxiety levels in the experimental animal populations6,17,50.  For distance traveled in the 
open field chamber, there was an effect of trial (p < 0.001) and an interaction between 
infection and eradication therapy treatment (p = 0.005). This interaction was driven by 
particularly high levels of activity in mock-infected rats that received eradication therapy 
treatment (Figure 5.5).  While the reason remains unclear as to why exposure to 
eradication therapy in mock-infected animals was associated with increased activity 
levels, such observations have been reported in other studies utilizing ß-lactam 
antibiotics in rodents51.   
 
5.3.4 Chronic H. pylori infection is not associated with changes in performance in 
object location memory. 
Object location memory testing evaluates spatial memory in the animals9.  
Animal are introduced to two identical objects for a fixed period of time, and after a 
delay, exposed again to the same two objects, one of which has been moved to a new 
location.  Animals that remember the previous exposure are expected to spend more 
time exploring the object in the new position.  No effect of infection or eradication on the 
preference for the moved object (Figure 5.6; all p > 0.8). In addition, there was no 
evidence that the rats spent more time investigating the moved object, relative to the 
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unmoved object (one sample t-test vs 0.5, all p > 0.4).  these data indicate that chronic 
H. pylori infection is not associated with direct impairment of spatial memory. 
 
5.3.5 Chronic H. pylori infection is associated with lasting and irreversible 
impairment of learning memory and behavioral flexibility. 
T maze tasks measure an integration of hippocampal driven memory and 
prefrontal cortex mediated decision making10,45,47,49,52.  Performance was assessed 
during response training sessions and reversal tests (Figures 5.7). Infection affected the 
number of incorrect choices made across both training and test sessions (p = 0.028) and 
the number of incorrect responses also depended on session (p < 0.001). When 
incorrect response training sessions were examined alone, an effect of session (p < 
0.001) and an interaction between H. pylori infection, antibiotic treatment, and session (p 
= 0.048) was found. This interaction was driven by the high level of incorrect choices 
during the first training session in H. pylori rats who had their infection eradicated with 
antibiotics. When reversal sessions alone were examined; however, the effect of 
infection failed to reach significance (p = 0.073) and performance improved by the 
second test session (p < 0.001).  
Because the number of completed trials varied by rat, accuracy was also 
examined (Figure 5.7).  Overall accuracy across the 4 days was affected by infection (p 
= 0.016) and session (p < 0.001). Within response training sessions, accuracy was 
affected by a main effect of session (p < 0.001) and an interaction between infection and 
session (p = 0.031). The interaction was driven by poorer performance in the H. pylori 
rats, regardless of whether the infection had been treated with antibiotics, during the 
second retraining session (session 3). Accuracy during the reversal tests was affected 
by main effects of infection (p = 0.039) and session (p < 0.001). Collectively, these data 
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While sickness-like behavior is tied to hippocampal IL-6 levels42 and includes 
anhedonia and reduced activity levels3,33, no effect of H. pylori infection was detected on 
either the saccharin preference test or the open-field test. This may be because chronic, 
rather than acute, infection was modeled. The effects of LPS on anhedonia and activity 
are acute and fade within 24 hours of injection3. A study using infection (e.g., Calmette-
Guérin bacillus) to model chronic inflammation revealed that anhedonia fades within the 
first 14 days of infection, while activity levels return to normal within 7 days19. However, 
older mice in that study continued to display signs of sickness for at least 21 days, 
suggesting that infection may have more serious consequences on behavior in aged 
populations. Although H. pylori infection did not affect activity levels, it is worth noting 
that antibiotic treatment (the eradication therapy) increased activity levels among mock-
infected rats. The reason for this is unclear and antibiotics did not influence saccharin 
preference or cognitive performance.  
Rats that were infected with H. pylori displayed cognitive deficits during the 
acquisition and reversal of the T-maze task and these deficits were present even when 
the infection had been eradicated for 13 weeks. The cognitive deficits included increased 
errors during a retraining session, where rats were reinforced for choosing the arm that 
had been baited the day before, as well as increased errors during the two reversal test 
sessions. Deficits in hippocampal function can cause poorer performance on both 
acquisition and reversal on tasks that require spatial memory, including the T-maze 
task29,53 and the water maze43,53. Hippocampal damage would also be expected to impair 
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performance on the object location task38, although no effect of infection was found 
during object location performance. However, none of the groups examined displayed 
preference for the moved object (i.e., memory for the unmoved object); therefore, it is 
difficult to interpret these results.  Another region that may be involved in the cognitive 
deficits is the prefrontal cortex, as lesions to this region can impair reversal learning in 
both T-maze29 and operant35,44 tasks.  Taken together, these results suggest that H. 
pylori leads to cognitive deficits through lasting and irreversible damage to the 
hippocampus and/or prefrontal cortex.  
These effects on cognition are enduring, as rats who had undergone the 
eradication regimen no longer displayed elevated inflammation within the hippocampus 
but they still displayed cognitive deficits. One recent study examined the long-lasting 
effects of early-life inflammation and reported that a single dose of LPS, when 
administered during the juvenile period, caused depressive-like behavior and greater 
sensitivity to inflammation in adult mice8. This is consistent with the theory that juveniles 
and adolescents may be especially sensitive to the effects of stress and neuro-
inflammation on disrupting hippocampal and prefrontal development13,34. Rats in this 
study were infected with H. pylori during adolescence and maintained high levels of 
inflammation until their infection was eradicated, so it could be that the eradication 
group’s deficits are caused by the early-life exposure to neuro-inflammation.  This theory 
could be tested in a follow-up group where infection occurs during adulthood. Our results 
highlight the need for early intervention, as later eradication may not be enough to 
reverse the damage caused by early infection.  
Finally, these findings raise questions regarding current established standards of 
care in regard to management of H. pylori infection in pediatric populations.  Risk of the 
establishment of chronic H. pylori infection during childhood has been found to be 
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inversely related to socioeconomic status11,30-32,41.  Furthermore, low socioeconomic 
status has been found to be a tremendous burden during cognitive development in 
children4,16,18,39,40.  Current standards of care recommend testing of children for chronic 
H. pylori infection only in the cases of recurrent gastric complaint or active ulcer disease 
and eradication of H. pylori only in children with active ulcer disease15.  The “watchful 
vigilance” approach espoused by the current standards of care may be placing these 
vulnerable populations at elevated of lasting detrimental cognitive effects.  As such, 
these findings add to a growing body of work that suggest that the extra-gastric influence 













1 .0×1 0 5
2 .0×1 0 5
3 .0×1 0 5
2 6  w e e k  in fe c tio n
 
Figure 5.1.  Bacterial load of H. pylori G27 from animals actively infected for 26 
weeks that were utilized in cognitive behavioral testing. Whole stomach tissue was 
cut into 1 cm2 pieces and washed vigorously in sterile media prior to plating on H. pylori 
selective medium (Columbia Blood Agar supplemented with vancomycin (10 mg/mL), 
trimethoprim (5mg/mL), cefsulodin (5 mg/mL), and amphotericin B (5 mg/mL)). Bacterial 
load was calculated as number of CFU per mg of gastric tissue. Each filled circle 
represents the bacterial load of an individual animal (n = 12). Data were collected across 
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Figure 5.2. Inflammatory profile in cognitive experimental population that were 
utilized in active infection studies.  Quantitative ELISA based assessment of the 
degree of change of levels of TNF-α, IL-6, and CRP following 26-week long infections 
utilizing H. pylori G27 infection.  H. pylori associated changes in inflammatory markers 
are reported as fold difference between actively infected animals relative to mock-
infected animals.  Data were collected across 1 experiments, each utilizing 12 mock-
infected and 12 actively infected animals. Results from mock-infected animals (black 
bars) were averaged and normalized to 1. Results from actively infected animals (white 
bars) were averaged and rendered relative to mock-infected animals. The height of each 
bar corresponds to the mean difference between inflammatory markers, and the error 
bars correspond to the standard error of the mean. Data were analyzed by 2-way 
ANOVA of H. pylori status and tissue type (p < 0.01) followed by pairwise comparison’s 
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 Figure 5.3. Inflammatory profile in cognitive experimental population that were 
utilized in eradication studies.  Quantitative ELISA based assessment of the degree of 
change of levels of TNF-α, IL-6, and CRP following eradication of H. pylori G27 infection.  
In eradication studies, 13-week infections were carried out in Sprague-Dawley rats 
utilizing H. pylori G27, followed by an eradication regimen (lansoprazole (3.75 mg/kg), 
clarithromycin (2.25 mg/kg), and amoxicillin (4.5 mg/kg) administered orally, twice daily 
for 10 days). After 13 weeks following eradication regimen, tissue samples were 
collected and inflammatory markers measured by quantitative ELISA.  H. pylori 
associated changes in inflammatory markers is reported as fold difference between 
actively infected animals relative to mock-infected animals.  Data were collected across 
3 independent experiments, each utilizing 3 mock-infected and 3 actively infected 
animals. Results from mock-infected animals (black bars) were averaged and 
normalized to 1. Results from actively infected animals (white bars) were averaged and 
rendered relative to match mock-infected animals. The height of each bar corresponds 
to the mean difference between inflammatory markers, and the error bars correspond to 
the standard error of the mean. Significant differences were not observed in levels of 
TNF-α, IL-6, or CRP, indicating that inflammatory marker levels returned to baseline 
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Figure 5.4. Chronic H. pylori infection does not induce anhedonia in infected 
animals.  Animals were presented with two pre-measured water bottle: 1) distilled water 
and 2) distilled water with 0.025% saccharin.  Animals were allowed to consume ab litum 
for 24 hours.  At that time, the remaining water from each bottle was measured, and the 
process repeated for a second day.  The proportion of saccharin containing water 
consumed by animals is reported for each treatment groups with mock-infected animals 
represented by black bars and H. pylori infected animal represented by white bars.  The 
height of the bars corresponds to the mean for each group and the error bars represent 
the standard error of the mean.  No significant difference was observed across any of 
the treatment groups (3-way ANOVA of H. pylori status, eradication therapy status, and 
day: p > 0.3), indicating that neither H. pylori status nor exposure to H. pylori eradication 
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Figure 5.5. H. pylori status in not associated with changes in open field behavior.  
Animals were placed in an open field arena and allowed to freely explore for 10 minutes 
before being returned to their home cage for 60 minutes after which they were again 
allowed to explore the open field arena for an additional 10 minutes.  Total distance 
traveled was recorded for each animal during each exposure to the open field arena.  
Each treatment group was composed of 12 animals with mock-infected animals 
represented by black bars and H. pylori infected animal represented by white bars.  The 
height of each bar corresponds to the mean distance traveled and the error bars 
represent the standard error of the mean.  Data were analyzed by 3-way ANOVA of H. 
pylori status, eradication therapy, and trial (eradication/trial p < 0.01) and were followed 
by pairwise testing by Tukey’s multiple comparison test (significant p values are reported 
above the relevant comparisons), indicating that eradication therapy in mock-infected 

































2 6  w e e k  in fe c tio n



























e ra d ic a tio n
 
Figure 5.6. Chronic H. pylori infection is not associated with changes in 
performance during object location testing.  Two identical objects were placed in the 
open field arena, and animals were allowed to explore each object for 5 minutes.  
Animals were then returned to their home cage for 60 minutes.  One of the objects was 
then moved to a new location.  The animals were then allowed to explore each object for 
3 minutes.  The amount of time spent exploring each object was measured and 
preference calculated as the proportion of time spent exploring the moved object with 
mock-infected animals represented by black bars and H. pylori infected animal 
represented by white bars.  Each treatment group was composed of 12 animals.  The 
height of each bar corresponds to the mean preference for the moved object and the 
error bars represent the standard error of the mean.  Data were analyzed by one sample 
student’s t test vs 0.5.  No significant difference (p > 0.4) was found, indicating that 
chronic H. pylori did not result in a direct impairment of spatial memory (hippocampal 
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Figure 5.7. Chronic H. pylori infection is associated with lasting and irreversible 
impairment of learning memory and behavioral flexibility.  Animals were trained to 
turn toward a baited arm (e.g., left) on the first day.  For the second session, the 
previously un-baited arm (e.g., right) was baited to test the animal for reversibility of 
learned behavior.  For the third session, the same arm was baited (e.g., right) to test for 
memory of the reversal.  For the fourth session, the initially baited arm was again baited 
(e.g., left) to again assess behavioral flexibility.  Incorrect choices were recorded when 
the animal chose the un-baited arm.  Accuracy was recorded as the fraction of correct 
choices made by an animal during all trials for a given session.  Data were analyzed by 
3-way ANOVA of H. pylori status, exposure to eradication therapy, and session (session: 
p < 0.001; interaction between H. pylori status, exposure to eradication therapy, session: 
p = 0.48).  Pairwise comparisons by Sidak’s multiple comparison test were significant for 
accuracy during session #3 for mock-infected vs H. pylori infected animals. *p value < 
0.01 for the comparison of animals actively infected with H. pylori vs H. pylori cleared by 
eradication therapy during session #1 for incorrect choices.  These findings suggest that 
H. pylori status (both active infection and cleared by eradication therapy) was associated 
with lasting and potentially irreversible impairment of hippocampal and/or prefrontal 
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Chapter 6: Helicobacter pylori associated iron deficiency 
6.1 Introduction 
The curious history of H. pylori associated iron deficiency anemia began with a 
single case study involving a 15 year old female patient suffering increasing fatigue and 
pallor with an acute onset of syncopic episodes9.  Personal and family history were 
unremarkable.  Patient’s diet was normal concerning normal iron intake, and no 
gastrointestinal complaints were reported.  Frank and occult blood loss was absent.  
Extensive laboratory tests revealed no abnormality in physiology.  The patient was 
prescribed oral iron supplements pending follow-up upper and lower endoscopy 
exanimations.  In the intervening two-week period, the patient’s hemoglobin levels did 
not improve.  The patient’s lower endoscopy series was normal with no evidence of frank 
or occult bleeding was observed.  Upper endoscopy revealed the presence of superficial 
gastritis of the gastric antrum.  No evidence of frank or occult bleeding was observed.  
Gastric biopsy samples were positive for H. pylori infection.  H. pylori infection was 
treated by standard eradication therapy.  At a three-week follow-up, the patient’s 
hemoglobin levels showed clear improvement, and at six-week follow-up, the patient’s 
hemoglobin levels had returned to the mean for her age bracket.  It was concluded that 
H. pylori infection resulted in a discrete micro-hemorrhagic gastritis in which microscopic 
bleeds resulted in iron-deficiency anemia9. 
In the decade following, a series of case studies across Europe and Asia would 
report similar findings of resolution of idiopathic iron deficient anemia following 
eradication of H. pylori infection4,6,10,11,17,21,22,33,46,52.  In several epidemiology studies, H. 
pylori seropositivity was associated with reduction in iron stores8,35,37,38,42.  An analysis of 
cross-sectional data from a German national health survey, H. pylori seropositivity was 
associated with a 17% decrease in serum ferritin levels after controlling for age and sex8.  
In a Danish population-based study, H. pylori seropositivity, independent of age, sex, 
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and socioeconomic status, was associated with a 40% increased risk of having a serum 
ferritin levels below 30 µg/L (indicative of iron-deficient anemia)18.  In a large-scale study 
of Alaskan natives, H. pylori seropositivity was associated with an relative risk of 1.13 of 
low serum ferritin levels, particularly among persons less than 20 years of age52. In a 
study of Korean children aged 6-12 years, H. pylori seropositive was associated with a 
15 ng/mL and an 11.1% increase in prevalence of iron deficiency anemia42.  A follow-up 
study in Korean adolescents found that H. pylori associated decreases in iron stores was 
more common and more pronounced in females as compared to males12.   
Several hypotheses have been put forward to explain the relationship between H. 
pylori infection and iron deficiency anemia.  The first proposed mechanism is that of 
occult blood loss secondary to chronic erosive gastritis.  In a descriptive study in Alaskan 
natives showed high prevalence of iron-deficiency anemia associated with an atypical, 
grossly hemorrhagic gastritis related to H. pylori infection51.  However, all subjects 
presented with evidence of elevated fecal hemoglobin levels prior to selection for 
undergoing endoscopy.  Most published case studies and case series have found no 
evidence of bleeding lesions at time of endoscopy or reported negative fecal occult 
blood testing among study subjects3,4,6,16,17,21,22,32.  The preponderance of available 
evidence, therefore, argues against chronic blood as an etiology for iron deficiency 
associated with H. pylori infection.   
A second proposed hypothesis is that increased uptake and utilization of iron by 
H. pylori limits its availability to the host.  Many H. pylori strains possess a 19 kDa iron-
binding protein morphologically and biochemically similar to ferritin16 which is highly 
expressed in the presence of iron48.  Additionally, H. pylori possesses several high 
affinity iron transporters49.  Another proposed mechanism is H. pylori’s capability to 
acquire iron bound by host derived lactoferrin19 by a lactoferrin binding receptor that is 
expressed under iron-deplete conditions15.  Gastric lactoferrin concentration is increased 
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during H. pylori infection, further suggesting a role for H. pylori lactoferrin receptor during 
infection13,15.  Several membrane proteins have been described which are capable of 
binding heme that may also be involved in the uptake of host derived iron50.  Finally, H. 
pylori derived neutrophil activating protein (NapA) has been shown to act as iron-binding 
protein49.  Together these findings demonstrate numerous adaptations by which H. pylori 
may subvert its host’s ability to access dietary iron. 
A final hypothesis for the mechanism by which H. pylori may contribute to iron 
deficiency is malabsorption secondary to gastritis associated changes in gastric 
homeostasis.  Reduction of ferric iron to ferrous iron is dependent upon the pH of the 
gastric juice, and ferrous iron facilitates membrane transport and uptake26.  Absorption of 
ferrous iron is further mediated by gastric secreted ascorbic acid which complexes with 
ferrous iron and maintains solubility at the pH range encountered in the duodenum and 
jejunum20, where iron absorption occurs26.   The secretion of ascorbic acid is 
dramatically reduced during H. pylori infection41,53.  Eradication of active H. pylori 
infection has been shown to improve gastric ascorbic acid levels5,43. 
     
6.2 Materials and Methods 
Animal care. All experiments involving the use of live vertebrate animals were 
conducted with the approval of the University of Illinois at Urbana-Champaign 
Institutional Animals Care and Use Committee (IACUC).  Animal populations were 
composed of male Sprague-Dawley rats (Envigo, formerly Harlan Laboratories, 
Indianapolis, IN).  Animals were group housed (3 or 5 animals per cage) with 12 h light-
dark cycle, mean temperature of 22.1°C, humidity of 50%, and allowed food and water 
ad libitum.  Animals were fed standard rodent chow (Teklad F6 Rodent Diet; Envigo) 




Bacterial strains. Rat-adapted Helicobacter pylori G27 (cag PAI+, vacA s1/m1; NCTC 
13282) was cultured in media in bisulfite- and sulfite-free Brucella broth (BSFB) 
supplemented with 5% fetal bovine serum (Sigma Aldrich, St. Louis, MO) for 36 h at 
37ºC under microaerophilic conditions (5% CO2, 10% O2).  Culture was diluted to 2x107 
cells per mL as estimated by disposable hemocytometer (inCYTO, Seonggeo-gil, South 
Korea).  Dilution was confirmed by serial dilution and spread plating on Columbia Blood 
Agar (Thermo Fisher, Hanover Park, IL) supplemented with 7% defibrinated sheep’s 
blood (Thermo Fisher), 10 µg/ml vancomycin (Sigma Aldrich), 5 µg/ml trimethoprim 
(Sigma Aldrich), 5 µg/ml cefsulodin (Sigma Aldrich), and 5 µg/ml amphotericin B (Sigma 
Aldrich).  Plates were incubated for 5 days at 37ºC under microaerophilic conditions (5% 
CO2, 10% O2), prior to confirming bacterial cell density by colony counting. 
 
Establishment of H. pylori infections. Male Sprague-Dawley rats (Envigo), aged 19-
21 days, were orally fed 3.75 mg/kg lansoprazole (Sigma Aldrich) suspended in 20% 
sucrose solution once daily for 7 days.  On days 3 and 5 of treatment, animals received 
0.5 mL of mid-log phase H. pylori culture diluted to 2x107 cells/ml (active H. pylori 
infection) or 0.5 mL of sterile BSFB media (mock infected controls) by oral gavage using 
a 20 G disposable feeding needle (Thermo Fisher).  Inoculum dosage was estimated by 
hemocytometer and verified by CFU plating.  Length of infection (8-weeks) was defined 
as the number of weeks following competition of lansoprazole treatment prior to 
euthanasia and tissue collection.  Active infection studies were conducted in two 
independent blocks each composed of 3 actively infected animals and 3 mock infected 
animals.  Eradication studies were conducted as a single independent block composed 
of 5 actively infected animals and 5 mock infected animals.  Nutritional intervention 
studies were conducted in a single independent block of actively infected animals 
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composed of 5 mock intervention animals, 5 iron intervention animals, 5 vitamin C 
intervention animals, and 5  combined iron and vitamin C intervention animals. 
 
Eradication of active H. pylori infection. Animals assigned to the eradication studies 
underwent H. pylori eradication therapy 4 weeks after competition of lansoprazole 
treatment administered as part of the inoculation procedures.  In brief, animals received 
eradication therapy consisting of 3.75 mg/kg lansoprazole (Sigma Aldrich), 2.25 mg/kg 
clarithromycin (Sigma Aldrich), and 4.5 mg/kg amoxicillin (Sigma Aldrich) suspended in 
30% sucrose solution orally twice daily for 10 days.  Prior infection status was confirmed 
by Instant-View H. pylori Rapid Test seropositivity assay (Alpha Scientific, Poway, CA) 
using whole blood samples collected by terminal cardiac puncture.  Successful 
eradication of H. pylori was confirmed inability to culture H. pylori from stomach tissue 
collected during necropsy. 
 
Nutritional intervention. Animals assigned to the nutritional intervention studies 
received either mock intervention (0.35 mL of 10% sucrose solution), iron 
supplementation intervention (0.35 mL of ferrous sulfate oral iron supplement; equivalent 
to 3 mg of elemental iron per animal; GeriCare, Brooklyn, NY), vitamin C 
supplementation intervention (250 mg/kg ascorbic acid in 10% sucrose solution; Thermo 
Fisher), or combined iron and vitamin C supplementation intervention (0.35 mL of 
ferrous sulfate oral iron supplement combined with 250 mg/kg ascorbic acid).  Nutritional 
interventions began the day following competition of lansoprazole treatment and were 
administered every other day for the duration of the 8-week infection period. 
 
Temporal measurements. Beginning 24 hours before the start of lansoprazole 
treatment, animals were weighed and hemoglobin and hematocrit were measured.  In 
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brief, animals were transferred into a pre-tared clean mouse cage and weighed on 
portable balance (Thermo Fisher).  Tail veins were dilated by gently warming by hold the 
animal’s tail in closed hand for several minutes.  The tail was cleaned and disinfected 
using a sterile alcohol wipe.  Using a #15 scalpel blade a small nick was made 
transverse across the lateral tail vein.  The first drop of blood was discarded.  Blood was 
collected using 2 StateSpin SafeCrit plastic microhematocrit tubes containing heparin 
(Beckman Coulter, Brea, CA) and 2 Hemocue HB201 hemoglobin microcuvettes 
(Hemocue America, Brea, CA).  Hemoglobin concentration was determined by Hemocue 
HB201 meter (Hemocue America).  Microhematocrit tubes were centrifuge for 6 minutes 
at 1300 x g at room temperature.  Hematocrit value was determined by use of a Damon 
IEC Microcapillary reader (Thermo Fisher). 
 
Terminal collection of tissue samples. At experimental end points, whole stomach 
tissue and large volume blood samples were collected.  In brief, animals were placed 
under surgical plane anesthesia by intraperitoneal administration of 100 mg/kg ketamine 
(Med Vet International, Mettawa, IL) and 10 mg/kg xylazine hydrochloride (Sigma 
Aldrich).  Cardiovascular function was stabilized by intramuscular injection of 0.05 mg/ml 
atropine sulfate (Med Vet International).  Animal’s abdominal and thoracic cavity were 
opened and cardiac puncture blood draw conducted via the left ventricle using a 19 G 
needle.  Collected blood was split between EDTA anti-coagulated blood collection tubes 
(2 mL; Becton, Dickinson, and Company, Franklin Lake, NJ) and serum separation tubes 
(remainder; Becton, Dickinson, and Company).  A 4-0 silk braided suture (MYCO 
Medical, Apex, NC) was used to tie a loop around the duodenum just inferior to the 
pyloric sphincter. The stomach was then cut free of the gastrointestinal tract just inferior 
to the suture and just superior to cardiac sphincter.  The stomach was immediately 
placed in in cold PBS prior to processing.  Serum samples were prepared by inverting 
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tubes 5 times and allowing blood to clot for 30 minutes at room temperature.  Samples 
were then centrifuged for 10 min at 1200 x g at room temperature to separate serum.  
Serum was stored at 4°C until assayed for total serum, unsaturated iron-binding 
capacity, total iron-binding capacity, serum ferritin, and serum soluble transferrin 
receptor. 
  
Determination of bacterial load. Stomach tissue was roughly chopped into 1 cm2 
pieces and washed vigorously in sterile BSFB media for 10 minutes.  Resulting wash 
serially diluted and plated onto Columbia Agar (Thermo Fisher) supplemented with 7% 
defibrinated sheep’s blood, 10 µg/mL vancomycin (Sigma Aldrich), 5 µg/mL trimethoprim 
(Sigma Aldrich), 5 µg/mL cefsulodin (Sigma Aldrich), and 5 µg/mL amphotericin B 
(Sigma Aldrich).  Plates were incubated for 5 days at 37ºC under microaerophilic 
conditions (5% CO2, 10% O2).  Stomach tissue was blotted dry using sterile gauze and 
weighed.  Bacterial load was then determined as CFU per mg of stomach tissue. 
 
Determination of RBC indices.  Terminal hematocrit and hemoglobin were determined 
immediately following collection of blood from cardiac puncture.  Blood was collected 
using 2 StateSpin SafeCrit plastic microhematocrit tubes containing heparin (Beckman 
Coulter, Brea, CA) and centrifuge for 6 minutes at 1300 x g at room temperature.  
Hematocrit value was determined by use of a Damon IEC Microcapillary reader (Thermo 
Fisher).    Blood was collected into 2 Hemocue HB201 hemoglobin microcuvettes 
(Hemocue America, Brea, CA) and hemoglobin concentration was determined by 
Hemocue HB201 meter (Hemocue America).  Concentration of red blood cells was 
determined by disposable hemocytometer (inCYTO) using EDTA anti-coagulated blood 
diluted 1:200 with normal saline.  Mean corpuscular volume was calculated as the 
hematocrit divided by the red blood cell concentration.  Mean corpuscular hemoglobin 
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was calculated as hemoglobin divided by red blood cell concentration.  Mean 
corpuscular hemoglobin concentration was calculated as hemoglobin divided by 
hematocrit. 
 
Measurement of serum iron, unsaturated iron-binding capacity, and total iron-
binding capacity.  Total serum iron, unsaturated iron-binding capacity, and total iron-
binding capacity were determined from serum samples within 48 hours of collection by 
ferrozine reaction using Iron/TIBC Reagent Set (Pointe Scientific, Ann Arbor, MI).  
Briefly, total serum iron was determined by releasing bound iron and reducing it to 
ferrous ions by use of acidic buffer prior to reaction with ferrozine reagent.  Resulting 
violet colored complex was measured spectrophotometrically at 560 nm using a BioTek 
Synergy 2 plate reader (BioTek, Winooski, VT).  The unsaturated iron-binding capacity 
was determined by additional of a known quantity of ferrous ions in alkaline buffer.  
Excess, unbound ferrous ions were then measured by the measured by ferrozine 
reaction.  The difference between the known quantity of added ferrous ions and the 
measurement taken after binding represented the unsaturated iron-binding capacity.  
Total iron-binding capacity was calculated total serum iron plus the unbound iron-binding 
capacity. 
 
Determination of serum ferritin and soluble transferrin receptor. Serum ferritin 
levels were determined by quantitative rat ferritin ELISA (Abcam, Cambridge, UK) from 
serum samples within 48 hours of collection.  Samples were diluted 1:100 using supplied 
sample dilution buffer and protocol was followed according to manufactures 
recommendations.  Measurements of absorbance at 450 nm were conducted using a 
BioTek Synergy 2 plate reader (BioTek).  Serum soluble transferrin receptor levels were 
determined by quantitative rat transferrin ELISA (LifeSpan BioSciences, Seattle, WA).  
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Samples were diluted 1:100 using supplied sample dilution buffer and protocol was 
followed according to manufactures recommendations.  Measurements of absorbance at 
450 nm were conducted using a BioTek Synergy 2 plate reader (BioTek). 
 
Statistical analysis. Active H. pylori infection experiments were conducted in two 
independent blocks with each block composed of 3 mock infected and 3 actively infected 
animals.  All data was mean and variance tested prior to combining into a single data set 
from final analyses.  Eradication studies were conducted as a single independent block 
composed of 5 mock infected and 5 actively infected animals.  Nutritional intervention 
studies were conducted as a single independent block composed of 20 actively infected 
animals, 5 of which were assigned to mock intervention, 5 to iron supplementation 
intervention, 5 to vitamin C supplementation intervention, and 5 to combine iron and 
vitamin C supplementation intervention.  Growth rates of animals were assessed by non-
linear regression of weight data.  Active infection and eradication studies were evaluated 
by two-way ANOVA (H. pylori status vs eradication therapy) with subsequent pairwise 
testing by Tukey’s multiple comparison test.  Nutritional intervention studies were 
evaluated by one-way ANOVA with subsequent pairwise testing by Tukey’s multiple 
comparison test.  Experiments were designed such that a family-wise alpha was 
maintained at 0.05 and overall power was maintained at 0.80 for determination of 
statistical significance.  Graphical figures were generated in Graphpad Prism (v6.01; 
Graphpad Software, La Jolla, CA).  All statistical analyses were conducted in SAS (v.9.3; 





6.3  Results 
6.3.1 H. pylori infection is associated with an iron deficient state. 
  Following 8 week long infections utilizing H. pylori G27, bacterial load was 
determined to be 1.83 x 105 ± 7.4 x 103 CFU/mg of gastric tissue, comparable levels to 
the bacterial load observed during previous studies utilizing 8 week long infections.  
Time series data indicate the initial hemoglobin and hematocrit response to infection by 
H. pylori is a mild increase in both markers (Figure 6.1).  These findings are 
hypothesized to occur during to transient behavioral changes associated with the initial 
stages of H. pylori infection.  During periods of acute distress, in this case dyspepsia 
associated with initial colonization of the gastric mucosa by H. pylori, rats will naturally 
reduce and/or abstain from normal feeding and drinking behaviors7.  In turn, the 
development of transient dehydration results in the temporary elevation of both 
hemoglobin and hematocrit.  However, analyses of growth rate (Figure 6.2) indicate that 
such behavioral changes are highly transient as no perturbation is observed in growth 
rate of actively infected animals relative to mock infected.  Two weeks after completion 
of lansoprazole therapy, hemoglobin and hematocrit levels in actively infected animals 
were significantly lower than those of mock infected animals (Figure 6.1) and remained 
reduced throughout the remaining experimental period. 
 Following the collection of blood via terminal cardiac puncture, standard red 
blood cell indices were calculated for actively infected and mock infected animals (Table 
6.1).  Hemoglobin, hematocrit, red blood cell concentration, and mean corpuscular 
hemoglobin concentration were found to be significantly reduced in actively infected 
animals relative to mock infected animals.  However, mean corpuscular volume, and 
mean corpuscular hemoglobin were not significantly affected by active H. pylori infection.  
These data indicate that active H. pylori infection is associated with a normocytic, 
normochromatic reduction in iron levels consistent with iron deficiency. 
198 
 
 Further supporting the hypothesis that H. pylori infection is associated with an 
iron deficient state, total serum iron (the amount of iron freely present in the serum as 
well as that released by acid hydrolysis of serum proteins) is significantly reduced (Table 
6.2).  The unsaturated iron binding capacity and total iron binding capacity are 
significantly elevated while transferrin saturation is significantly reduced in actively 
infected animals.  To verify these observations, serum ferritin and soluble transferrin 
receptor levels were determined by quantitative ELISA.  Serum ferritin was found to be 
significantly reduced in actively infected animals (Table 6.3) to approximately 77% of the 
levels seen in mock infected animals.  Conversely, soluble transferrin receptor levels 
were found to be significantly increased in actively infected animals (Table 6.3) to 
approximately 160% of the levels seen in mock infected animals.   
 Ultimately, these data support a model in which actively H. pylori infection is 
associated with development of an iron deficient state, persisting throughout the course 
of infection.  This iron deficient state presents with the hallmark signs of a normocytic, 
normochromatic iron deficient state. 
 
6.3.2 Eradication of H. pylori infection leads to rapid recovery from associated 
iron deficient state. 
 To determine if active H. pylori infection is causative for H. pylori associated iron 
level reduction, eradication studies were conducted.  During these studies animals were 
either actively infected with rat-adapted H. pylori G27 or mock infected with sterile 
bacterial culture media.  Four week after completing inoculation procedures, all animals 
underwent standard H. pylori eradication therapy consisting of 3.75 mg/kg lansoprazole, 
2.25 mg/kg clarithromycin, and 4.5 mg/kg amoxicillin administered twice daily for 10 
days.  Following completion of eradication therapy, monitoring of animals continued until 
the completion of the 8-week study.  After terminal blood collection, animals were tested 
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for seropositivity to H. pylori.  All animals which were part of the actively infected group 
yielded a positive result (presence of anti-H. pylori antibodies) while those animals which 
were mock infected yielded a negative result.  Additionally, H. pylori could not be 
recovered from the stomachs of either set of animals, indicating that H. pylori infection in 
the animals assigned to the active infection group was successfully cleared by 
eradication therapy. 
 As seen in previous active infection studies, H. pylori infection was associated 
with a transient increase in both hemoglobin and hematocrit followed by significant 
reduction in actively infected animals after approximately two weeks of infection (Figure 
6.1).  Again, the initial observation of an increase in hemoglobin and hematocrit is 
hypothesized to result from distress induced behavioral changes relating to food and 
water consumption which rapidly subside following the establishment of H. pylori 
infection as neither H. pylori status or administration of eradication therapy was 
associated with changes in growth rate (Figure 6.2).  The reduction in hemoglobin and 
hematocrit observed during the active infection stage of these eradication studies were 
comparable to those seen in non-eradication studies at equivalent time points. 
 In H. pylori infected animals, hemoglobin and hematocrit levels began to show 
signs of recovery at approximately the mid-point of the eradication therapy regimen.  
Approximately 3 weeks after initiation of eradication therapy, hemoglobin and hematocrit 
levels of H. pylori infected animals were no longer significantly different than mock 
infected control animals (Figure 6.1).  Evaluation of standard red blood cell indices 
showed no significant difference between animals in which H. pylori infection was 
cleared and mock infected animals (Table 6.1).  Evaluation of total serum iron, 
unsaturated iron binding capacity, total iron binding capacity, and transferrin saturation 
revealed no significant difference between animals in which H. pylori infection had been 
cleared and mock infected animals (Table 6.2).  Furthermore, serum ferritin and soluble 
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transferrin receptor levels were not significantly different between these two 
experimental groups (Table 6.3).  Collectively, these data support the hypothesis that H. 
pylori infection is indeed the causative factor    
  
6.3.3 H. pylori associated iron deficiency is malabsorptive in nature. 
 To evaluate whether the relationship between iron deficiency and chronic H. 
pylori infection is nutritional intervention studies were conducted over the course of 8 
week long infections.  Hemoglobin levels from infected animals receiving high dose oral 
iron supplementation (3 mg every other day) were monitored through time in comparison 
to those obtained from infected animals receiving placebo intervention (an equivalent 
volume of sterile 10% sucrose solution).  Difference in bacterial load was to be 
insignificant with 1.79 x 105 ± 4.9 x 103 CFU/mg of gastric tissue for the placebo 
intervention and 1.89 x 105 ± 8.5 x 103 CFU/mg of gastric tissue for the oral iron 
supplementation intervention.  This bacterial loads are comparable to those observed 
during H. pylori infection in the absence of any intervention.  No significant difference in 
hemoglobin levels were observed throughout the 8-week long infection (Figure 6.3).  No 
significant difference was observed in the growth rate of animals during the course of the 
8-week infection.  Evaluation of red blood indices following euthanasia of animals 
showed no significant difference between placebo intervention and oral iron 
supplementation intervention (Table 6.4).  Likewise, no significant difference was 
observed in total serum iron, unsaturated iron binding capacity, total iron binding 
capacity, and transferrin saturation (Table 6.5) or in serum levels of ferritin and soluble 
transferrin receptor (Table 6.6). 
 Together, these data indicate that the reduction in iron levels observed during H. 
pylori infection are not a direct consequence of the bacteria outcompeting its host for 
dietary iron.  The amount of iron provided by oral supplementation far exceeds that 
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which could reasonably by utilized by H. pylori; however, no improvement in iron levels 
in observed in the animals receiving oral supplementation.  
 
6.3.4 H. pylori associated iron deficiency results from loss of gastric mucosal 
associated ascorbic acid levels. 
 To evaluate the influence on ascorbic acid on H. pylori associated iron 
deficiency, nutritional intervention studies included infected animals which received oral 
ascorbic acid supplementation intervention (250 mg/kg every other day).  Additionally, to 
determine if synergistic effects existed an additional group of infected animals received 
both oral iron supplementation (3 mg every other day) and oral ascorbic acid 
supplementation intervention (250 mg/kg every other day).  Difference in bacterial load 
was to be significantly lower (ANOVA p value: < 0.01; Tukey’s pairwise comparison test 
p value: < 0.01 for all comparisons) in animal receiving the ascorbic acid intervention 
with 1.66 x 105 ± 3.1 x 103 CFU/mg of gastric tissue in comparison to other intervention 
groups.  However, bacterial load in animals receiving both iron and ascorbic acid 
supplementation intervention were 1.80 x 105 ± 7.2 x 103 CFU/mg of gastric tissue and 
were not significantly different in comparison to placebo intervention or iron 
supplementation intervention.  Hemoglobin levels were found to be significantly elevated 
in comparison to animals receiving placebo intervention beginning approximately 1 week 
after inoculation with H. pylori and showed a trend in continual increase throughout the 
8-week infection (Figure 6.3).  No significant difference was observed in the growth rate 
of animals during the course of the 8-week infection. Red blood cell indices (Table 6.4) 
showed elevated levels of hemoglobin and hematocrit in both intervention group 
receiving ascorbic acid in comparison to placebo intervention (ANOVA p value: < 0.01; 
Tukey’s pairwise comparison test p value: < 0.01 for all comparisons).  Similarly, red 
blood cell count, mean corpuscular volume, mean concentration of hemoglobin, and 
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mean corpuscular hemoglobin concentration were found to be elevated in comparison to 
placebo intervention (ANOVA p value: < 0.01; Tukey’s pairwise comparison test p value: 
< 0.01 for all comparisons).  Serum iron, total iron binding capacity, and transferrin 
saturation were significantly elevated while unsaturated iron binding capacity was 
significantly reduced in comparison to placebo intervention (ANOVA p value: < 0.01; 
Tukey’s pairwise comparison test p value: < 0.01 for all comparisons; Table 6.5).  
Likewise, serum ferritin levels were significantly elevated while serum levels of soluble 
transferrin receptor were significantly reduced in comparison to placebo intervention 
(ANOVA p value: < 0.01; Tukey’s pairwise comparison test p value: < 0.01 for all 
comparisons; Table 6.6). 
 Together, these data indicate that high dose oral ascorbic acid supplementation 
is capable of rescuing H. pylori associated iron deficiency.  Furthermore, these data are 
indicative that iron supplementation alongside of ascorbic acid supplementation has 
minimal impact on rescuing H. pylori associated iron deficiency.  These findings support 
the hypothesis that gastric ascorbic acid levels play an important role in the development 
of iron deficiency during chronic H. pylori infection. 
 
6.4 Discussion 
 Iron deficiency is the most common nutritional deficiency worldwide34,36,45.  It is 
estimated that approximately two billion people worldwide are nutritionally deficient in 
iron44.  Even with affluent nations iron deficiency remains a major public health concern.  
Within the United States, it is estimated that 10 million individuals are iron deficient, 
including 5 million who have iron deficient anemia14.  In comparison, the prevalence of 
iron deficient anemia is far higher in the nations of Africa (64.6%), Asia (47.7%) and 
Latin America (39.5%) among children aged birth to 5 years34.   
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 Iron deficiency during infancy has been associated with reduction in test scores 
for cognitive, motor, social-emotional, and neurophysiological development in 
comparison to non-iron deficient infants27.  Iron deficiency within the first few years of life 
is linked with impaired development of both auditory and visual centers with subtle 
impairments persisting for years after correction of the nutritional deficiceny1,39.  
Furthermore, iron deficiency in early childhood has been observed to have long term 
consequences for cognitive development with detrimental effects from a single episode 
of iron deficiency anemia during early childhood associated with reduced cognitive 
performance measured nearly 20 years later28.   
 All animals infected with H. pylori, with the exception of those receiving oral 
ascorbic acid supplementation, rapidly developed iron levels below those observed in 
mock infected animals.  Eradication of active H. pylori infection was followed by return of 
depressed iron levels to normal values.  As such, these studies support not only that 
chronic H. pylori infection is associated with an iron deficient state but also that H. pylori 
infection is an etiological agent of the observed iron deficient state.  While no infected 
animal developed clinical anemia during the course of these 8-week infection studies, 
infected animals did present with marginal iron deficiency which has been shown to have 
detrimental influence on cognitive development in rodent models23-25.  Therefore, it is 
likely that H. pylori associated iron deficiency poses a risk factor in the potential 
development of detrimental cognitive effects. 
 Finally, it must be noted that, like H. pylori infection29-31, the prevalence of iron 
deficiency shows clear disparity along socioeconomic standing with higher prevalence 
among those of lower standing2,28,40,47.   As in the case of impairment of cognition, 
chronic H. pylori likely acts as an additional burden on these populations, placing them 
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Figure 6.1. Active H. pylori infection is associated with a reduction in hemoglobin 
and hematocrit levels.  Time series data for hemoglobin and hematocrit levels 
measured from tail vein blood during chronic H. pylori G27 infection.  Infection 
experiments were carried out for 8 weeks (inoculation procedure period highlighted in 
blue).  Animals assigned to the eradication therapy group were infected for 4 weeks prior 
to the administration of H. pylori eradication (eradication therapy highlighted in red). 
Eradication therapy regimen consisted of lansoprazole (3.75 mg/kg), clarithromycin (2.25 
mg/kg), and amoxicillin (4.5 mg/kg) administered orally, twice daily for 10 days.  
Experimental populations consisted of 6 mock-infected and 6 H. pylori G27 animals 
infected for the 8-week infection group and 5 mock-infected and 5 H. pylori cleared 
animals for the eradication group.  The mean difference between mock-infected and H. 
pylori infected animals is represented by a circle and the error bars correspond to the 
95% confidence interval.  The data indicate that active H. pylori infection is associated 
with a significant reduction in hemoglobin and hematocrit levels and that clearance of 
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Figure 6.2. Growth rate is not influenced by H. pylori infection or eradication 
therapy.  Weight measurements were conducted at each blood collection throughout the 
infection experiments.  Infection experiments were carried out for 8 weeks (inoculation 
procedure period highlighted in blue).  Animals assigned to the eradication therapy 
group were infected for 4 weeks prior to the administration of H. pylori eradication 
(eradication therapy highlighted in red). Eradication therapy regimen consisted of 
lansoprazole (3.75 mg/kg), clarithromycin (2.25 mg/kg), and amoxicillin (4.5 mg/kg) 
administered orally, twice daily for 10 days.  Experimental populations consisted of 6 
mock-infected and 6 H. pylori G27 animals infected for the 8-week infection group and 5 
mock-infected and 5 H. pylori cleared animals for the eradication group.  Each point 
represents the weight of an individual animal.  Mock-infected animals are represented by 
black circles, and H. pylori infected animals by red squares.  Data were analyzed by 
logistic regression analysis and no significant difference was found among the 4 
experiments groups (p > 0.4), indicating the neither H. pylori infection nor eradication 







 8 week infection eradication 
 mock-infection 
n = 6 
H. pylori G27 
n = 6 
mock-infection 
n = 5 
H. pylori G27 
n = 5 
Hb (g/dL) 14.9 (0.2) 13.1 (0.1) 14.7 (0.2) 14.9 (0.3) 
HCT (%) 53.3 (2.1) 43.3 (0.6) 55.4 (1.5) 54.2 (1.8) 
[RBC] (M/µL) 7.1 (0.2) 6.2 (0.1) 7.1 (0.2) 7.0 (0.3) 
MCV (fL) 75.7 (2.4) 74.0 (3.5) 78.4 (3.9) 77.3 (5.8) 
MCH (gHB/M cells) 21.1 (0.8) 21.2 (0.2) 20.6 (0.6) 21.1 (1.1) 
MCHC (gHb/dL) 28.0 (1.1) 30.2 (0.5) 26.3 (0.7) 27.3 (1.3) 
Table 6.1. Chronic H. pylori infection is associated with changes to red blood cell 
indices consistent with an iron deficient state.  Red blood indices for hemoglobin 
(Hb), hematocrit (HCT), red blood cell count ([RBC]), mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration 
(MCHC) were measured following terminal blood collection from the experimental 
animals.  Data were by ANOVA (p < 0.01) followed by Tukey’s pairwise multiple 
comparison test.  Measurements significantly different (p < 0.01) from the mock-infected 
group are denoted in bold. These data indicate that H. pylori infection is associated with 






 8 week infection eradication 
 mock-infection 
n = 6 
H. pylori G27 
n = 6 
mock-infection 
n = 5 
H. pylori G27 
n = 5 
total Fe (µg/dL) 165.7 (4.1) 128.3 (3.7) 164.6 (4.2) 161.2 (3.8 
UIBC (µg/dL) 216.3 (9.3) 288.3 (11.5) 223.4 (7.4) 225.9 (10.0) 
TIBC (µg/dL) 381.9 (8.6) 416.7 (10.1) 389.0 (10.0) 385.1 (9.5) 
transferrin 
saturation (%)  0.43 (0.01) 0.31 (0.02) 0.42 (0.01) 0.41 (0.01) 
Table 6.2. H. pylori infection is associated with reduction in total serum iron and 
transferrin saturation. Total serum iron (total Fe), unsaturated iron binding capacity 
(UIBC), total iron binding capacity (TIBC), and transferrin saturation were measured 
following terminal blood collection from experimental animals.  Data were by ANOVA (p 
< 0.01) followed by Tukey’s pairwise multiple comparison test.  Measurements 
significantly different (p < 0.01) from the mock-infected group are denoted in bold.  
These data indicated that active H. pylori infection is associated with changes to red 






 8 week infection eradication 
 mock-infection 
n = 6 
H. pylori G27 
n = 6 
mock-infection 
n = 5 
H. pylori G27 
n = 5 
serum ferritin 
(pg/mL) 8126 (190) 6270 (255) 8260 (510) 8302 (654) 
soluble transferrin 
receptor (pg/mL)  5721 (610) 9180 (1123) 5500 (243) 5517 (177) 
Table 6.3. Chronic H. pylori infection is associated with physiological changes 
consistent with iron reserve depletion.  Serum ferritin and soluble transferrin receptor 
levels were measured by quantitative ELISA following terminal blood collection from 
experimental animals.  Data were by ANOVA (p < 0.01) followed by Tukey’s pairwise 
multiple comparison test.  Measurements significantly different (p < 0.01) from the mock-
infected group are denoted in bold.  These data indicated that active H. pylori infection is 
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Figure 6.3.  H. pylori associated reduction in hemoglobin levels is refractory to 
oral iron supplementation but rescued by oral ascorbate supplementation.  Time 
series data for hemoglobin levels measured from tail vein blood during chronic H. pylori 
G27 infection.  Infection experiments were carried out for 8 weeks (inoculation procedure 
period highlighted in blue).  Animals assigned to the iron supplementation group 
received oral supplementation of 3 mg of ferrous iron every other day; animals assigned 
to the ascorbate supplementation group received 250 mg/kg of ascorbate every other 
day, and animals assigned to the iron/ascorbate supplementation group received 3 mg 
of ferrous iron and 250 mg/kg of ascorbate every other day.  Experimental populations 
consisted of 5 placebo intervention (10% sucrose), 5 iron supplementation, 5 ascorbate 
supplementation, 5 iron/ascorbate supplementation animals.  All animals were infected 
with H. pylori G27.  The mean difference between placebo intervention and nutritional 
intervention animals is represented by a circle and the error bars correspond to the 95% 
confidence interval.  The data indicate that H. pylori associated reduction in hemoglobin 









 10% sucrose 
n = 5 
iron 
n = 5 
ascorbate 
n = 5 
iron/ascorbate 
n = 5 
Hb (g/dL) 10.4 (0.4) 10.6 (0.2) 17.1 (0.1) 17.3 (0.4) 
HCT (%) 42.8 (1.9) 43.8 (0.8) 56.4 (1.1) 59.6 (1.1) 
[RBC] (M/µL) 6.1 (0.2) 6.1 (0.2) 7.8 (0.1) 7.9 (0.3) 
MCV (fL) 70.8 (3.2) 71.9 (3.0) 76.6 (1.6) 71.2 (3.5) 
MCH (gHB/M cells) 17.1 (0.6) 17.3 (0.8) 22.0 (0.3) 21.9 (0.7) 
MCHC (gHb/dL) 24.2 (0.5) 24.1 (0.3) 28.7 (0.6) 30.7 (1.2) 
Table 6.4.  Oral administration of ascorbate rescues H. pylori associated changes 
in red blood cell indices.  Red blood indices for hemoglobin (Hb), hematocrit (HCT), 
red blood cell count ([RBC]), mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) were 
measured following terminal blood collection from the experimental animals.  Data were 
by ANOVA (p < 0.01) followed by Tukey’s pairwise multiple comparison test.  
Measurements significantly different (p < 0.01) from the placebo treated group (10% 
sucrose) group are denoted in bold. These data indicate that oral ascorbate 









 10% sucrose 
n = 5 
iron 
n = 5 
ascorbate 
n = 5 
iron/ascorbate 
n = 5 
total Fe (µg/dL) 138.7 (3.3) 127.2 (9.8) 171.6 (8.0) 188.8 (10.9) 
UIBC (µg/dL) 388.5 (6.5) 385.7 (7.1) 231.1 (3.4) 204.9 (8.9) 
TIBC (µg/dL) 527.2 (3.0) 512.8 (9.5) 402.7 (10.2) 393.7 (18.0) 
transferrin 
saturation (%)  0.26 (0.04) 0.25 (0.02) 0.43 (0.01) 0.48 (0.01) 
Table 6.5.  Oral ascorbate administration rescues H. pylori associated depletion of 
iron reserves. Total serum iron (total Fe), unsaturated iron binding capacity (UIBC), 
total iron binding capacity (TIBC), and transferrin saturation were measured following 
terminal blood collection from experimental animals.  Data were by ANOVA (p < 0.01) 
followed by Tukey’s pairwise multiple comparison test.  Measurements significantly 
different (p < 0.01) from the placebo treated group (10% sucrose) group are denoted in 
bold.  These data indicated that oral ascorbate administration is capable of rescuing H. 








 10% sucrose 
n = 5 
iron 
n = 5 
ascorbate 
n = 5 
iron/ascorbate 
n = 5 
serum ferritin 
(pg/mL) 5760 (281) 5780 (241) 9553 (363) 9781 (656) 
soluble transferrin 
receptor (pg/mL)  8979 (1158) 9214 (838) 4836 (360) 5262 (484) 
Table 6.6. Oral ascorbate supplementation is associated with reversal of iron 
reserve physiological changes observed during chronic H. pylori infection.    
Serum ferritin and soluble transferrin receptor levels were measured by quantitative 
ELISA following terminal blood collection from experimental animals.  Data were by 
ANOVA (p < 0.01) followed by Tukey’s pairwise multiple comparison test.  
Measurements significantly different (p < 0.01) from the placebo treated group (10% 
sucrose) group are denoted in bold.  These data indicate that the physiological changes 
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Chapter 7: Conclusions and future work 
7.1  Introduction 
 The major gaps in knowledge sought to be addressed by this work include 
whether chronic H. pylori infection is associated with a systemic inflammatory response, 
whether chronic H. pylori infection is associated with the development of a neuro-
inflammatory response, whether chronic H. pylori infection influences cognition, and 
whether chronic H. pylori infection is associated with iron deficiency.  These areas of 
study address fundamental gaps in not only the study of H. pylori but also provide insight 
into the potential consequences of other chronic bacterial infections.  While large-scale 
epidemiological studies have suggested links between isolated chronic bacterial 
infections and the development of systemic and neuro-inflammation few have been able 
to address aspects of causation as this study has.   
 
7.2 Major Findings 
 This work addressed several major gaps of knowledge in the study of the extra-
gastric influence of chronic H. pylori infection.  From the work, new lines of research 
remain to fully understand and characterize the impact of bacterial associated systemic 
and neuro-inflammation on cognitive and nutritional health. 
 
7.2.1 Development of a rat-based model of chronic Helicobacter pylori infection. 
 Given that H. pylori is a human-specific pathogen whose natural history of 
infection begins in early childhood and persists throughout life, the development of a rat-
based model creates a powerful tool for examining the influence of chronic H. pylori in 
the absence of clinical gastric disease.  In addition to the generation of strains of H. 
pylori adapted to infecting Sprague-Dawley rats, the following major findings were made: 
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• Chronic H. pylori infection in Sprague-Dawley rats results in consist bacterial load 
and consistent elevation of gastric inflammatory markers 
• Chronic infection in Sprague-Dawley rats is largely consistent across multiple 
strains of H. pylori  
• Eradication of active H. pylori infection in Sprague-Dawley rats results in 
inflammatory markers returning to baseline levels 
• Chronic H. pylori infection in Sprague-Dawley rats recapitulates many of 
histological changes observed during natural infection in human prior to the onset 
of clinical disease 
• The major H. pylori virulence factors VacA, cag pathogenicity island, and NapA 
are only minor players in the gastric inflammatory response to H. pylori infection 
in Sprague-Dawley rats 
 
Altogether, these findings support the use of this animal model as a better analog 
to natural human infection than was previously available in the field.  The identification of 
the tissue specific changes associated with chronic infection prior to the onset of clinical 
disease indicates the potential for this animal model to be utilized for addressing the 
early stages of H. pylori infection which remain poorly characterized. 
 
7.2.2 Systemic inflammatory response to chronic Helicobacter pylori infection.  
 Given that gastric H. pylori infection results in prolonged activation of the 
inflammatory response of the immune system, it was predicted that chronic H. pylori 
infection would be associated with a systemic inflammatory response.  In evaluation of 
the association between chronic H. pylori infection and systemic inflammation the 
following major findings were made: 
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• Chronic H. pylori infection is associated with elevated inflammatory markers in 
the liver, spleen, and plasma 
• The elevated levels of systemic inflammatory markers are largely consistent 
across multiple strains of H. pylori 
• Eradication of active H. pylori infection results in inflammatory markers returning 
to baseline levels 
• H. pylori associated systemic inflammation is mild in comparison to systemic 
inflammation associated with administration of E. coli derived LPS 
• Administration of heat killed H. pylori or innocuous bacteria does not result in a 
systemic inflammatory response consist with that observed during chronic H. 
pylori infection 
• Gastritis induced chemically does not result in a systemic inflammatory response 
consistent with that observed during chronic H. pylori infection 
• Absence of T cell populations abrogates H. pylori associated systemic 
inflammation 
• Chronic H. pylori infection is associated with polarization of the Th1:Th2 ratio 
toward pro-inflammatory Th1 populations, but also associated with polarization of 
the Th17:Treg ratio toward tolerogenic Treg populations 
• The major H. pylori virulence factors VacA, cag pathogenicity island, and NapA 
are only minor players in the systemic inflammatory response to H. pylori 
infection in Sprague-Dawley rats 
 
Altogether, these findings support a model by which gastric infection by H. pylori 
results in development of a systemic inflammatory response.  These findings support the 
hypotheses put forward in epidemiological studies which have found an association 
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between H. pylori seropositivity and elevated levels of circulating inflammatory markers.  
Furthermore, these studies indicate that H. pylori associated systemic inflammation 
resolves following eradication of active infection, indicating the H. pylori infection is 
indeed the etiological factor for the observed elevation in systemic inflammatory 
markers.  Finally, these findings suggest that T cell populations are key players in the 
development of H. pylori associated systemic inflammation. 
 
7.2.3 Neuro-inflammatory response to chronic Helicobacter pylori infection. 
 Given that chronic H. pylori infection was associated with a systemic 
inflammatory response, it was hypothesized that H. pylori may contribute to the 
development of neuro-inflammation.  In evaluation of the neuro-inflammatory response 
to chronic H. pylori infection, the following major findings were made: 
• Chronic H. pylori infection is associated with elevated inflammatory markers in 
both the hippocampus and the cerebellum 
• The neuro-inflammatory response associated with H. pylori infection is consistent 
across multiple strains of H. pylori  
• Eradication of active H. pylori infection results in inflammatory markers returning 
to baseline levels 
• H. pylori associated neuro-inflammation is mild in comparison to that observed 
following systemic administration of LPS 
• Gastritis that is chemically induced does not result in neuro-inflammation 
• Absence of T cell populations is associated with an absence of a neuro-
inflammatory response during active H. pylori infection 
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• Inhibition of the systemic inflammatory response by indomethacin anti-
inflammatory blockade prevent the develop of H. pylori associated inflammation 
at all levels 
• The major H. pylori virulence factors VacA, cag pathogenicity island, and NapA 
are only minor players in the neuro-inflammatory response to H. pylori infection in 
Sprague-Dawley rats 
Altogether, these findings support a model by which the immunological response 
to chronic H. pylori generates chronic, low-grade neuro-inflammation.  Furthermore, that 
active H. pylori infection is needed to both develop and maintain the observed elevation 
of neuro-inflammatory markers.  Finally, these studies suggest that the systemic 
inflammatory response plays a key role in the development of H. pylori associated 
neuro-inflammation. 
  
7.2.4 Influence of chronic Helicobacter pylori infection on cognition. 
 As neuro-inflammation has been linked to the development of cognitive 
impairment, it was hypothesized that chronic H. pylori infection may be associated with 
the development of cognitive deficits.  In evaluation of the influence of chronic H. pylori 
infection the following major findings were made: 
• Chronic H. pylori infection is not associated with anhedonia 
• Chronic H. pylori infection is not associated with direct impairment of 
hippocampal mediated spatial memory 
• Chronic H. pylori is associated with impairment of performance of learning 
memory and behavioral flexibility 
• H. pylori associated impairment of learning memory and behavioral flexibility are 




Altogether, these findings suggest that chronic H. pylori infection is associated 
with detrimental cognitive effects.  These effects influence learning memory and 
behavioral flexibility, suggesting perturbations in pre-frontal cortex mediated cognition.  
Furthermore, these effects persist even after eradication of active H. pylori infection, 
suggesting that these detrimental cognitive effects may be permanent. 
 
7.2.5 Helicobacter pylori associated iron deficiency. 
 Previous epidemiological studies have suggested that H. pylori may be an 
etiological factor in the development of idiopathic iron deficiency anemia.  However, 
systematic attempts to determine if H. pylori is truly a causative agent of these 
association and the mechanism by which iron deficiency develops during chronic H. 
pylori infection have been lacking.  To address these issues, the rat-based model of 
chronic H. pylori infection developed in this work was utilized.  By use of this animal 
model, the following major findings were made: 
• Chronic H. pylori infection is associated with a significant decrease in 
hemoglobin and hematocrit 
• Eradication of active H. pylori infection leads to a rapid normalization of 
hemoglobin and hematocrit 
• Chronic H. pylori infection is associated with changes to red blood cell 
indices, serum iron, transferrin saturation, serum ferritin, and serum soluble 
transferrin receptor levels that are consistent with iron malabsorption 
• H. pylori associated iron deficiency is refractory to oral iron supplementation 
• Oral administration of high dose ascorbic acid rescues H. pylori associated 




Altogether, these findings support a model by which chronic H. pylori infection is 
associated with the development of iron deficiency and that associated iron deficiency 
rapidly resolves following eradication of active infection, indicating that H. pylori infection 
is the likely etiological agent.  Furthermore, these findings suggest that H. pylori 
associated iron deficiency is malabsorptive in nature and that the physiological cause of 
the malabsorption is modulation of gastric ascorbic acid levels during chronic H. pylori 
infection. 
 
7.3  Conclusion 
 The completion of the aforementioned studies has added new illumination into 
the extra-gastric influences of chronic H. pylori infection.  In particular, these studies 
support a model by which chronic gastric infection by H. pylori is able to induce the 
development of low-grade systemic and neuro-inflammation.  Furthermore, these extra-
gastric manifestations of inflammation have been associated with detrimental effects of 
pre-frontal cortex mediated cognition in the experimental animal population.  Strikingly, 
H. pylori associated cognitive detriments do not resolve following eradication of active 
infection in the time frame evaluated in these studies, suggesting that these effects may, 
in fact, be permanent.  Current standards of medical care in pediatric populations 
recommend eradication of active H. pylori infection only in the presence of active ulcer 
disease.  As such, the findings of these studies indicate that such guidelines may place 
pediatric populations at elevated risk both due to risk of overt detrimental cognitive 
effects but also due to the elevated risk associated with the development of a chronic 
inflammatory state.  The additional findings that chronic H. pylori infection is an 
etiological agent of iron deficiency further places these pediatric populations at risk as 
iron deficiency during childhood development is a known risk factor in many long term 
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pathophysiological conditions.  As such, these studies lay the necessary groundwork for 
expanding these experiments into human populations where they hold the promise to 
change public health practices in meaningful ways. 
 
7.4 Future Work 
 In addition to addressing several important gaps in knowledge in the study of the 
extra-gastric influence of chronic H. pylori infection, this work identified numerous future 
studies to be pursued. 
 
7.4.1 Systemic inflammatory response to chronic Helicobacter pylori infection. 
 While T cell populations were shown to be key players in the development of H. 
pylori associated systemic inflammation, which specific T cells mediate and drive the 
systemic inflammation in response to chronic H. pylori infection remains unknown.  For 
future work, isolation of the contribution of these immune cell sub-population needs to be 
evaluated.  Furthermore, as the studies were conducted in rats, a non-natural host to H. 
pylori, validation of the findings of a systemic inflammatory response in humans is 
needed. 
 
7.4.2 Neuro-inflammatory response to chronic Helicobacter pylori infection. 
 The mechanism by which chronic H. pylori infection induces a neuro-
inflammatory response remains unknown.  For future work, evaluation of the contribution 
of the major pathways by which systemic pro-inflammatory signaling reaches the central 
nervous system needs to be evaluated.  Additionally, the potential role of microglial cell 
populations, which serve as the major immune effectors of the central nervous system, 
in the development and maintenance of H. pylori associated neuro-inflammation needs 




7.4.3 Influence of chronic Helicobacter pylori infection on cognition. 
 The mechanism by which chronic H. pylori infection negatively influences 
cognition remains an open question.  For future work, further evaluation of the aspects of 
cognition impacted by chronic H. pylori infection is needed.  Additionally, evaluation of 
whether establishment of chronic H. pylori during adulthood, after completion of 
cognitive development, also results in cognitive deficits is needed.  Finally, the influence 
of chronic H. pylori infection on human cognition is in need of study.  
 
7.4.4 Helicobacter pylori associated iron deficiency. 
 Ascorbic acid was found to be capable of rescuing H. pylori associated iron 
deficiency.  However, the manner in which H. pylori infection modulates natural gastric 
ascorbic acid levels remains unknown.  Evaluation of the pathophysiological processes 
that result in loss of gastric ascorbic acid needs to be evaluated.  Additionally, as current 
standards of care in pediatric patients chronically infected with H. pylori recommend 
against eradication therapy in the absence of active ulcer disease, the application of oral 
ascorbic acid supplementation for management of H. pylori associated iron deficiency in 
pediatric populations is in need of study. 
 
